🏷

Classifications

Harrison's Part

👪

Inheritance

2

X-linked HP:0001417

X-linked recessive transmission of L1CAM-related disease (HSAS and the wider L1 syndrome spectrum), and of AP1S2-related Fried/Pettigrew syndrome. Affected males inherit the variant from a heterozygous mother; heterozygous females are usually unaffected but may show typically mild manifestations.

X-linked inheritance

Show evidence (1 reference)

PMID:20301657 SUPPORT Human Clinical

"Males who inherit the L1CAM pathogenic variant will be affected; females who inherit the pathogenic variant will be heterozygotes and will usually not be affected but may have a range of (typically mild) clinical manifestations."

GeneReviews statement of the X-linked transmission pattern and of female heterozygote expression.

Autosomal Recessive HP:0000007

Biallelic transmission of CCDC88C (HYC1), MPDZ (HYC2), WDR81 (HYC3) and CRB2. Several index families were consanguineous, and the disease is typically severe with prenatal presentation.

Autosomal recessive inheritance

Show evidence (1 reference)

PMID:23240096 SUPPORT Human Clinical

"We have identified a family in which severe congenital hydrocephalus of the communicating type follows an autosomal recessive mode of inheritance."

Direct statement of autosomal recessive segregation in a molecularly solved congenital hydrocephalus family.

◆

Subtypes

8

X-linked hydrocephalus with stenosis of the aqueduct of Sylvius (L1CAM / L1 syndrome) MONDO:0010611

L1CAM hgnc:6470 {'name': 'X-linked'}

The severe end of the L1CAM-related L1 syndrome spectrum (which also includes MASA syndrome / X-linked complicated spastic paraplegia type 1 and X-linked complicated corpus callosum agenesis). Affected males are born with severe hydrocephalus, adducted thumbs and spasticity, and hypoplasia or aplasia of the corticospinal tracts is near-constant at autopsy. It is the single most frequently identified monogenic cause of otherwise isolated congenital hydrocephalus. Note the phenotypic overlap trap: callosal abnormality, aqueductal stenosis and adducted thumbs are all seen in L1CAM-negative hydrocephalus too, so none of them confirms or excludes the diagnosis.

Show evidence (2 references)

PMID:20301657 SUPPORT Human Clinical

"Males with HSAS are born with severe hydrocephalus, adducted thumbs, and spasticity; intellectual disability is severe."

GeneReviews statement of the defining HSAS clinical triad and its severity.

PMID:34092257 SUPPORT Human Clinical

"Pathogenic L1CAM variants are responsible for a wide phenotypic spectrum, X-linked hydrocephalus with stenosis of the aqueduct of Sylvius (AS) being the most common genetic form, with a prevalence of 1:30,000 and accounting for approximately 5–10% of males with non-syndromic congenital hydrocephalus."

Establishes HSAS as the most common genetic form and quantifies its share of non-syndromic congenital hydrocephalus in males.

Hydrocephalus, nonsyndromic, autosomal recessive 1 (CCDC88C) MONDO:0009360

CCDC88C hgnc:19967 {'name': 'Autosomal Recessive'}

Autosomal recessive congenital hydrocephalus caused by biallelic loss of CCDC88C, which encodes DAPLE, a Dishevelled-binding regulator of non-canonical Wnt signalling and of ependymal cell planar polarity. Fetal neuropathology shows multifocal atresia-forking of the aqueduct of Sylvius and of the central canal of the medulla, periventricular neuronal heterotopias and choroid plexus hydrops — i.e. a developmental malformation of the ependymal-lined channels rather than a simple mechanical plug.

Show evidence (2 references)

PMID:21031079 SUPPORT Human Clinical

"Via positional cloning in a consanguineous family with autosomal recessive hydrocephalus we have now identified a homozygous splice site mutation in the CCDC88C gene as a novel cause of a complex hydrocephalic brain malformation."

The original gene-discovery report establishing biallelic CCDC88C loss as a cause of autosomal recessive non-syndromic hydrocephalus.

PMID:34092257 SUPPORT Human Clinical

"In both fetuses, brain lesions consisted of multifocal atresia-forking along the aqueduct of Sylvius and the central canal of the medulla, periventricular neuronal heterotopias and choroid plexus hydrops."

Defines the neuropathological signature of the CCDC88C subtype in human fetal material.

Hydrocephalus, nonsyndromic, autosomal recessive 2 (MPDZ) MONDO:0014085

MPDZ hgnc:7208 {'name': 'Autosomal Recessive'}

Severe autosomal recessive congenital hydrocephalus caused by biallelic truncating variants in MPDZ (MUPP1), a multi-PDZ scaffold of apical tight junctions that binds DAPLE. Unlike the classic aqueductal-obstruction picture, the index families were described as communicating hydrocephalus, and mouse work attributes the mechanism to hyperpermeability of the choroid plexus epithelial barrier rather than to a mechanical block.

Show evidence (2 references)

PMID:23240096 SUPPORT Human Clinical

"We have identified a family in which severe congenital hydrocephalus of the communicating type follows an autosomal recessive mode of inheritance."

Establishes the autosomal recessive, communicating character of MPDZ-related congenital hydrocephalus in the index family.

PMID:23240096 SUPPORT Human Clinical

"Direct sequencing of these genes revealed a truncating mutation in MPDZ, encoding a tight junction protein."

Identifies the causal gene and its tight-junction protein product, the basis of the barrier-permeability mechanism curated for this subtype.

Hydrocephalus, congenital, 3, with brain anomalies (WDR81) MONDO:0054794

WDR81 hgnc:26600 {'name': 'Autosomal Recessive'}

Autosomal recessive congenital hydrocephalus with additional brain anomalies attributed to biallelic WDR81 variants. Curated here as a recognized member of the non-syndromic autosomal recessive series (HYC1/HYC2/HYC3) for completeness of the subtype axis; the entry does not curate a WDR81-specific mechanism chain, because the mechanistic literature is thinner than for CCDC88C and MPDZ.

Show evidence (1 reference)

PMID:39135208 SUPPORT Other

"the 4 genes currently associated with CH (two X-linked genes L1CAM and AP1S2, two autosomal recessive MPDZ and CCDC88C)"

Recorded to make the boundary of the classical four-gene set explicit. WDR81 sits outside it, which is why this subtype is curated for series completeness on the strength of the MONDO disease-series-by-gene axiom for MONDO:0054794 rather than on a primary gene-discovery snippet this entry has verified. Evidence source is OTHER (review).

Hydrocephalus secondary to myelomeningocele with Chiari II malformation

Hydrocephalus complicating open neural tube defect. The great majority of infants undergoing myelomeningocele repair carry a diagnosis of hydrocephalus. Under the McLone-Knepper unified theory the hindbrain deformity itself is a downstream consequence of the open neural tube: fluid and pressure fail to accumulate in the embryonic ventricular system, the posterior fossa stays small, and the hindbrain is displaced — which then obstructs CSF egress. This subtype is a comorbid complication of myelomeningocele, and cross-references but does not absorb the separate spina bifida cystica disease entity.

Show evidence (1 reference)

PMID:31574479 SUPPORT Human Clinical

"A weighted total of 10,627 inpatient MMC repairs were documented in the NIS, 8233 (77.5%) of which had documented hydrocephalus"

Nationwide inpatient data quantifying how consistently hydrocephalus accompanies myelomeningocele repair.

Hydrocephalus associated with Dandy-Walker malformation MONDO:0017110

Hydrocephalus accompanying the Dandy-Walker malformation (vermian hypoplasia, cystic dilatation of the fourth ventricle, enlarged posterior fossa). The obstruction is distal — at the level of the fourth ventricle and its outflow tracts — rather than at the aqueduct, and a single shunt controlling both ventricle and cyst is generally effective. Outcome is governed more by the associated malformations and the degree of vermian involvement than by the hydrocephalus itself.

Show evidence (2 references)

PMID:21928031 SUPPORT Human Clinical

"Among therapeutical strategies, single shunting (ventriculo-peritoneal or cyst-peritoneal shunts) appears effective in the control of both ventricle and cyst size."

Characterizes the CSF-diversion behaviour specific to the Dandy-Walker subtype, where the ventricle and the posterior fossa cyst behave as one compartment.

PMID:21928031 SUPPORT Human Clinical

"Prognosis and intellectual outcome mostly depend on the presence of associated malformations, the degree of vermian malformation and the adequate control of hydrocephalus."

Supports curating outcome in this subtype as malformation-determined rather than determined by ventricular size alone.

Post-haemorrhagic hydrocephalus (perinatal/prenatal intraventricular haemorrhage) NCIT:C116383

Progressive ventricular dilatation following intraventricular haemorrhage, most often germinal matrix haemorrhage in the preterm infant but also following cryptic prenatal intraventricular microhaemorrhage, which can present as apparently idiopathic congenital hydrocephalus. Mechanistically this subtype is not purely a reabsorption failure: intraventricular blood triggers a TLR4-NF-kB inflammatory response in the choroid plexus epithelium that drives SPAK-NKCC1-dependent CSF hypersecretion.

Show evidence (2 references)

PMID:24932902 SUPPORT Human Clinical

"The most common cause of acquired hydrocephalus in infants is hemorrhage, most often as a consequence of prematurity."

Establishes haemorrhage of prematurity as the dominant acquired cause in this age group.

PMID:24932902 SUPPORT Human Clinical

"Thus, some apparently idiopathic hydrocephalus may in fact be due to unrecognized prenatal intraventricular hemorrhage."

Justifies curating post-haemorrhagic hydrocephalus as a subtype of *congenital* hydrocephalus and not only as a postnatal acquired entity.

Post-infectious congenital hydrocephalus NCIT:C116384

Hydrocephalus following intrauterine or neonatal infection. Intrauterine infection with cytomegalovirus, Toxoplasma gondii, lymphocytic choriomeningitis virus and enterovirus has been associated with hydrocephalus, and neonatal ventriculitis is the dominant cause of infant hydrocephalus in sub-Saharan Africa, where post-infectious disease drives much of the global case burden. Curated as a subtype because these forms are frequently present at birth or in early infancy and are indistinguishable at presentation from the developmental forms.

Show evidence (2 references)

PMID:29262276 SUPPORT Human Clinical

"Hydrocephalus in this region is most commonly postinfectious, occurring after neonatal ventriculitis."

Establishes post-infectious hydrocephalus after neonatal ventriculitis as the predominant form in the region carrying the largest share of global infant hydrocephalus.

PMID:29701543 SUPPORT Human Clinical

"The high crude birth rate, greater proportion of patients with postinfectious etiology, and higher incidence of NTDs all contribute to a case volume in low- and middle-income countries that outweighs that in high-income countries by more than 20-fold."

Quantifies the contribution of the post-infectious subtype to the global distribution of paediatric hydrocephalus.

◈

Mechanistic Hypotheses

2

CSF Dynamics (Obstruction, Hypersecretion and Absorption Failure) Model

csf_dynamics_model CANONICAL

Evidence balance 1 support

The classical and still-dominant reading: hydrocephalus is an active distension of the ventricular system caused by physical or functional obstruction of CSF flow between its point of production and its point of absorption, with post-haemorrhagic disease adding a hypersecretory component. Under this model the ventricular enlargement is the primary lesion, raised intracranial pressure is its mediator, and CSF diversion is mechanistically curative of the fluid problem.

Scope boundary: this model is not in dispute for post-haemorrhagic, post-infectious and frankly obstructive disease. What the alternative hypothesis disputes is its sufficiency for the sporadic and Mendelian developmental forms.

Pathograph links

L1CAM-Mediated Neural Adhesion and Axon Guidance Failure -> Aqueductal Stenosis, Atresia and Forking INDIRECT UNKNOWN INTERMEDIATES L1CAM-dependent malformation of the periaqueductal neuroepithelium narrows or occludes the aqueduct.

Neuroepithelial Planar Polarity and Apical Constriction Failure -> Aqueductal Stenosis, Atresia and Forking DIRECT Failure of neuroepithelial polarity and junctional integrity along the aqueduct and central canal produces atresia-forking of those channels.

Ependymal Motile Cilia Beat Dysfunction and Loss of Directional CSF Flow -> Progressive Ventricular Dilatation and Raised Intracranial Pressure INDIRECT UNKNOWN INTERMEDIATES Slowed and disorganized intraventricular CSF movement contributes to net ventricular fluid accumulation. Curated as indirect and hypothesis-scoped: the quantitative contribution of ciliary flow to human ventricular volume is contested.

Aqueductal Stenosis, Atresia and Forking -> Progressive Ventricular Dilatation and Raised Intracranial Pressure DIRECT Proximal obstruction at the aqueduct prevents egress of CSF from the lateral and third ventricles, which distend.

Neural Tube Defect with Chiari II Hindbrain Herniation and Small Posterior Fossa -> Progressive Ventricular Dilatation and Raised Intracranial Pressure INDIRECT UNKNOWN INTERMEDIATES Caudal displacement of the hindbrain into a small posterior fossa obstructs fourth ventricular outflow and CSF passage at the foramen magnum.

Intraventricular Haemorrhage and Choroid Plexus Inflammatory Activation -> Choroid Plexus CSF Hypersecretion DIRECT TLR4-NF-kB activation in the choroid plexus epithelium drives the secretory phenotype at the next node.

Intraventricular Haemorrhage and Choroid Plexus Inflammatory Activation -> Impaired CSF Absorption and Perivascular Clearance INDIRECT UNKNOWN INTERMEDIATES Blood products in the subarachnoid space are the classical route to obliterative arachnoiditis and impaired CSF translocation, the reading that post-haemorrhagic hydrocephalus was historically attributed to.

Choroid Plexus CSF Hypersecretion -> Progressive Ventricular Dilatation and Raised Intracranial Pressure DIRECT A sustained increase in CSF production against unchanged clearance raises net intraventricular fluid volume.

Impaired CSF Absorption and Perivascular Clearance -> Progressive Ventricular Dilatation and Raised Intracranial Pressure INDIRECT UNKNOWN INTERMEDIATES Failure to translocate CSF into the venous and lymphatic circulations raises the steady-state intracranial CSF volume without any point of intraventricular obstruction — the communicating pattern.

Progressive Ventricular Dilatation and Raised Intracranial Pressure -> Neurodevelopmental Impairment and Periventricular White Matter Injury INDIRECT UNKNOWN INTERMEDIATES Sustained ventricular distension and raised pressure compress and stretch the periventricular white matter.

Progressive Ventricular Dilatation and Raised Intracranial Pressure -> Increased Intracranial Pressure DIRECT Under the CSF-dynamics model, distension against a fixed cranial volume raises intracranial pressure. The dysgenesis arm does not require this step, which is why the edge is hypothesis-scoped.

Show evidence (1 reference)

PMID:24932902 SUPPORT Human Clinical

"Our preferred definition is that proposed as part of the International Hydrocephalus Working Group, which describes “an active distension of the ventricular system...resulting from inadequate passage of cerebrospinal fluid from its point of production within the cerebral ventricles to its point..."

The consensus definition on which the CSF-dynamics model rests.

Neural Stem Cell Fate Disruption and Fetal Brain Dysgenesis Model

neural_stem_cell_dysgenesis_model EMERGING

Evidence balance 2 support

The competing reading from large trio exome cohorts: in a substantial fraction of sporadic congenital hydrocephalus the causal lesion is genetic disruption of early brain development — ventricular-zone neural stem cell fate and prenatal neuro-gliogenesis — rather than impaired CSF dynamics. Ventriculomegaly is then a consequence of the dysgenesis, which predicts that CSF diversion will relieve pressure without restoring neurodevelopmental trajectory. Curated as EMERGING, not CANONICAL: the evidence is strong human genetics with a stated mechanistic inference, and it applies to a subset of patients, not to the disease as a whole.

The two hypotheses are not mutually exclusive at the level of the disease — they may both be true of different patients — but they are mutually exclusive at the level of an individual case, and they make different predictions about what shunting can achieve. That is why they are curated as two hypothesis groups over a shared central effector node rather than as one blended chain.

Pathograph links

Genetic Disruption of Ventricular Zone Neural Stem Cell Fate -> Impaired Fetal Neuro-Gliogenesis and Brain Dysgenesis DIRECT Loss of normal neural stem cell fate regulation in the ventricular zone distorts the prenatal neuro-gliogenic programme that builds the periventricular brain.

Impaired Fetal Neuro-Gliogenesis and Brain Dysgenesis -> Progressive Ventricular Dilatation and Raised Intracranial Pressure INDIRECT UNKNOWN INTERMEDIATES Under the dysgenesis reading the ventricle enlarges because the periventricular parenchyma is deficient, so the association with raised pressure is variable rather than obligatory.

Impaired Fetal Neuro-Gliogenesis and Brain Dysgenesis -> Neurodevelopmental Impairment and Periventricular White Matter Injury DIRECT Under this model the neurodevelopmental deficit is primary and shares its origin with the ventriculomegaly, rather than being caused by it.

Impaired Fetal Neuro-Gliogenesis and Brain Dysgenesis -> Intellectual Disability INDIRECT UNKNOWN INTERMEDIATES Cognitive outcome on this arm is a consequence of the dysgenesis itself, which is why it is not expected to be rescued by pressure relief alone.

Show evidence (2 references)

PMID:33077954 SUPPORT Human Clinical

"These data implicate genetic disruption of early brain development, not impaired CSF dynamics, as the primary pathomechanism of a significant number of patients with sporadic CH."

The explicit statement of the alternative pathomechanism, in direct contrast to the canonical model.

PMID:29983323 SUPPORT Human Clinical

"These results implicate impaired neurogenesis (rather than active CSF accumulation) in the pathogenesis of a subset of CH patients, with potential diagnostic, prognostic, and therapeutic ramifications."

Independent cohort reaching the same conclusion and, importantly, restricting it to a subset of patients.

?

Discussions and Knowledge Gaps

4

Does ependymal motile cilia dysfunction cause human congenital hydrocephalus, or is the mouse ciliopathy phenotype a species-specific result that does not translate to the human fetal brain?

HUMAN MODEL MISMATCH OPEN gap_cilia_hypothesis_human_translatability

Attached to

pathophysiology#Ependymal Motile Cilia Beat Dysfunction and Loss of Directional CSF Flow pathophysiology#Neuroepithelial Planar Polarity and Apical Constriction Failure

This is a HUMAN_MODEL_MISMATCH rather than a KNOWLEDGE_GAP: the evidence exists and is strong, but it is murine, and its translational validity is precisely what is disputed. Three mismatches apply. Human ventriculomegaly typically arises in utero, before ependymal cilia have functionally matured, so cilia cannot be the primary propeller of CSF at the time the phenotype begins. Human motile ciliopathies — primary ciliary dyskinesia — infrequently cause hydrocephalus, in contrast to the mouse models on which the hypothesis was built. And ciliary genes have functions in signalling and neural stem cell fate beyond generating flow, so a hydrocephalus phenotype in a ciliary-gene mutant may report altered neurodevelopment rather than lost flow — which would move the finding onto the dysgenesis hypothesis arm of this entry rather than the CSF-dynamics arm. Curators should not upgrade the module-conformance link at these nodes into a claim that cilia-driven flow determines human fetal ventricular volume.

Proposed experiments

Timing of ependymal ciliary maturation relative to onset of ventriculomegaly in human fetal brain

exp_ch_cilia_human_fetal_flow_timing

In human fetal brain across the gestational window in which ventriculomegaly is first detectable by ultrasound (14-20 weeks), stage ependymal multiciliation and ciliary beat competence against the timing of ventricular enlargement in the same specimens, and compare cases carrying ciliary-gene variants against cases carrying neural-stem-cell-fate gene variants. The discriminating prediction is that ventricular enlargement preceding functional ciliary maturation cannot be caused by lost cilia-generated flow.

Systematic ventricular volumetry in a genotyped primary ciliary dyskinesia cohort

exp_ch_pcd_cohort_ventricular_volume

Measure ventricular volume systematically, rather than by clinical referral, in a genotyped primary ciliary dyskinesia cohort stratified by the affected axonemal component, to establish whether subclinical ventriculomegaly is common in human motile ciliopathy and merely under-ascertained, or genuinely rare as the clinical literature implies.

Show evidence (3 references)

PMID:36341771 REFUTE Other

"Second, we highlight that in contrast to mouse models, motile ciliopathies infrequently cause hydrocephalus in humans."

The core mismatch: the human phenotype does not follow the mouse phenotype, which is what makes this a translational-validity question rather than an evidence gap.

PMID:36341771 REFUTE Other

"First, we discuss neuroembryology and physiology data that do not support a role for ependymal cilia as the primary propeller of CSF movement across the ventricles in the human brain, particularly during in utero development prior to the functional maturation of ependymal cilia."

The developmental-timing argument: the cilia are not yet functional when human congenital ventriculomegaly begins.

PMID:36341771 SUPPORT Other

"Finally, we postulate that certain cases of hydrocephalus associated with ciliary gene mutations may arise not necessarily just from loss of cilia-generated CSF flow but also from altered neurodevelopment, given the potential functions of ciliary genes in signaling and neural stem cell fate..."

Proposes the reassignment of ciliary-gene hydrocephalus to the neurodevelopmental arm, which is why this discussion is attached to the ciliary nodes rather than resolved against them.

Do disturbances of perivascular (glymphatic) and cranial-nerve-sheath lymphatic CSF efflux contribute causally to human congenital hydrocephalus, or is impaired absorption in this disease adequately described by failure at the arachnoid granulations?

KNOWLEDGE GAP OPEN gap_csf_absorption_glymphatic_role_in_hydrocephalus

Attached to

pathophysiology#Impaired CSF Absorption and Perivascular Clearance

This is a KNOWLEDGE_GAP, not a HUMAN_MODEL_MISMATCH: the human evidence is absent rather than contradicted by a model. Up to a third of CSF is known to leave the skull along cranial nerve sheaths into the lymphatic system, and paravascular CSF-parenchyma exchange is established physiology, but the source literature states plainly that whether disturbances of that efflux route participate in the pathogenesis of human hydrocephalus is not known. This entry therefore declines to declare conformance to the glymphatic module at all: conformance is a structural assertion tooling reads as satisfied, and the anatomical route is established while its causal role in human hydrocephalus is not. The module's own unresolved convective-versus-diffusive controversy is a second reason to withhold the link rather than a caveat attached to a declared one. This discussion is the artifact that records the relationship instead. Resolving this matters practically: if the lymphatic and perivascular routes are causal contributors, communicating congenital hydrocephalus acquires a therapeutic target that CSF diversion does not address.

Proposed experiments

Non-invasive assessment of perivascular and lymphatic CSF efflux in infant hydrocephalus

exp_ch_perivascular_efflux_infant_tracer

In infants with communicating congenital hydrocephalus versus age-matched controls, assess perivascular and cranial-nerve-sheath lymphatic efflux with non-invasive imaging (intrathecal-contrast-free MRI surrogates plus cervical lymphatic imaging), acquired before and after CSF diversion. Measuring both before and after diversion is what separates a causal absorption deficit from a consequence of the distended ventricle — the cause-versus-consequence ambiguity the source review flags for CSF pulsatility.

Show evidence (3 references)

PMID:24932902 SUPPORT Human Clinical

"but whether they play a role in the pathogenesis of human hydrocephalus is not yet known"

The explicit statement of the gap, made by the review that introduces the lymphatic efflux route into the hydrocephalus literature.

PMID:24932902 SUPPORT Human Clinical

"Altered pulsatility of CSF flow has repeatedly been described in conjunction with human hydrocephalus"

Records the human observation adjacent to this gap. The source's own caveat is quoted separately in the next evidence item rather than paraphrased here.

PMID:24932902 SUPPORT Human Clinical

"but whether it is cause or consequence remains unclear"

The source's cause-versus-consequence caveat on that observation, quoted as its own item because the inline numeric citation marker between the two clauses cannot be carried in a single verbatim snippet.

Does inflammation-driven choroid plexus CSF hypersecretion occur in human post-haemorrhagic hydrocephalus, or is the TLR4-SPAK-NKCC1 axis a rodent finding whose magnitude and therapeutic relevance in the preterm human infant are unmeasured?

HUMAN MODEL MISMATCH OPEN gap_csf_hypersecretion_human_translatability

Attached to

pathophysiology#Choroid Plexus CSF Hypersecretion pathophysiology#Intraventricular Haemorrhage and Choroid Plexus Inflammatory Activation

This is a HUMAN_MODEL_MISMATCH for the same reason as the cilia discussion: the evidence is strong and mechanistically complete — including loss-of-function rescue — but it is entirely rat. No human measurement of post-haemorrhagic CSF secretion rate is curated here. The mismatch matters because this node carries the entry's only pharmacological target: if human post-haemorrhagic hydrocephalus is dominated by impaired absorption rather than by hypersecretion, then bumetanide or SPAK inhibition would be treating a mechanism that is not rate-limiting in patients, and the observed benefit of choroid plexus cauterization would need a different explanation. The entry states the rodent provenance in the node description rather than letting the SPAK-NKCC1 chain read as established human physiology.

Proposed experiments

Direct measurement of CSF secretion rate in preterm infants with post-haemorrhagic ventricular dilatation

exp_ch_human_phh_csf_secretion_rate

In preterm infants already undergoing CSF drainage for post-haemorrhagic ventricular dilatation, measure CSF production rate directly from drainage volumes under controlled pressure, comparing infants with recent intraventricular haemorrhage against infants drained for non-haemorrhagic indications. Pair with choroid plexus inflammatory markers and phospho-NKCC1 in the drained CSF. The discriminating prediction is that the haemorrhagic group shows a raised production rate; if production is equal and only clearance differs, the rodent axis does not carry to humans.

Show evidence (1 reference)

PMID:28692063 SUPPORT Model Organism

"PHH is classically attributed to primary impairments in CSF reabsorption, but little experimental evidence supports this concept. In contrast, the potential contribution of CSF secretion to PHH has received little attention."

The authors' own framing: neither the classical absorption account nor the secretion account rests on human experimental evidence, which is precisely the open question recorded here.

For an individual infant with congenital hydrocephalus, what evidence assigns the case to the CSF-dynamics model versus the neural stem cell dysgenesis model, and does that assignment predict the neurodevelopmental benefit of CSF diversion?

OPEN QUESTION OPEN gap_ch_dysgenesis_versus_dynamics_case_assignment

Attached to

pathophysiology#Progressive Ventricular Dilatation and Raised Intracranial Pressure pathophysiology#Impaired Fetal Neuro-Gliogenesis and Brain Dysgenesis

The two mechanistic hypotheses curated in this entry are not merely theoretical alternatives — they predict different things about what shunting can achieve, and the persistence of ventriculomegaly and poor neurodevelopmental outcome in some post-surgical patients is the clinical observation that motivated the dysgenesis model. What is missing is a prospective test: whether genotype (a burdened neural-stem-cell-fate gene versus an obstructive or haemorrhagic aetiology) predicts the neurodevelopmental response to CSF diversion. Until that exists, curators should not collapse the two hypothesis groups, and should not present genotype as a treatment-selection criterion.

Proposed experiments

Genotype-stratified prospective cohort of neurodevelopmental outcome after CSF diversion

exp_ch_genotype_stratified_shunt_outcome

Enrol infants undergoing first CSF diversion for congenital hydrocephalus with trio exome or genome sequencing at baseline, and follow standardized neurodevelopmental outcome to at least 24 months. Pre-specify the comparison of patients carrying damaging variants in neural-stem-cell-fate genes against those with obstructive, haemorrhagic or infectious aetiology. The dysgenesis model predicts that pressure relief is achieved in both groups while neurodevelopmental trajectory improves only in the second.

Show evidence (1 reference)

PMID:33077954 SUPPORT Human Clinical

"The poor neurodevelopmental outcomes and persistence of ventriculomegaly in some post-surgical patients highlight our limited knowledge of disease mechanisms."

States the unexplained clinical observation that this open question is asking to resolve.

⚙

Pathophysiology

12

Genetic Disruption of Ventricular Zone Neural Stem Cell Fate

Damaging de novo and transmitted variants in genes that govern the fate of ventricular-zone neural stem cells — TRIM71, SMARCC1, PTCH1 and duplication of its ligand SHH, plus a longer list emerging from larger cohorts — are found in a substantial minority of sporadic, neurosurgically treated congenital hydrocephalus. These are not CSF-handling genes: every one of them is required for neural tube development and regulates neural stem cell fate, which is what makes this arm mechanistically distinct from the obstruction arm rather than merely another route into it.

Neural Stem Cell Fate Disruption and Fetal Brain Dysgenesis Model

neural stem cell CL:0000047 radial glial cell CL:0000681

TRIM71 hgnc:32669 SMARCC1 hgnc:11104 PTCH1 hgnc:9585

neural precursor cell proliferation GO:0061351 ⚠ ABNORMAL smoothened signaling pathway GO:0007224 ⚠ ABNORMAL

brain ventricle UBERON:0004086

Downstream

Impaired Fetal Neuro-Gliogenesis and Brain Dysgenesis Loss of normal neural stem cell fate regulation in the ventricular zone distorts the prenatal neuro-gliogenic programme that builds the periventricular brain.

Show evidence (2 references)

PMID:29983323 SUPPORT Human Clinical

"Strikingly, all four genes are required for neural tube development and regulate ventricular zone neural stem cell fate."

States the convergence of the significantly burdened genes on ventricular-zone neural stem cell fate, which is the claim this node makes.

PMID:33077954 SUPPORT Human Clinical

"Through whole-exome sequencing of 381 patients (232 trios) with sporadic, neurosurgically treated CH, we found that damaging de novo mutations account for >17% of cases, with five different genes exhibiting a significant de novo mutation burden."

Quantifies the de novo mutational burden in a large sporadic cohort, establishing that this arm accounts for a substantial fraction of cases.

L1CAM-Mediated Neural Adhesion and Axon Guidance Failure

Loss-of-function variants in L1CAM remove a neural recognition molecule of the immunoglobulin superfamily required for intercellular adhesion, neuronal migration, axon guidance and fasciculation. The consequence is a set of structural malformations — corticospinal tract hypoplasia or aplasia, callosal abnormality, and obstruction of CSF flow most commonly at the aqueduct — rather than a primary defect of CSF secretion or absorption.

CSF Dynamics (Obstruction, Hypersecretion and Absorption Failure) Model

L1CAM hgnc:6470 AP1S2 hgnc:560

cell adhesion GO:0007155 ↓ DECREASED axon guidance GO:0007411 ⚠ ABNORMAL

brain UBERON:0000955

Downstream

Aqueductal Stenosis, Atresia and Forking L1CAM-dependent malformation of the periaqueductal neuroepithelium narrows or occludes the aqueduct.

Adducted Thumbs Adducted thumbs accompany L1CAM loss of function in 88% of mutation-positive autopsy subjects; the intermediates between the adhesion/guidance defect and the thumb posture are not established.

Spasticity Hypoplasia or aplasia of the corticospinal tracts, present in 98% of L1CAM-mutation-positive autopsy subjects, is the intermediate between the axon-guidance defect and the spastic phenotype.

Abnormal Corpus Callosum Morphology Failure of callosal axon guidance and fasciculation produces the callosal abnormality seen in 98% of L1CAM-mutation-positive autopsy subjects.

Show evidence (2 references)

PMID:24932902 SUPPORT Other

"The L1CAM gene product is a neural recognition molecule that plays key roles in neuronal migration and axon guidance"

States the molecular function whose loss defines this node.

PMID:24932902 SUPPORT Human Clinical

"When mutated, it gives rises to several structural malformations that obstruct CSF flow, most commonly at the level of the aqueduct"

Connects L1CAM loss of function to the obstructive malformation this node feeds, and locates the obstruction at the aqueduct.

Neuroepithelial Planar Polarity and Apical Constriction Failure

The autosomal recessive arm converges on the planar-polarity and apical constriction machinery of the ventricular neuroepithelium. CCDC88C encodes DAPLE, a Dishevelled-binding protein that contributes to ependymal planar polarity by inhibiting non-canonical Wnt signalling and that physically interacts with MPDZ (a multi-PDZ apical junction scaffold) and CRB2; the three cooperate to promote apical cell constriction during neurulation. The node is named for apical constriction rather than for junctional disruption on the strength of its own negative evidence: in the human CRB2 fetal cases, PAR-complex components and tight- and adherens-junction molecules were normally localized, so the lesion is not a generalized loss of apicobasal polarity. What it produces is frank malformation of the ependymal-lined channels (atresia and forking) with periventricular neuronal heterotopia.

CSF Dynamics (Obstruction, Hypersecretion and Absorption Failure) Model

ependymal cell CL:0000065 choroid plexus epithelial cell CL:0000706

CCDC88C hgnc:19967 MPDZ hgnc:7208 CRB2 hgnc:18688 WDR81 hgnc:26600

establishment of planar polarity GO:0001736 ⚠ ABNORMAL non-canonical Wnt signaling pathway GO:0035567 ⚠ ABNORMAL

brain ventricle UBERON:0004086

Downstream

Aqueductal Stenosis, Atresia and Forking Failure of neuroepithelial polarity and junctional integrity along the aqueduct and central canal produces atresia-forking of those channels.

Ependymal Motile Cilia Beat Dysfunction and Loss of Directional CSF Flow Rotational and translational planar polarity of ependymal basal bodies is what aligns ciliary beating; losing it decouples the cilia from a common axis even when the cilia themselves are assembled normally.

Periventricular Nodular Heterotopia Failure of the ventricular neuroepithelial surface leaves nodules of arrested neurons along the ventricular wall, observed directly in human CCDC88C fetal material.

Show evidence (5 references)

PMID:34092257 SUPPORT Human Clinical

"CCDC88C encodes the protein DAPLE which contributes to ependymal cell planar polarity by inhibiting the non-canonical Wnt signaling pathway and interacts with MPDZ and PARD3."

States the shared planar-polarity/non-canonical-Wnt module that unites the CCDC88C and MPDZ subtypes at this node.

PMID:21031079 SUPPORT Human Clinical

"CCDC88C encodes DAPLE (HkRP2), a Hook-related protein with a binding domain for the central Wnt signalling pathway protein Dishevelled."

Independent confirmation of the DAPLE-Dishevelled interaction that places this subtype in the non-canonical Wnt/planar-polarity module.

PMID:34092257 SUPPORT Model Organism

"The pathophysiology of MPDZ-linked hydrocephalus has been attributed to hyperpermeability of the choroid plexus epithelial cells in mice"

Records the MPDZ-specific barrier-permeability reading of this node; evidence is murine, which the entry does not upgrade to a human claim.

+ 2 more references

Ependymal Motile Cilia Beat Dysfunction and Loss of Directional CSF Flow

Multiciliated ependymal cells line the ventricular wall and generate directional CSF movement by coordinated ciliary beating. When intracellular and intercellular rotational alignment of the basal bodies is lost — as in compound ablation of the Dishevelled genes, the same non-canonical Wnt effectors that DAPLE regulates — the cilia are present and the cells differentiate normally, but the flow they generate is significantly slower, and hydrocephalus follows. This node is curated with an explicit caveat: the supporting mechanistic evidence is murine, human motile ciliopathies infrequently cause hydrocephalus, and the entry does not treat cilia-driven flow as the primary determinant of human fetal ventricular volume (see the HUMAN_MODEL_MISMATCH discussion).

CSF Dynamics (Obstruction, Hypersecretion and Absorption Failure) Model

ependymal cell CL:0000065

FOXJ1 hgnc:3816

cilium movement GO:0003341 ⚠ ABNORMAL cerebrospinal fluid circulation GO:0090660 ↓ DECREASED

brain ventricle UBERON:0004086

Animal models

Dishevelled compound-mutant mouse (ependymal planar polarity) Mouse recapitulates Reproduces loss of intracellular and intercellular rotational alignment of ependymal motile cilia, with measurably slower generated flow and consequent hydrocephalus.

Downstream

Progressive Ventricular Dilatation and Raised Intracranial Pressure Slowed and disorganized intraventricular CSF movement contributes to net ventricular fluid accumulation. Curated as indirect and hypothesis-scoped: the quantitative contribution of ciliary flow to human ventricular volume is contested.

Show evidence (3 references)

PMID:25043421 SUPPORT Model Organism

"Defects in ependymal (E) cells, which line the ventricle and generate cerebrospinal fluid flow through ciliary beating, can cause hydrocephalus."

States the node's core claim linking ependymal ciliary beating to CSF flow and to hydrocephalus.

PMID:25043421 SUPPORT Model Organism

"In hGFAP-Cre;Dvl1(-/-);2(flox/flox);3(+/-) mutants, E cells differentiated normally, but the intracellular and intercellular rotational alignments of ependymal motile cilia were disrupted."

Establishes that the lesion is one of ciliary alignment rather than of ependymal differentiation, which is what makes this node the downstream partner of the planar-polarity node rather than a duplicate of it.

PMID:35903173 SUPPORT Other

"Ependymal cilia protrude from ECs, and their synchronous pulsing transports CSF from the lateral ventricle to the third and fourth ventricles, and then to the subarachnoid cavity for absorption."

Review statement of the normal physiology this node perturbs. Evidence source is OTHER because the snippet is a background mechanistic statement.

Aqueductal Stenosis, Atresia and Forking

Narrowing, atresia or forking of the cerebral aqueduct is the single most common structural lesion in hydrocephalus that is otherwise confined to the brain, and it is the classic proximal obstruction. In CCDC88C-related disease the lesion is not a plug but a developmental malformation: multifocal atresia-forking, with the residual channel replaced by rosettes of ependymal cells, extending beyond the aqueduct into the central canal of the medulla. Note that aqueductal patency at autopsy does not exclude the subtype — an affected 20-week fetus in one CCDC88C family had a patent aqueduct despite MRI evidence of obstruction.

CSF Dynamics (Obstruction, Hypersecretion and Absorption Failure) Model

ependymal cell CL:0000065

cerebrospinal fluid circulation GO:0090660 ↓ DECREASED

midbrain cerebral aqueduct UBERON:0002289

Downstream

Progressive Ventricular Dilatation and Raised Intracranial Pressure Proximal obstruction at the aqueduct prevents egress of CSF from the lateral and third ventricles, which distend.

Aqueductal Stenosis The narrowed or atretic aqueduct is what is reported radiologically and at autopsy as aqueductal stenosis.

Show evidence (2 references)

PMID:24932902 SUPPORT Human Clinical

"Of patients whose clinical phenotype is characterized by hydrocephalus without additional major clinical exam findings, the majority have obstruction at the level of the aqueduct"

Establishes aqueductal obstruction as the dominant lesion site in brain-limited congenital hydrocephalus.

PMID:34092257 SUPPORT Human Clinical

"AS atresia consisted of few rosettes lined by ependymal cells"

Human fetal histology showing that the aqueductal lesion is a malformation of the ependymal-lined channel rather than a simple blockage.

Neural Tube Defect with Chiari II Hindbrain Herniation and Small Posterior Fossa

In open neural tube defects the hindbrain deformity and the hydrocephalus share a single embryological origin. Under the McLone-Knepper unified theory the open neural tube prevents the embryonic ventricular system from distending; without that distension the posterior fossa never reaches normal size, and the cerebellum, fourth ventricle and medulla are displaced caudally. The resulting Chiari II configuration obstructs CSF egress at the fourth ventricular outflow and foramen magnum — a distal, not proximal, obstruction. This entry cross-references, and deliberately does not absorb, the separate spina bifida cystica disease entity.

CSF Dynamics (Obstruction, Hypersecretion and Absorption Failure) Model

cerebrospinal fluid circulation GO:0090660 ↓ DECREASED

brain UBERON:0000955

Downstream

Progressive Ventricular Dilatation and Raised Intracranial Pressure Caudal displacement of the hindbrain into a small posterior fossa obstructs fourth ventricular outflow and CSF passage at the foramen magnum.

Chiari Type II Malformation The hindbrain herniation with small posterior fossa is what is reported radiologically as the Chiari II malformation.

Show evidence (3 references)

PMID:2699756 SUPPORT Other

"The cause of the Chiari II hindbrain deformity in children born with a myelomeningocele can be explained by the lack of distention of the embryonic ventricular system."

States the unified-theory mechanism curated at this node. Evidence source is OTHER because the snippet is a theoretical/mechanistic proposal rather than a reported study result.

PMID:2699756 SUPPORT Other

"Defective occlusion and an open neural tube precludes the accumulation of fluid and pressure within the cranial vesicles."

Names the proximate embryological failure — loss of ventricular pressure through the open neural tube — that this node depends on.

PMID:24932902 SUPPORT Model Organism

"Animal models suggest that chronic intrauterine CSF leakage produces the distinctive Chiari II malformation"

Independent statement of the same causal direction — CSF leak upstream of the Chiari II malformation — with the model-organism basis named.

Intraventricular Haemorrhage and Choroid Plexus Inflammatory Activation

Intraventricular blood — germinal matrix haemorrhage of prematurity, or cryptic prenatal microhaemorrhage detectable only as hemosiderin-laden macrophages within a structurally normal aqueduct — activates a Toll-like receptor 4 and NF-kB-dependent inflammatory response in the choroid plexus epithelium. This is an inflammatory rather than a mechanical lesion, and it is why post-haemorrhagic hydrocephalus is curated as more than an obstructed or scarred absorption surface.

CSF Dynamics (Obstruction, Hypersecretion and Absorption Failure) Model

choroid plexus epithelial cell CL:0000706

choroid plexus UBERON:0001886

Downstream

Choroid Plexus CSF Hypersecretion TLR4-NF-kB activation in the choroid plexus epithelium drives the secretory phenotype at the next node.

Impaired CSF Absorption and Perivascular Clearance Blood products in the subarachnoid space are the classical route to obliterative arachnoiditis and impaired CSF translocation, the reading that post-haemorrhagic hydrocephalus was historically attributed to.

Show evidence (2 references)

PMID:28692063 SUPPORT Model Organism

"In a rat model of PHH, we demonstrate that IVH causes a Toll-like receptor 4 (TLR4)- and NF-κB-dependent inflammatory response in the CPE that is associated with a ∼3-fold increase in bumetanide-sensitive CSF secretion."

Establishes the inflammatory response of the choroid plexus epithelium to intraventricular haemorrhage that defines this node.

PMID:24932902 SUPPORT Human Clinical

"Thus, some apparently idiopathic hydrocephalus may in fact be due to unrecognized prenatal intraventricular hemorrhage."

Supports treating haemorrhage as a prenatal trigger of congenital hydrocephalus, not only a postnatal complication.

Choroid Plexus CSF Hypersecretion

The choroid plexus epithelium secretes more fluid than any other epithelium. In a rat model of post-haemorrhagic hydrocephalus, TLR4-dependent activation of the Ste20-type stress kinase SPAK phosphorylates and stimulates the apical NKCC1 cotransporter, producing an approximately three-fold, bumetanide-sensitive increase in CSF secretion — so on that evidence the secretion rate rises rather than the absorption surface simply failing. Scope caveat, and it is the same discipline applied to the cilia and perivascular-clearance nodes: the entire SPAK-NKCC1 chain here is rodent, and no human measurement of post-haemorrhagic CSF hypersecretion is curated in this entry. The node carries a HUMAN_MODEL_MISMATCH discussion for that reason. It remains the node with the clearest pharmacological handle in the entry, and it is the mechanistic rationale for choroid plexus cauterization as a component of endoscopic treatment.

CSF Dynamics (Obstruction, Hypersecretion and Absorption Failure) Model

choroid plexus epithelial cell CL:0000706

cerebrospinal fluid secretion GO:0033326 ↑ INCREASED

NKCC1 sodium-potassium-chloride cotransport GO:0008511 ↑ INCREASED

choroid plexus UBERON:0001886

Animal models

Rat post-haemorrhagic hydrocephalus (intraventricular haemorrhage model) Rat recapitulates Reproduces the post-haemorrhagic secretory phenotype and supplies the loss-of-function rescue that establishes SPAK-NKCC1 as necessary for it.

Downstream

Progressive Ventricular Dilatation and Raised Intracranial Pressure A sustained increase in CSF production against unchanged clearance raises net intraventricular fluid volume.

Show evidence (2 references)

PMID:28692063 SUPPORT Model Organism

"IVH-induced hypersecretion of CSF is mediated by TLR4-dependent activation of the Ste20-type stress kinase SPAK, which binds, phosphorylates, and stimulates the NKCC1 co-transporter at the CPE apical membrane."

Names the SPAK-NKCC1 signalling axis that this node asserts.

PMID:28692063 SUPPORT Model Organism

"Genetic depletion of TLR4 or SPAK normalizes hyperactive CSF secretion rates and reduces PHH symptoms"

Loss-of-function rescue establishing the axis as necessary for the hypersecretion phenotype rather than merely correlated with it.

Impaired CSF Absorption and Perivascular Clearance

The distal, non-obstructive route to ventricular enlargement: CSF is produced normally but cannot be translocated out of the craniospinal compartment. In the familiar bulk-flow model this is failure at the arachnoid granulations, but up to a third of CSF leaves the skull along cranial nerve sheaths into the lymphatic system, and CSF has been shown to move along paravascular pathways into the parenchyma and thence to the systemic circulation. This entry deliberately does NOT declare conforms_to against the glymphatic_dysfunction module here. Conformance is a structural assertion that tooling reads as satisfied, and the honest state of the evidence does not support it: the source literature states plainly that whether disturbances of the lymphatic exit pathway contribute to human hydrocephalus is not known, and the module itself carries an unresolved convective-versus-diffusive controversy. The relationship is recorded as a KNOWLEDGE_GAP discussion attached to this node instead, which is where a claim this uncertain belongs.

CSF Dynamics (Obstruction, Hypersecretion and Absorption Failure) Model

astrocyte CL:0000127

cerebrospinal fluid circulation GO:0090660 ↓ DECREASED

perivascular space UBERON:0014930 brain UBERON:0000955

Downstream

Progressive Ventricular Dilatation and Raised Intracranial Pressure Failure to translocate CSF into the venous and lymphatic circulations raises the steady-state intracranial CSF volume without any point of intraventricular obstruction — the communicating pattern.

Show evidence (3 references)

PMID:24932902 SUPPORT Other

"Recently, CSF has also been found to flow in a pulsatile manner from the intracranial subarachnoid space into the brain parenchyma, and then into the systemic circulation, along paravascular pathways"

Establishes the paravascular efflux route as normal physiology within the hydrocephalus literature. It describes the route, not a lesion in hydrocephalus — which is exactly why this entry records the relationship as a KNOWLEDGE_GAP rather than as module conformance. Evidence source is OTHER because the snippet is review background citing rodent work.

PMID:24932902 SUPPORT Other

"Notably, up to one third of CSF exits the skull along cranial nerve sheaths and into the lymphatic system rather than into the venous sinuses"

Quantifies the non-arachnoid-granulation efflux route whose failure this node models.

PMID:24932902 NO_EVIDENCE Other

"but whether they play a role in the pathogenesis of human hydrocephalus is not yet known"

Recorded as NO_EVIDENCE rather than PARTIAL: the source is not partially supporting the claim, it is stating that the evidence does not exist. This is why the entry declines to declare glymphatic module conformance at this node.

Impaired Fetal Neuro-Gliogenesis and Brain Dysgenesis

The parallel, non-plumbing arm. Multiple congenital hydrocephalus genes are regulators of neural stem cell biology and converge on human transcriptional networks and cell types specific to fetal neuro-gliogenesis. On this reading, the enlarged ventricle in a subset of patients is a read-out of periventricular brain that was never properly built, rather than of fluid pushed against an obstruction. The prediction is clinical and testable: CSF diversion should not normalize outcome in these patients, and indeed poor neurodevelopmental outcomes and persistent ventriculomegaly after surgery are what motivated the search.

Neural Stem Cell Fate Disruption and Fetal Brain Dysgenesis Model

neural stem cell CL:0000047 radial glial cell CL:0000681

neural precursor cell proliferation GO:0061351 ⚠ ABNORMAL gliogenesis GO:0042063 ⚠ ABNORMAL

brain UBERON:0000955

Downstream

Progressive Ventricular Dilatation and Raised Intracranial Pressure Under the dysgenesis reading the ventricle enlarges because the periventricular parenchyma is deficient, so the association with raised pressure is variable rather than obligatory.

Neurodevelopmental Impairment and Periventricular White Matter Injury Under this model the neurodevelopmental deficit is primary and shares its origin with the ventriculomegaly, rather than being caused by it.

Intellectual Disability Cognitive outcome on this arm is a consequence of the dysgenesis itself, which is why it is not expected to be rescued by pressure relief alone.

Show evidence (2 references)

PMID:33077954 SUPPORT Human Clinical

"Multiple CH genes are key regulators of neural stem cell biology and converge in human transcriptional networks and cell types pertinent for fetal neuro-gliogenesis."

States the convergence on fetal neuro-gliogenesis that defines this node.

PMID:29983323 SUPPORT Human Clinical

"These results implicate impaired neurogenesis (rather than active CSF accumulation) in the pathogenesis of a subset of CH patients"

Explicitly contrasts this arm with the CSF-accumulation arm, which is why the two are curated as competing hypotheses rather than as one chain.

Progressive Ventricular Dilatation and Raised Intracranial Pressure

The convergent node of the entry: active distension of the ventricular system, reached from proximal obstruction (aqueduct), distal obstruction (fourth ventricular outflow, foramen magnum), CSF hypersecretion, failed absorption, or — on the competing reading — primary brain dysgenesis. Progressive distension raises intracranial pressure, which in the infant with open sutures presents as accelerating head growth, a full fontanelle and splayed sutures before it presents as classical intracranial hypertension.

CSF Dynamics (Obstruction, Hypersecretion and Absorption Failure) Model

cerebrospinal fluid circulation GO:0090660 ⚠ ABNORMAL

brain ventricle UBERON:0004086 telencephalic ventricle UBERON:0002285

Downstream

Neurodevelopmental Impairment and Periventricular White Matter Injury Sustained ventricular distension and raised pressure compress and stretch the periventricular white matter.

Hydrocephalus Active distension of the ventricular system is what the clinical phenotype of hydrocephalus names.

Ventriculomegaly Ventricular enlargement is the imaging read-out of this node, detectable prenatally from 14-20 weeks of gestation.

Increased Intracranial Pressure Under the CSF-dynamics model, distension against a fixed cranial volume raises intracranial pressure. The dysgenesis arm does not require this step, which is why the edge is hypothesis-scoped.

Macrocephaly In the fetus and infant with unfused sutures the cranium expands in response to the rising intraventricular volume, so head circumference grows rather than pressure rising acutely.

Show evidence (2 references)

PMID:24932902 SUPPORT Human Clinical

"Hydrocephalus is a common but complex condition caused by physical or functional obstruction of CSF flow that leads to progressive ventricular dilatation."

States the canonical definition of the central effector node and its upstream requirement of physical or functional obstruction.

PMID:39218781 SUPPORT Other

"In many cases, prenatal ultrasound can readily identify ventriculomegaly as early as 14-20 weeks of gestation, with severe cases showing poor neurodevelopmental outcomes."

Establishes the prenatal timing at which this node becomes detectable and links its severity to outcome. Evidence source is OTHER (scoping review).

Neurodevelopmental Impairment and Periventricular White Matter Injury

The clinical end state: motor, cognitive, visual and epileptic sequelae on a background of periventricular white matter compromise. Crucially, this node is reached by both hypothesis arms, and the entry does not assume CSF diversion reverses it — ventriculoperitoneal shunting does not address a genetic cause, carries high complication rates, and yields only marginal improvement of neurocognitive deficits.

astrocyte CL:0000127

brain UBERON:0000955

Show evidence (2 references)

PMID:39218781 SUPPORT Other

"Postnatal surgical approaches, such as ventriculoperitoneal shunts, do not address the underlying genetic causes, have high complication rates, and result in a marginal improvement of neurocognitive deficits."

Supports curating the neurodevelopmental end state as only partially reversible by CSF diversion. Evidence source is OTHER (scoping review).

PMID:33077954 SUPPORT Human Clinical

"The poor neurodevelopmental outcomes and persistence of ventriculomegaly in some post-surgical patients highlight our limited knowledge of disease mechanisms."

The post-surgical observation that motivates treating this node as partly independent of the CSF-dynamics arm.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

15

Head and Neck 2

Large Fontanelles HP:0000239

Show evidence (1 reference)

PMID:26352494 SUPPORT Human Clinical

"These children had LVA width ≥ 15 mm, showed increased HC, or had bulging fontanels."

Reports bulging fontanels as one of the observed findings in the hydrocephalic children requiring shunting in this cohort.

Macrocephaly HP:0000256

Show evidence (1 reference)

PMID:34092257 SUPPORT Human Clinical

"which revealed macrocephaly (head circumference >> 97th percentile) with severe bilateral ventriculomegaly"

Prenatal ultrasound finding of macrocephaly accompanying severe ventriculomegaly in a molecularly confirmed case.

Musculoskeletal 1

Spasticity HP:0001257

Course: PROGRESSIVE

Show evidence (1 reference)

PMID:20301657 SUPPORT Human Clinical

"Males with HSAS are born with severe hydrocephalus, adducted thumbs, and spasticity; intellectual disability is severe."

Names spasticity as a defining feature of the HSAS presentation.

Nervous System 7

Hydrocephalus HP:0000238

Show evidence (1 reference)

PMID:24932902 SUPPORT Human Clinical

"In infants, hydrocephalus without an obvious extrinsic cause is usually referred to as congenital hydrocephalus, since it is often present at birth."

Defines the entity and its timing, which is what this phenotype records.

Ventriculomegaly HP:0002119

Show evidence (1 reference)

PMID:39218781 SUPPORT Other

"In many cases, prenatal ultrasound can readily identify ventriculomegaly as early as 14-20 weeks of gestation, with severe cases showing poor neurodevelopmental outcomes."

Establishes prenatal ventriculomegaly as the presenting finding and gives its gestational timing. Evidence source is OTHER (scoping review).

Abnormal Corpus Callosum Morphology HP:0001273

Show evidence (1 reference)

PMID:24932902 SUPPORT Human Clinical

"Among the 79 autopsy subjects without L1CAM mutations, callosal abnormalities were seen in 73%, corticospinal tract abnormalities in 59%, aqueductal stenosis in 46%, and adducted thumbs in 27%."

Quantifies the same findings in L1CAM-negative cases, which is the basis for curating callosal abnormality as non-discriminating.

Intellectual Disability HP:0001249

Show evidence (1 reference)

PMID:20301657 SUPPORT Human Clinical

"In less severely affected males, hydrocephalus may be subclinically present and documented only because of developmental delay; intellectual disability ranges from mild (IQ: 50-70) to moderate (IQ: 30-50)."

Gives the range of cognitive outcome across the spectrum, which is why this phenotype is curated without a frequency band.

Periventricular Nodular Heterotopia HP:0032388

Show evidence (1 reference)

PMID:34092257 SUPPORT Human Clinical

"Subependymal gray matter heterotopias were observed in both cases"

Direct neuropathological observation of periventricular heterotopia in the CCDC88C subtype.

Increased Intracranial Pressure HP:0002516

Show evidence (1 reference)

PMID:33077954 SUPPORT Human Clinical

"In these cases, an increase in CSF production relative to CSF reabsorption leads to an increase in intracranial pressure (ICP), which causes tissue damage, neurological impairment and death if untreated."

Directly asserts raised intracranial pressure as a consequence of the CSF imbalance, and names the tissue damage and neurological impairment that make it a clinically consequential phenotype rather than a number.

Seizure FREQUENT HP:0001250

Show evidence (2 references)

PMID:31563496 SUPPORT Human Clinical

"One-hundred forty-three patients with HC (n = 361) had a diagnosis of epilepsy (39.6%)."

Quantifies epilepsy at 39.6% in a shunted hydrocephalus cohort, which places it in the FREQUENT band (30-79%).

PMID:31563496 SUPPORT Human Clinical

"The most significant influence on the development of epilepsy is that of the HC itself and its underlying aetiology"

Attributes epilepsy risk to the hydrocephalus aetiology rather than to shunting, and identifies haemorrhage as the highest-risk subtype — which is why this phenotype is not curated as a treatment complication.

Other 5

Aqueductal Stenosis HP:0002410

Show evidence (1 reference)

PMID:24932902 SUPPORT Human Clinical

"Of those mutation-positive patients, 98% had abnormalities of the corpus callosum, 98% had hypoplasia or aplasia of the corticospinal tracts, 90% had aqueductal stenosis, and 88% had adducted thumbs."

Autopsy series quantifying aqueductal stenosis in L1CAM-mutation-positive patients.

Adducted Thumbs VERY_FREQUENT HP:0001181

Show evidence (2 references)

PMID:24932902 SUPPORT Human Clinical

"Of those mutation-positive patients, 98% had abnormalities of the corpus callosum, 98% had hypoplasia or aplasia of the corticospinal tracts, 90% had aqueductal stenosis, and 88% had adducted thumbs."

Quantifies adducted thumbs at 88% of L1CAM-mutation-positive autopsy cases, supporting the VERY_FREQUENT band for this subtype.

PMID:20301657 SUPPORT Human Clinical

"Males with HSAS are born with severe hydrocephalus, adducted thumbs, and spasticity; intellectual disability is severe."

GeneReviews confirmation that adducted thumbs are part of the defining HSAS presentation.

Chiari Type II Malformation HP:0025660

Show evidence (1 reference)

PMID:21306277 SUPPORT Human Clinical

"Nearly all infants who are born with myelomeningocele have the Arnold–Chiari II malformation, which includes a constellation of anomalies that include hindbrain herniation (downward displacement of the medulla, fourth ventricle, and cerebellum into the spinal canal), brain-stem abnormalities,..."

States both the near-universal co-occurrence with myelomeningocele and the anatomical content of the malformation.

Myelomeningocele HP:0002475

Show evidence (1 reference)

PMID:24932902 SUPPORT Human Clinical

"The vast majority of patients with neural tube defects have hydrocephalus."

Establishes the tight association between open neural tube defect and hydrocephalus that this phenotype records.

Dandy-Walker Malformation HP:0001305

Show evidence (1 reference)

PMID:21928031 SUPPORT Human Clinical

"Further confusion is added by the inclusion, in some classification, of different malformations with different prognosis and therapeutic strategy under the same label of "Dandy-Walker"."

States the classification hazard that governs how this phenotype must be read: the "Dandy-Walker" label has been applied to malformations with different prognosis and treatment, so the subtype boundary is a curation decision rather than a given.

🧬

Genetic Associations

10

L1CAM

Gene: L1CAM hgnc:6470 relationship_type: CAUSATIVE variant_origin: GERMLINE

X-linked

Show evidence (1 reference)

PMID:24932902 SUPPORT Human Clinical

"Of these patients, L1CAM mutations remain the single most common cause, although mutations in this gene still explain only a minority of hydrocephalus."

Establishes L1CAM as the leading single-gene cause while bounding its explanatory share, both of which this entry curates.

CCDC88C

Gene: CCDC88C hgnc:19967 relationship_type: CAUSATIVE variant_origin: GERMLINE

Autosomal Recessive

Show evidence (1 reference)

PMID:21031079 SUPPORT Human Clinical

"The mutation in the affected patients, a homozygous substitution in the donor splice site of intron 29, resulted in a shorter transcript due to exclusion of exon 29 and loss of functional protein, as shown by Western blotting"

Demonstrates loss of functional DAPLE protein as the consequence of the causal allele, establishing the loss-of-function mechanism.

MPDZ

Gene: MPDZ hgnc:7208 relationship_type: CAUSATIVE variant_origin: GERMLINE

Autosomal Recessive

Show evidence (1 reference)

PMID:23240096 SUPPORT Human Clinical

"Remarkably, we have also identified the same founder mutation in a stillbirth with massive congenital hydrocephalus from another family."

Independent segregation of the same founder allele with severe congenital hydrocephalus in a second family, which is what establishes causality.

WDR81

Gene: WDR81 hgnc:26600 relationship_type: CAUSATIVE variant_origin: GERMLINE

Autosomal Recessive

TRIM71

Gene: TRIM71 hgnc:32669 relationship_type: CAUSATIVE variant_origin: DE_NOVO

Show evidence (1 reference)

PMID:29983323 SUPPORT Human Clinical

"Exome sequencing of 125 CH trios and 52 additional probands identified three genes with significant burden of rare damaging de novo or transmitted mutations: TRIM71 (p = 2.15 × 10-7), SMARCC1 (p = 8.15 × 10-10), and PTCH1 (p = 1.06 × 10-6)."

Names TRIM71 explicitly as one of the three genes reaching exome-wide significance for rare damaging de novo or transmitted mutations in congenital hydrocephalus.

SMARCC1

Gene: SMARCC1 hgnc:11104 relationship_type: CAUSATIVE variant_origin: DE_NOVO

Show evidence (1 reference)

PMID:29983323 SUPPORT Human Clinical

"Exome sequencing of 125 CH trios and 52 additional probands identified three genes with significant burden of rare damaging de novo or transmitted mutations: TRIM71 (p = 2.15 × 10-7), SMARCC1 (p = 8.15 × 10-10), and PTCH1 (p = 1.06 × 10-6)."

Names SMARCC1 explicitly, with the strongest burden statistic of the three genes reaching exome-wide significance in this cohort.

PTCH1

Gene: PTCH1 hgnc:9585 relationship_type: CAUSATIVE variant_origin: DE_NOVO

Show evidence (2 references)

PMID:29983323 SUPPORT Human Clinical

"Exome sequencing of 125 CH trios and 52 additional probands identified three genes with significant burden of rare damaging de novo or transmitted mutations: TRIM71 (p = 2.15 × 10-7), SMARCC1 (p = 8.15 × 10-10), and PTCH1 (p = 1.06 × 10-6)."

Names PTCH1 explicitly as one of the three significantly burdened genes.

PMID:29983323 SUPPORT Human Clinical

"Additionally, two de novo duplications were identified at the SHH locus, encoding the PTCH1 ligand"

Adds the ligand-side de novo duplications, supporting a Hedgehog-pathway contribution rather than a PTCH1-only effect.

AP1S2

Gene: AP1S2 hgnc:560 relationship_type: CAUSATIVE variant_origin: GERMLINE

X-linked

Show evidence (1 reference)

PMID:34092257 SUPPORT Human Clinical

"Pathogenic AP1S2 variants have been linked to Pettigrew syndrome characterized by intellectual disability with prominent basal ganglia iron deposition or calcification and variable severity of hydrocephalus."

Places AP1S2 among the small set of genes linked to congenital hydrocephalus as an isolated or major clinical feature, with the distinctive basal ganglia imaging clue.

FOXJ1

Gene: FOXJ1 hgnc:3816 relationship_type: CAUSATIVE variant_origin: DE_NOVO

Autosomal Dominant

Show evidence (2 references)

PMID:34132502 SUPPORT Human Clinical

"Recently, pathogenic variants in FOXJ1 (Chr 17q25.1) were identified causing PCD associated with hydrocephalus, reduced respiratory cilia number, axonemal microtubule disorganization, and occurring in a de novo, autosomal dominant inheritance pattern."

Establishes de novo autosomal dominant FOXJ1 variants as a human cause of hydrocephalus arising through a motile-cilia mechanism.

PMID:34132502 SUPPORT Human Clinical

"Though motile, ependymal cilia influencing cerebrospinal fluid flow in the central nervous system share many aspects of structure and function with motile cilia in the respiratory tract, hydrocephalus is rarely associated with PCD."

Recorded as PARTIAL, and deliberately kept alongside the item above, because it states the very asymmetry the HUMAN_MODEL_MISMATCH discussion rests on: FOXJ1 is a genuine human motile-cilia route to hydrocephalus, and it is the exception rather than the rule among human motile ciliopathies.

CRB2

Gene: CRB2 hgnc:18688 relationship_type: CAUSATIVE variant_origin: GERMLINE

Autosomal Recessive

Show evidence (2 references)

PMID:36803301 SUPPORT Human Clinical

"Here, we report 3 cases from 2 families with congenital hydrocephalus due to bi-allelic variations in CRB2, a gene previously reported to cause nephrotic syndrome, variably associated with hydrocephalus."

Establishes biallelic CRB2 variation as a cause of congenital hydrocephalus, extending the apical-junction gene group beyond CCDC88C and MPDZ.

PMID:36803301 SUPPORT Human Clinical

"Neurohistopathological analysis allowed us to demonstrate that, contrary to what was previously proposed, the pathological mechanisms underlying hydrocephalus secondary to CRB2 variations are not due to stenosis but to atresia of both Sylvius Aqueduct and central medullar canal."

Human fetal neuropathology distinguishing atresia from stenosis, the same lesion pattern independently reported for CCDC88C.

💊

Medical Actions

4

Ventriculoperitoneal Shunt Placement

Action: ventriculoperitoneal shunt placement Ontology label: Ventriculoperitoneal Shunt Placement NCIT:C168483

The conventional treatment: surgical diversion of CSF from the ventricle to the peritoneal cavity. It reliably relieves raised intracranial pressure and generally produces a greater reduction in ventricular size than endoscopic treatment, but it creates lifelong shunt dependence with a substantial revision and infection burden, and — importantly for this entry — it does not address a genetic cause and yields only marginal improvement in neurocognitive deficits.

Mechanism Target:

INHIBITS Progressive Ventricular Dilatation and Raised Intracranial Pressure — CSF diversion acts on the central effector node — it removes the accumulated fluid and lowers intracranial pressure — and on nothing upstream of it.

Show evidence (1 reference)

PMID:20301657 SUPPORT Human Clinical

"Shunting of the cerebrospinal fluid should be performed as needed to reduce intracranial pressure."

States the mechanism and indication of shunting: reduction of intracranial pressure, the central effector node's proximate readout.

Show evidence (1 reference)

PMID:39218781 SUPPORT Other

"Postnatal surgical approaches, such as ventriculoperitoneal shunts, do not address the underlying genetic causes, have high complication rates, and result in a marginal improvement of neurocognitive deficits."

Recorded as PARTIAL because it supports shunting as standard care while explicitly bounding what it achieves. Evidence source is OTHER (scoping review).

Endoscopic Third Ventriculostomy with Choroid Plexus Cauterization

Action: endoscopic third ventriculostomy Ontology label: Third Ventriculostomy NCIT:C182204

The shunt-free alternative: an endoscopic stoma in the floor of the third ventricle diverts CSF flow, and cauterization of the choroid plexus reduces CSF production. It is technically harder than shunting and fails more often in the first months, but virtually all its failures occur within six months, after which the risk is low — a decisive advantage where urgent shunt-revision surgery is not reliably available. In a randomized trial in Ugandan infants with post-infectious hydrocephalus, cognitive outcomes at 12 months did not differ significantly from ventriculoperitoneal shunting. Uniquely among the treatments here, its cauterization component acts on the CSF hypersecretion node rather than only on the fluid already accumulated.

Mechanism Target:

INHIBITS Choroid Plexus CSF Hypersecretion — Cauterization of the choroid plexus reduces the secretory surface and so lowers CSF production, acting on the hypersecretion node directly.

Show evidence (1 reference)

PMID:29262276 SUPPORT Human Clinical

"The endoscopic procedure relieves hydrocephalus by diverting the flow of cerebrospinal fluid (CSF), and cauterization of the choroid plexus reduces CSF production, further reducing hydrocephalus."

States both mechanisms of the combined procedure, and specifically that the cauterization component reduces CSF production.

Show evidence (2 references)

PMID:29262276 SUPPORT Human Clinical

"This single-center study involving Ugandan infants with postinfectious hydrocephalus showed no significant difference between endoscopic ETV-CPC and ventriculoperitoneal shunting with regard to cognitive outcomes at 12 months."

Randomized-trial conclusion establishing cognitive equipoise between the two procedures in the post-infectious subtype.

PMID:29262276 SUPPORT Human Clinical

"In contrast, ETV–CPC is technically more difficult than shunting, but it has the advantage that virtually all failures occur within 6 months"

States the failure-timing profile that motivates ETV-CPC where urgent shunt revision is not reliably accessible.

Prenatal Repair of Myelomeningocele

Action: neurosurgical procedure Ontology label: Neurosurgical Procedure NCIT:C15656

In utero closure of the open neural tube defect before 26 weeks of gestation. In the MOMS randomized trial it roughly halved the rate of shunt placement by 12 months and improved hindbrain herniation, at the cost of increased preterm delivery and uterine dehiscence. Mechanistically this is the only treatment in the entry that acts on the *upstream* trigger rather than on the accumulated fluid: closing the defect restores the embryonic ventricular pressure whose absence produces the Chiari II configuration.

Mechanism Target:

INHIBITS Neural Tube Defect with Chiari II Hindbrain Herniation and Small Posterior Fossa — Closing the open neural tube in utero halts chronic CSF leakage, allowing the embryonic ventricular system to distend and the posterior fossa to develop, which reduces hindbrain herniation and the need for shunting.

Show evidence (1 reference)

PMID:21306277 SUPPORT Human Clinical

"Prenatal surgery also resulted in improvement in the composite score for mental development and motor function at 30 months (P=0.007) and in improvement in several secondary outcomes, including hindbrain herniation by 12 months and ambulation by 30 months."

Shows prenatal repair improving hindbrain herniation itself, which is the node this treatment is asserted to act on.

Show evidence (2 references)

PMID:21306277 SUPPORT Human Clinical

"Actual rates of shunt placement were 40% in the prenatal-surgery group and 82% in the postnatal-surgery group (relative risk, 0.48; 97.7% CI, 0.36 to 0.64; P<0.001)."

Quantifies the reduction in shunt requirement, the outcome that makes this a hydrocephalus-modifying intervention.

PMID:21306277 SUPPORT Human Clinical

"However, prenatal surgery was associated with an increased risk of preterm delivery and uterine dehiscence at delivery."

Recorded as PARTIAL because it states the maternal and fetal harms that bound the recommendation.

Early Ventricular Intervention in Post-haemorrhagic Ventricular Dilatation

Action: cerebrospinal fluid diversion Ontology label: Cerebrospinal Fluid Diversion NCIT:C93208

Intervening at a low rather than a high ventriculomegaly threshold in preterm infants with progressive post-haemorrhagic ventricular dilatation. In a post hoc analysis of a multicentre randomized trial, the low-threshold strategy was associated with lower odds of death or severe neurodevelopmental disability. Curated with the trial's own caveat: this was a post hoc analysis and the primary comparison did not reach significance.

Mechanism Target:

INHIBITS Progressive Ventricular Dilatation and Raised Intracranial Pressure — Earlier CSF removal limits the duration and degree of ventricular distension before irreversible periventricular injury accrues.

Show evidence (1 reference)

PMID:32800815 SUPPORT Human Clinical

"In a post hoc analysis, earlier intervention was associated with a lower odds of death or severe neurodevelopmental disability in preterm infants with progressive posthemorrhagic ventricular dilatation."

Recorded as PARTIAL because the authors themselves label the finding a post hoc association rather than a confirmed primary result.

Show evidence (1 reference)

PMID:32800815 SUPPORT Human Clinical

"The composite adverse outcome was seen in 20 of 58 infants (35%) in the low threshold group and 28 of 55 (51%) in the high threshold (P = .07)."

The primary comparison, which did not reach conventional significance — the reason this treatment is curated as PARTIAL rather than SUPPORT.

🌍

Environmental Factors

2

Intrauterine infection (cytomegalovirus, Toxoplasma gondii, enterovirus, lymphocytic choriomeningitis virus)

No ECTO exposure_term is bound. The concept needed here is intrauterine infection by a specific congenital pathogen, and binding a generic infectious-agent exposure term would be less accurate than free text; see the dismech-terms rule that no term beats a bad one.

Congenital infection acquired in utero is an established route to hydrocephalus present at birth, and neonatal ventriculitis is the dominant aetiology of infant hydrocephalus in sub-Saharan Africa. The contribution of unrecognized intrauterine infection to apparently idiopathic congenital hydrocephalus is suspected but not quantified.

Show evidence (1 reference)

PMID:29701543 SUPPORT Human Clinical

"The high crude birth rate, greater proportion of patients with postinfectious etiology, and higher incidence of NTDs all contribute to a case volume in low- and middle-income countries that outweighs that in high-income countries by more than 20-fold."

Quantifies the epidemiological weight of the post-infectious route at global scale.

Mechanism Target:

TRIGGERS Impaired CSF Absorption and Perivascular Clearance — Ventriculitis and the ensuing inflammatory scarring of the ventricular system and subarachnoid space impede CSF translocation, the classical route from intrauterine or neonatal infection to hydrocephalus.

Show evidence (1 reference)

PMID:29262276 SUPPORT Human Clinical

"Hydrocephalus in this region is most commonly postinfectious, occurring after neonatal ventriculitis."

Establishes ventriculitis as the causal exposure route in the population carrying the largest share of infant hydrocephalus worldwide.

Isotretinoin exposure in pregnancy

Among the medications associated with infantile hydrocephalus when taken during pregnancy, isotretinoin has the best documented association. The mechanism is presumed to be disruption of retinoic acid morphogen gradients in the hindbrain, producing an obstructive malformation — a presumption, not a demonstrated chain, and curated as such.

Show evidence (1 reference)

PMID:24932902 SUPPORT Human Clinical

"The best documented association is with isotretinoin"

Identifies isotretinoin as the best-documented medication association with infantile hydrocephalus.

Mechanism Target:

TRIGGERS Aqueductal Stenosis, Atresia and Forking — Disruption of hindbrain retinoic acid gradients is the proposed route to an obstructive malformation of the CSF pathway. The intermediates are not established.

Show evidence (1 reference)

PMID:24932902 SUPPORT Human Clinical

"Though isotretinoin-associated hydrocephalus is incompletely characterized, it is presumably caused by a disruption of retinoic acid morphogen gradients in the hindbrain"

Recorded as PARTIAL because the source itself hedges: the association is documented but the mechanism is presumed rather than demonstrated.

🔬

Diagnosis

3

L1CAM Molecular Genetic Testing (Positive in affected males with L1 syndrome)

Hemizygous pathogenic L1CAM variant identified by molecular genetic testing in a male proband with suggestive findings establishes the diagnosis of L1 syndrome. Diagnosis in a female is unusual but possible. Testing should be strongly considered in every male with unexplained hydrocephalus and is regarded as mandatory where there is a positive family history or adducted thumbs — but note that no single finding or combination of findings confirms or excludes the diagnosis clinically, which is what makes the molecular test decisive rather than confirmatory.

Show evidence (4 references)

PMID:20301657 SUPPORT Human Clinical

"The diagnosis of L1 syndrome is established in a male proband with suggestive findings and a hemizygous pathogenic variant in L1CAM identified by molecular genetic testing."

GeneReviews diagnostic criterion for the HSAS subtype, quoted from the DIAGNOSIS/TESTING section.

PMID:20301657 SUPPORT Human Clinical

"The diagnosis of L1 syndrome in a female is unusual but not impossible (most likely in the setting of general delay and/or hydrocephalus) and is established with the identification of a heterozygous pathogenic variant in L1CAM by molecular genetic testing."

Recorded as PARTIAL because it bounds the male-proband criterion: female diagnosis is possible, so an X-linked pattern should not be used to exclude testing in a female with hydrocephalus and developmental delay.

PMID:24932902 SUPPORT Human Clinical

"Therefore, L1CAM testing should be strongly considered in all males with unexplained hydrocephalus, but should be regarded as mandatory for those with a family history or adducted thumbs."

States the testing indication curated in this diagnosis entry.

+ 1 more reference

Neuroimaging Assessment for Basal Ganglia Iron or Calcium Deposition (Positive in AP1S2-related disease)

In a male with intellectual disability and hydrocephalus, head CT or iron/calcium-sensitive MRI sequences (GRE, SWI) should be used to look for basal ganglia deposition, which points to AP1S2-related Fried/Pettigrew syndrome rather than L1 syndrome. Both iron and calcium may be subtle or invisible on standard MRI sequences, so a negative routine MRI does not exclude it.

Show evidence (2 references)

PMID:24932902 SUPPORT Human Clinical

"We recommend considering AP1S2 testing in males with intellectual disability and imaging abnormalities that suggest deposition of iron or calcium with the basal ganglia."

States the imaging-triggered testing recommendation curated here.

PMID:34092257 SUPPORT Human Clinical

"Pathogenic AP1S2 variants have been linked to Pettigrew syndrome characterized by intellectual disability with prominent basal ganglia iron deposition or calcification and variable severity of hydrocephalus."

Independent statement of the imaging finding that discriminates AP1S2-related disease within the congenital hydrocephalus differential.

Neurologic Surveillance After Diagnosis

Ongoing neurologic evaluation at regular intervals to monitor hydrocephalus, developmental progress and spastic paraplegia. Curated as a diagnostic activity rather than a treatment because it is a monitoring protocol, not an intervention that acts on a mechanism node.

Show evidence (1 reference)

PMID:20301657 SUPPORT Human Clinical

"Surveillance: Neurologic evaluation at regular intervals to monitor hydrocephalus, developmental progress, and spastic paraplegia."

GeneReviews surveillance recommendation, quoted from the MANAGEMENT section.

📊

Prevalence

3

Worldwide (high-income countries)

Birth Prevalence 79.0 per 100,000 (68.0–90.0) 1–9 per 10,000

Pooled incidence of congenital hydrocephalus in high-income countries, 79 per 100,000 births (95% CI 68-90), from a systematic review and meta-analysis of 78 articles across all WHO regions.

Show evidence (1 reference)

PMID:29701543 SUPPORT Human Clinical

"The incidence was higher in low- and middle-income countries (123 per 100,000 births; 95% CI 98-152 births) than in high-income countries (79 per 100,000 births; 95% CI 68-90 births)"

Directly reports the pooled high-income-country birth incidence curated here, alongside the LMIC figure recorded in the companion record.

Low- and middle-income countries

Birth Prevalence 123.0 per 100,000 (98.0–152.0) >1 in 1,000

Pooled incidence 123 per 100,000 births (95% CI 98-152); regional pooled incidence was highest in Latin America (316 per 100,000) and Africa (145 per 100,000). Nearly 400,000 new cases of paediatric hydrocephalus are predicted worldwide each year.

Show evidence (1 reference)

PMID:29701543 SUPPORT Human Clinical

"The pooled incidence of congenital hydrocephalus was highest in Africa and Latin America (145 and 316 per 100,000 births, respectively) and lowest in the United States/Canada (68 per 100,000 births)"

Reports the regional gradient underlying the LMIC pooled incidence curated here.

Infants diagnosed before one year of age (Denmark, population-based)

Birth Prevalence 110.0 per 100,000 >1 in 1,000

1.1 per 1,000 infants in a 30-year population-based Danish study of idiopathic infantile hydrocephalus; Chiari I and Dandy-Walker malformations were included but neural tube defects were excluded, so this figure understates the total burden.

Show evidence (1 reference)

PMID:24932902 SUPPORT Human Clinical

"The authors found an estimated prevalence of 1.1 per 1,000 infants."

The population-based Danish estimate that is the most widely cited prevalence figure for infantile hydrocephalus.

📊

Related Datasets

4

A Novel Silent Mutation in the L1CAM Gene causing Fetal Hydrocephalus geo:GSE133063

Human fetal case with an L1CAM variant causing hydrocephalus. Triaged as directly relevant: the disease and the causal gene both match the HSAS subtype curated in this entry, rather than merely sharing a gene symbol.

human n=1

PMID:31572438

Discovered with just discover-datasets (DIRECT, gene:L1CAM match) and resolved with just verify-datasets. Relevance triaged manually per CLAUDE.md: verification proves existence, not aboutness. No evidence block — bulk-discovered dataset records carry provenance notes rather than manufactured quotes.

RNA Sequencing of CSF Samples from Patients with Intraventricular Hemorrhage and Neural Tube Defects geo:GSE121867

CSF transcriptomes from human patients with intraventricular haemorrhage and with neural tube defects — the two acquired/malformation routes curated as the post-haemorrhagic and Chiari II-associated subtypes here.

human BULK RNA SEQ n=70

PMID:30951672

Discovered with just discover-datasets (DIRECT) and resolved with just verify-datasets. Relevance triaged manually: both patient groups map onto curated subtypes of this entry.

Lysophosphatidic acid (LPA)-dependent propagation of neuroinflammation in an optimized model of post-hemorrhagic hydrocephalus geo:GSE272062

Single-cell transcriptomics in a mouse model of post-haemorrhagic hydrocephalus, relevant to the intraventricular-haemorrhage and choroid plexus inflammatory nodes of this entry.

house mouse SINGLE CELL RNA SEQ n=6

PMID:40971013

Discovered with just discover-datasets (DIRECT) and resolved with just verify-datasets. Model-organism dataset; relevance triaged manually against the post-haemorrhagic subtype.

TRIM71R595H/R595H mutations and TRIM71-KO in mESC lead to similar transcriptomic changes geo:GSE189420

Transcriptomic consequences of TRIM71 hypomorphic and null alleles in mouse embryonic stem cells. TRIM71 is one of the neural-stem-cell-fate genes curated on the dysgenesis hypothesis arm of this entry.

house mouse BULK RNA SEQ n=20

PMID:35379995

Discovered with just discover-datasets (DIRECT, name match) and resolved with just verify-datasets. Relevance triaged manually: TRIM71 is curated in this entry's genetic section, so this is a gene-and-mechanism match rather than a gene-symbol-only hit.

🔬

Clinical Trials

3

NCT01936272 PHASE_III ACTIVE_NOT_RECRUITING

Randomized trial of endoscopic third ventriculostomy with choroid plexus cauterization versus ventriculoperitoneal shunting in Ugandan infants with post-infectious hydrocephalus, with BSID-3 cognitive score at 12 months as the primary outcome.

Target Phenotypes: Hydrocephalus HP:0000238

Show evidence (1 reference)

PMID:29262276 SUPPORT Human Clinical

"A total of 100 infants were enrolled; 51 were randomly assigned to undergo ETV-CPC, and 49 were assigned to undergo ventriculoperitoneal shunting."

Records the randomized allocation of the trial whose result grounds the ETV-CPC treatment entry.

NCT00060606 NOT_APPLICABLE COMPLETED

Management of Myelomeningocele Study (MOMS): randomized trial of prenatal versus postnatal repair of myelomeningocele, with a co-primary outcome of fetal or neonatal death or the need for CSF shunt placement by 12 months.

Target Phenotypes: Hydrocephalus HP:0000238 Myelomeningocele HP:0002475

Show evidence (1 reference)

PMID:21306277 SUPPORT Human Clinical

"One primary outcome was a composite of fetal or neonatal death or the need for placement of a cerebrospinal fluid shunt by the age of 12 months."

Defines the shunt-placement primary endpoint that makes this trial a hydrocephalus trial and not only a spina bifida trial.

ISRCTN43171322 NOT_APPLICABLE COMPLETED

ELVIS (Early versus Late Ventricular Intervention Study): multicentre randomized controlled trial comparing intervention at a low versus high ventriculomegaly threshold in preterm infants with post-haemorrhagic ventricular dilatation, reported here at 2 years. Registered on a WHO ICTRP primary registry (ISRCTN) rather than ClinicalTrials.gov.

Target Phenotypes: Ventriculomegaly HP:0002119

Show evidence (1 reference)

ICTRP:ISRCTN43171322 SUPPORT Other

"| Register | ISRCTN |"

WHO ICTRP registration record establishing the trial's identity on a non-ClinicalTrials.gov primary registry.

🐁

Animal Models

2

Rat post-haemorrhagic hydrocephalus (intraventricular haemorrhage model) INDUCED

Induced intraventricular haemorrhage in the rat, used to dissect the inflammatory route from blood in the ventricle to CSF hypersecretion. Genetic depletion of TLR4 or SPAK normalizes secretion and reduces symptoms, which is what makes the axis necessary rather than merely correlated.

Species

Rat

Genotype

Wild type with induced intraventricular haemorrhage; TLR4-null and SPAK-null comparators

Publication

PMID:28692063

Pathograph links

Choroid Plexus CSF Hypersecretion recapitulates fidelity: moderate Reproduces the post-haemorrhagic secretory phenotype and supplies the loss-of-function rescue that establishes SPAK-NKCC1 as necessary for it.

Limitations: The entire chain is rodent. No human measurement of post-haemorrhagic CSF hypersecretion is curated in this entry, and rat ventricular anatomy, CSF turnover rate and the timing of germinal matrix haemorrhage differ from the preterm human infant in whom the clinical syndrome occurs.

Readouts

Bumetanide-sensitive CSF secretion rate

Direction: INCREASED

Interpretation: Approximately three-fold rise in CSF secretion after intraventricular haemorrhage, sensitive to NKCC1 blockade.

Show evidence (1 reference)

PMID:28692063 SUPPORT Model Organism

"In a rat model of PHH, we demonstrate that IVH causes a Toll-like receptor 4 (TLR4)- and NF-κB-dependent inflammatory response in the CPE that is associated with a ∼3-fold increase in bumetanide-sensitive CSF secretion."

Reports the measurement and its magnitude directly.

Show evidence (1 reference)

PMID:28692063 SUPPORT Model Organism

"Genetic depletion of TLR4 or SPAK normalizes hyperactive CSF secretion rates and reduces PHH symptoms"

The rescue result that makes this model informative for the hypersecretion node rather than merely descriptive of it.

Dishevelled compound-mutant mouse (ependymal planar polarity) GENETICALLY_ENGINEERED

Compound conditional ablation of the three Dishevelled genes in the ependymal lineage. The informative feature is what is spared: ependymal cells differentiate normally and cilia are assembled, so the phenotype isolates loss of ciliary planar alignment from loss of cilia themselves.

Species

Mouse

Genotype

hGFAP-Cre;Dvl1(-/-);Dvl2(flox/flox);Dvl3(+/-)

Publication

PMID:25043421

Pathograph links

Ependymal Motile Cilia Beat Dysfunction and Loss of Directional CSF Flow recapitulates fidelity: low Reproduces loss of intracellular and intercellular rotational alignment of ependymal motile cilia, with measurably slower generated flow and consequent hydrocephalus.

Limitations: Fidelity is recorded as LOW deliberately, not because the mouse experiment is weak but because its translational validity to human congenital hydrocephalus is contested: human ventriculomegaly typically begins in utero before ependymal cilia functionally mature, and human motile ciliopathies infrequently cause hydrocephalus. See the gap_cilia_hypothesis_human_translatability discussion.

Readouts

Ependymal-generated cerebrospinal fluid flow velocity

Direction: DECREASED

Interpretation: Flow generated by mutant ependymal cells is significantly slower than control, linking the alignment defect to a transport deficit.

Show evidence (1 reference)

PMID:25043421 SUPPORT Model Organism

"As a consequence, the fluid flow generated by the hGFAP-Cre;Dvl1(-/-);2(flox/flox);3(+/-) E cells was significantly slower than that observed in control mice."

Reports the flow measurement that grounds this readout.

Show evidence (1 reference)

PMID:25043421 SUPPORT Model Organism

"In hGFAP-Cre;Dvl1(-/-);2(flox/flox);3(+/-) mutants, E cells differentiated normally, but the intracellular and intercellular rotational alignments of ependymal motile cilia were disrupted."

Establishes that the model isolates ciliary alignment from ependymal differentiation, which is what makes it informative for this node specifically.

{ }

Source YAML

click to show

name: Congenital Hydrocephalus
creation_date: "2026-08-20T00:00:00Z"
category: Complex
disease_term:
  preferred_term: congenital hydrocephalus
  term:
    id: MONDO:0016349
    label: congenital hydrocephalus
description: >-
  Congenital hydrocephalus (CH) is ventricular enlargement present at birth or in
  the first months of life, classically framed as an active distension of the
  ventricular system resulting from inadequate passage of cerebrospinal fluid
  (CSF) from its point of production to its point of absorption. It is
  aetiologically heterogeneous rather than a single disease: a Mendelian arm
  (L1CAM, CCDC88C, MPDZ, AP1S2, WDR81 and a much longer list of syndromic genes),
  a sporadic de novo arm converging on ventricular-zone neural stem cell fate
  (TRIM71, SMARCC1, PTCH1/SHH), a malformation arm secondary to neural tube
  defects with Chiari II malformation and to Dandy-Walker malformation, and an
  acquired-in-utero/perinatal arm following intraventricular haemorrhage or
  intrauterine and neonatal infection. A central and unsettled question runs
  through the entry: whether ventriculomegaly in a given patient is driven by CSF
  accumulation against an obstruction, or is a read-out of primary fetal brain
  dysgenesis in which the ventricle enlarges because the surrounding brain was
  never built. The two readings are curated as competing mechanistic hypotheses
  rather than blended, because they predict different responses to CSF diversion.
synonyms:
- congenital hydrocephaly
- hydrocephalus present at birth
- infantile hydrocephalus
parents:
- Hydrocephalus
- Congenital Nervous System Disorder
classifications:
  harrisons_chapter:
  - classification_value: NEUROLOGIC
    notes: >-
      Curated as a neurological disorder of CSF dynamics and fetal brain
      development; the neurosurgical management arm (shunting, endoscopic third
      ventriculostomy) sits within the same chapter scope.
references:
- reference: PMID:20301657
  title: "L1 Syndrome."
  tags:
  - GeneReviews
has_subtypes:
- name: HSAS
  display_name: X-linked hydrocephalus with stenosis of the aqueduct of Sylvius (L1CAM / L1 syndrome)
  subtype_term:
    preferred_term: X-linked hydrocephalus with stenosis of the aqueduct of Sylvius
    term:
      id: MONDO:0010611
      label: X-linked hydrocephalus with stenosis of the aqueduct of Sylvius
  description: >-
    The severe end of the L1CAM-related L1 syndrome spectrum (which also includes
    MASA syndrome / X-linked complicated spastic paraplegia type 1 and X-linked
    complicated corpus callosum agenesis). Affected males are born with severe
    hydrocephalus, adducted thumbs and spasticity, and hypoplasia or aplasia of
    the corticospinal tracts is near-constant at autopsy. It is the single most
    frequently identified monogenic cause of otherwise isolated congenital
    hydrocephalus. Note the phenotypic overlap trap: callosal abnormality,
    aqueductal stenosis and adducted thumbs are all seen in L1CAM-negative
    hydrocephalus too, so none of them confirms or excludes the diagnosis.
  genes:
  - preferred_term: L1CAM
    term:
      id: hgnc:6470
      label: L1CAM
  inheritance:
  - name: X-linked
  evidence:
  - reference: PMID:20301657
    reference_title: "L1 Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Males with HSAS are born with severe hydrocephalus, adducted thumbs, and
      spasticity; intellectual disability is severe.
    explanation: >-
      GeneReviews statement of the defining HSAS clinical triad and its severity.
  - reference: PMID:34092257
    reference_title: "Neuropathological hallmarks of fetal hydrocephalus linked to CCDC88C pathogenic variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Pathogenic L1CAM variants are responsible for a wide phenotypic spectrum,
      X-linked hydrocephalus with stenosis of the aqueduct of Sylvius (AS) being
      the most common genetic form, with a prevalence of 1:30,000 and accounting
      for approximately 5–10% of males with non-syndromic congenital
      hydrocephalus.
    explanation: >-
      Establishes HSAS as the most common genetic form and quantifies its share
      of non-syndromic congenital hydrocephalus in males.
- name: HYC1
  display_name: Hydrocephalus, nonsyndromic, autosomal recessive 1 (CCDC88C)
  subtype_term:
    preferred_term: hydrocephalus, nonsyndromic, autosomal recessive 1
    term:
      id: MONDO:0009360
      label: hydrocephalus, nonsyndromic, autosomal recessive 1
  description: >-
    Autosomal recessive congenital hydrocephalus caused by biallelic loss of
    CCDC88C, which encodes DAPLE, a Dishevelled-binding regulator of
    non-canonical Wnt signalling and of ependymal cell planar polarity. Fetal
    neuropathology shows multifocal atresia-forking of the aqueduct of Sylvius
    and of the central canal of the medulla, periventricular neuronal
    heterotopias and choroid plexus hydrops — i.e. a developmental malformation
    of the ependymal-lined channels rather than a simple mechanical plug.
  genes:
  - preferred_term: CCDC88C
    term:
      id: hgnc:19967
      label: CCDC88C
  inheritance:
  - name: Autosomal Recessive
  evidence:
  - reference: PMID:21031079
    reference_title: "Disturbed Wnt Signalling due to a Mutation in CCDC88C Causes an Autosomal Recessive Non-Syndromic Hydrocephalus with Medial Diverticulum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Via positional cloning in a consanguineous family with autosomal recessive
      hydrocephalus we have now identified a homozygous splice site mutation in
      the CCDC88C gene as a novel cause of a complex hydrocephalic brain
      malformation.
    explanation: >-
      The original gene-discovery report establishing biallelic CCDC88C loss as
      a cause of autosomal recessive non-syndromic hydrocephalus.
  - reference: PMID:34092257
    reference_title: "Neuropathological hallmarks of fetal hydrocephalus linked to CCDC88C pathogenic variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In both fetuses, brain lesions consisted of multifocal atresia-forking
      along the aqueduct of Sylvius and the central canal of the medulla,
      periventricular neuronal heterotopias and choroid plexus hydrops.
    explanation: >-
      Defines the neuropathological signature of the CCDC88C subtype in human
      fetal material.
- name: HYC2
  display_name: Hydrocephalus, nonsyndromic, autosomal recessive 2 (MPDZ)
  subtype_term:
    preferred_term: hydrocephalus, nonsyndromic, autosomal recessive 2
    term:
      id: MONDO:0014085
      label: hydrocephalus, nonsyndromic, autosomal recessive 2
  description: >-
    Severe autosomal recessive congenital hydrocephalus caused by biallelic
    truncating variants in MPDZ (MUPP1), a multi-PDZ scaffold of apical tight
    junctions that binds DAPLE. Unlike the classic aqueductal-obstruction
    picture, the index families were described as communicating hydrocephalus,
    and mouse work attributes the mechanism to hyperpermeability of the choroid
    plexus epithelial barrier rather than to a mechanical block.
  genes:
  - preferred_term: MPDZ
    term:
      id: hgnc:7208
      label: MPDZ
  inheritance:
  - name: Autosomal Recessive
  evidence:
  - reference: PMID:23240096
    reference_title: "Mutation in MPDZ causes severe congenital hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We have identified a family in which severe congenital hydrocephalus of
      the communicating type follows an autosomal recessive mode of inheritance.
    explanation: >-
      Establishes the autosomal recessive, communicating character of
      MPDZ-related congenital hydrocephalus in the index family.
  - reference: PMID:23240096
    reference_title: "Mutation in MPDZ causes severe congenital hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Direct sequencing of these genes revealed a truncating mutation in MPDZ,
      encoding a tight junction protein.
    explanation: >-
      Identifies the causal gene and its tight-junction protein product, the
      basis of the barrier-permeability mechanism curated for this subtype.
- name: HYC3
  display_name: Hydrocephalus, congenital, 3, with brain anomalies (WDR81)
  subtype_term:
    preferred_term: hydrocephalus, congenital, 3, with brain anomalies
    term:
      id: MONDO:0054794
      label: hydrocephalus, congenital, 3, with brain anomalies
  description: >-
    Autosomal recessive congenital hydrocephalus with additional brain anomalies
    attributed to biallelic WDR81 variants. Curated here as a recognized member
    of the non-syndromic autosomal recessive series (HYC1/HYC2/HYC3) for
    completeness of the subtype axis; the entry does not curate a
    WDR81-specific mechanism chain, because the mechanistic literature is
    thinner than for CCDC88C and MPDZ.
  genes:
  - preferred_term: WDR81
    term:
      id: hgnc:26600
      label: WDR81
  inheritance:
  - name: Autosomal Recessive
  evidence:
  - reference: PMID:39135208
    reference_title: "Congenital hydrocephalus: a review of recent advances in genetic etiology and molecular mechanisms."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      the 4 genes currently associated with CH (two X-linked genes L1CAM and AP1S2, two autosomal recessive MPDZ and CCDC88C)
    explanation: >-
      Recorded to make the boundary of the classical four-gene set explicit.
      WDR81 sits outside it, which is why this subtype is curated for series
      completeness on the strength of the MONDO disease-series-by-gene axiom for
      MONDO:0054794 rather than on a primary gene-discovery snippet this entry
      has verified. Evidence source is OTHER (review).
- name: Chiari II-associated
  display_name: Hydrocephalus secondary to myelomeningocele with Chiari II malformation
  description: >-
    Hydrocephalus complicating open neural tube defect. The great majority of
    infants undergoing myelomeningocele repair carry a diagnosis of
    hydrocephalus. Under the McLone-Knepper unified theory the hindbrain
    deformity itself is a downstream consequence of the open neural tube: fluid
    and pressure fail to accumulate in the embryonic ventricular system, the
    posterior fossa stays small, and the hindbrain is displaced — which then
    obstructs CSF egress. This subtype is a comorbid complication of
    myelomeningocele, and cross-references but does not absorb the separate
    spina bifida cystica disease entity.
  evidence:
  - reference: PMID:31574479
    reference_title: "Myelomeningocele-associated hydrocephalus: nationwide analysis and systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A weighted total of 10,627 inpatient MMC repairs were documented in the
      NIS, 8233 (77.5%) of which had documented hydrocephalus
    explanation: >-
      Nationwide inpatient data quantifying how consistently hydrocephalus
      accompanies myelomeningocele repair.
- name: Dandy-Walker-associated
  display_name: Hydrocephalus associated with Dandy-Walker malformation
  subtype_term:
    preferred_term: isolated Dandy-Walker malformation with hydrocephalus
    term:
      id: MONDO:0017110
      label: isolated Dandy-Walker malformation with hydrocephalus
  description: >-
    Hydrocephalus accompanying the Dandy-Walker malformation (vermian
    hypoplasia, cystic dilatation of the fourth ventricle, enlarged posterior
    fossa). The obstruction is distal — at the level of the fourth ventricle and
    its outflow tracts — rather than at the aqueduct, and a single shunt
    controlling both ventricle and cyst is generally effective. Outcome is
    governed more by the associated malformations and the degree of vermian
    involvement than by the hydrocephalus itself.
  evidence:
  - reference: PMID:21928031
    reference_title: "Hydrocephalus in Dandy-Walker malformation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Among therapeutical strategies, single shunting (ventriculo-peritoneal or
      cyst-peritoneal shunts) appears effective in the control of both ventricle
      and cyst size.
    explanation: >-
      Characterizes the CSF-diversion behaviour specific to the Dandy-Walker
      subtype, where the ventricle and the posterior fossa cyst behave as one
      compartment.
  - reference: PMID:21928031
    reference_title: "Hydrocephalus in Dandy-Walker malformation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Prognosis and intellectual outcome mostly depend on the presence of
      associated malformations, the degree of vermian malformation and the
      adequate control of hydrocephalus.
    explanation: >-
      Supports curating outcome in this subtype as malformation-determined
      rather than determined by ventricular size alone.
- name: Post-haemorrhagic
  display_name: Post-haemorrhagic hydrocephalus (perinatal/prenatal intraventricular haemorrhage)
  subtype_term:
    preferred_term: post-hemorrhagic hydrocephalus
    term:
      id: NCIT:C116383
      label: Post-Hemorrhagic Hydrocephalus
  description: >-
    Progressive ventricular dilatation following intraventricular haemorrhage,
    most often germinal matrix haemorrhage in the preterm infant but also
    following cryptic prenatal intraventricular microhaemorrhage, which can
    present as apparently idiopathic congenital hydrocephalus. Mechanistically
    this subtype is not purely a reabsorption failure: intraventricular blood
    triggers a TLR4-NF-kB inflammatory response in the choroid plexus epithelium
    that drives SPAK-NKCC1-dependent CSF hypersecretion.
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The most common cause of acquired hydrocephalus in infants is hemorrhage,
      most often as a consequence of prematurity.
    explanation: >-
      Establishes haemorrhage of prematurity as the dominant acquired cause in
      this age group.
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Thus, some apparently idiopathic hydrocephalus may in fact be due to
      unrecognized prenatal intraventricular hemorrhage.
    explanation: >-
      Justifies curating post-haemorrhagic hydrocephalus as a subtype of
      *congenital* hydrocephalus and not only as a postnatal acquired entity.
- name: Post-infectious
  display_name: Post-infectious congenital hydrocephalus
  subtype_term:
    preferred_term: post-inflammatory hydrocephalus
    term:
      id: NCIT:C116384
      label: Post-Inflammatory Hydrocephalus
  description: >-
    Hydrocephalus following intrauterine or neonatal infection. Intrauterine
    infection with cytomegalovirus, Toxoplasma gondii, lymphocytic
    choriomeningitis virus and enterovirus has been associated with
    hydrocephalus, and neonatal ventriculitis is the dominant cause of infant
    hydrocephalus in sub-Saharan Africa, where post-infectious disease drives
    much of the global case burden. Curated as a subtype because these forms are
    frequently present at birth or in early infancy and are indistinguishable at
    presentation from the developmental forms.
  evidence:
  - reference: PMID:29262276
    reference_title: "Endoscopic Treatment versus Shunting for Infant Hydrocephalus in Uganda."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hydrocephalus in this region is most commonly postinfectious, occurring
      after neonatal ventriculitis.
    explanation: >-
      Establishes post-infectious hydrocephalus after neonatal ventriculitis as
      the predominant form in the region carrying the largest share of global
      infant hydrocephalus.
  - reference: PMID:29701543
    reference_title: "Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The high crude birth rate, greater proportion of patients with
      postinfectious etiology, and higher incidence of NTDs all contribute to a
      case volume in low- and middle-income countries that outweighs that in
      high-income countries by more than 20-fold.
    explanation: >-
      Quantifies the contribution of the post-infectious subtype to the global
      distribution of paediatric hydrocephalus.
prevalence:
- population: Worldwide (high-income countries)
  measure_type: BIRTH_PREVALENCE
  prevalence_class: BAND_1_5_PER_10000
  rate_per_100000: 79.0
  rate_low: 68.0
  rate_high: 90.0
  notes: >-
    Pooled incidence of congenital hydrocephalus in high-income countries,
    79 per 100,000 births (95% CI 68-90), from a systematic review and
    meta-analysis of 78 articles across all WHO regions.
  evidence:
  - reference: PMID:29701543
    reference_title: "Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The incidence was higher in low- and middle-income countries (123 per
      100,000 births; 95% CI 98-152 births) than in high-income countries (79
      per 100,000 births; 95% CI 68-90 births)
    explanation: >-
      Directly reports the pooled high-income-country birth incidence curated
      here, alongside the LMIC figure recorded in the companion record.
- population: Low- and middle-income countries
  measure_type: BIRTH_PREVALENCE
  prevalence_class: ABOVE_1_IN_1000
  rate_per_100000: 123.0
  rate_low: 98.0
  rate_high: 152.0
  notes: >-
    Pooled incidence 123 per 100,000 births (95% CI 98-152); regional pooled
    incidence was highest in Latin America (316 per 100,000) and Africa (145 per
    100,000). Nearly 400,000 new cases of paediatric hydrocephalus are predicted
    worldwide each year.
  evidence:
  - reference: PMID:29701543
    reference_title: "Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The pooled incidence of congenital hydrocephalus was highest in Africa and
      Latin America (145 and 316 per 100,000 births, respectively) and lowest in
      the United States/Canada (68 per 100,000 births)
    explanation: >-
      Reports the regional gradient underlying the LMIC pooled incidence curated
      here.
- population: Infants diagnosed before one year of age (Denmark, population-based)
  measure_type: BIRTH_PREVALENCE
  prevalence_class: ABOVE_1_IN_1000
  rate_per_100000: 110.0
  notes: >-
    1.1 per 1,000 infants in a 30-year population-based Danish study of
    idiopathic infantile hydrocephalus; Chiari I and Dandy-Walker malformations
    were included but neural tube defects were excluded, so this figure
    understates the total burden.
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The authors found an estimated prevalence of 1.1 per 1,000 infants.
    explanation: >-
      The population-based Danish estimate that is the most widely cited
      prevalence figure for infantile hydrocephalus.
pathophysiology:
- name: Genetic Disruption of Ventricular Zone Neural Stem Cell Fate
  biological_scale: MOLECULAR
  role: trigger
  genes:
  - preferred_term: TRIM71
    term:
      id: hgnc:32669
      label: TRIM71
  - preferred_term: SMARCC1
    term:
      id: hgnc:11104
      label: SMARCC1
  - preferred_term: PTCH1
    term:
      id: hgnc:9585
      label: PTCH1
  description: >-
    Damaging de novo and transmitted variants in genes that govern the fate of
    ventricular-zone neural stem cells — TRIM71, SMARCC1, PTCH1 and duplication
    of its ligand SHH, plus a longer list emerging from larger cohorts — are
    found in a substantial minority of sporadic, neurosurgically treated
    congenital hydrocephalus. These are not CSF-handling genes: every one of
    them is required for neural tube development and regulates neural stem cell
    fate, which is what makes this arm mechanistically distinct from the
    obstruction arm rather than merely another route into it.
  cell_types:
  - preferred_term: neural stem cell
    term:
      id: CL:0000047
      label: neural stem cell
  - preferred_term: radial glial cell
    term:
      id: CL:0000681
      label: radial glial cell
  biological_processes:
  - preferred_term: neural precursor cell proliferation
    term:
      id: GO:0061351
      label: neural precursor cell proliferation
    modifier: ABNORMAL
  - preferred_term: smoothened signaling pathway
    term:
      id: GO:0007224
      label: smoothened signaling pathway
    modifier: ABNORMAL
  locations:
  - preferred_term: brain ventricle
    term:
      id: UBERON:0004086
      label: brain ventricle
  evidence:
  - reference: PMID:29983323
    reference_title: "De Novo Mutation in Genes Regulating Neural Stem Cell Fate in Human Congenital Hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Strikingly, all four genes are required for neural tube development and
      regulate ventricular zone neural stem cell fate.
    explanation: >-
      States the convergence of the significantly burdened genes on
      ventricular-zone neural stem cell fate, which is the claim this node makes.
  - reference: PMID:33077954
    reference_title: "Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Through whole-exome sequencing of 381 patients (232 trios) with sporadic,
      neurosurgically treated CH, we found that damaging de novo mutations
      account for >17% of cases, with five different genes exhibiting a
      significant de novo mutation burden.
    explanation: >-
      Quantifies the de novo mutational burden in a large sporadic cohort,
      establishing that this arm accounts for a substantial fraction of cases.
  downstream:
  - target: Impaired Fetal Neuro-Gliogenesis and Brain Dysgenesis
    causal_link_type: DIRECT
    hypothesis_groups:
    - neural_stem_cell_dysgenesis_model
    description: >-
      Loss of normal neural stem cell fate regulation in the ventricular zone
      distorts the prenatal neuro-gliogenic programme that builds the
      periventricular brain.
- name: L1CAM-Mediated Neural Adhesion and Axon Guidance Failure
  biological_scale: MOLECULAR
  role: trigger
  genes:
  - preferred_term: L1CAM
    term:
      id: hgnc:6470
      label: L1CAM
  - preferred_term: AP1S2
    term:
      id: hgnc:560
      label: AP1S2
  description: >-
    Loss-of-function variants in L1CAM remove a neural recognition molecule of
    the immunoglobulin superfamily required for intercellular adhesion, neuronal
    migration, axon guidance and fasciculation. The consequence is a set of
    structural malformations — corticospinal tract hypoplasia or aplasia,
    callosal abnormality, and obstruction of CSF flow most commonly at the
    aqueduct — rather than a primary defect of CSF secretion or absorption.
  biological_processes:
  - preferred_term: cell adhesion
    term:
      id: GO:0007155
      label: cell adhesion
    modifier: DECREASED
  - preferred_term: axon guidance
    term:
      id: GO:0007411
      label: axon guidance
    modifier: ABNORMAL
  locations:
  - preferred_term: brain
    term:
      id: UBERON:0000955
      label: brain
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The L1CAM gene product is a neural recognition molecule that plays key
      roles in neuronal migration and axon guidance
    explanation: >-
      States the molecular function whose loss defines this node.
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      When mutated, it gives rises to several structural malformations that
      obstruct CSF flow, most commonly at the level of the aqueduct
    explanation: >-
      Connects L1CAM loss of function to the obstructive malformation this node
      feeds, and locates the obstruction at the aqueduct.
  downstream:
  - target: Aqueductal Stenosis, Atresia and Forking
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - csf_dynamics_model
    description: >-
      L1CAM-dependent malformation of the periaqueductal neuroepithelium
      narrows or occludes the aqueduct.
  - target: Adducted Thumbs
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Adducted thumbs accompany L1CAM loss of function in 88% of
      mutation-positive autopsy subjects; the intermediates between the
      adhesion/guidance defect and the thumb posture are not established.
  - target: Spasticity
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Hypoplasia or aplasia of the corticospinal tracts, present in 98% of
      L1CAM-mutation-positive autopsy subjects, is the intermediate between the
      axon-guidance defect and the spastic phenotype.
  - target: Abnormal Corpus Callosum Morphology
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Failure of callosal axon guidance and fasciculation produces the callosal
      abnormality seen in 98% of L1CAM-mutation-positive autopsy subjects.
- name: Neuroepithelial Planar Polarity and Apical Constriction Failure
  biological_scale: CELLULAR
  role: effector
  genes:
  - preferred_term: CCDC88C
    term:
      id: hgnc:19967
      label: CCDC88C
  - preferred_term: MPDZ
    term:
      id: hgnc:7208
      label: MPDZ
  - preferred_term: CRB2
    term:
      id: hgnc:18688
      label: CRB2
  - preferred_term: WDR81
    term:
      id: hgnc:26600
      label: WDR81
  conforms_to: "ciliopathy_dysfunction#Planar Cell Polarity and Non-Canonical Wnt Disruption"
  description: >-
    The autosomal recessive arm converges on the planar-polarity and apical
    constriction machinery of the ventricular neuroepithelium. CCDC88C encodes
    DAPLE, a Dishevelled-binding protein that contributes to ependymal planar
    polarity by inhibiting non-canonical Wnt signalling and that physically
    interacts with MPDZ (a multi-PDZ apical junction scaffold) and CRB2; the
    three cooperate to promote apical cell constriction during neurulation.
    The node is named for apical constriction rather than for junctional
    disruption on the strength of its own negative evidence: in the human CRB2
    fetal cases, PAR-complex components and tight- and adherens-junction
    molecules were normally localized, so the lesion is not a generalized loss
    of apicobasal polarity. What it produces is frank malformation of the
    ependymal-lined channels (atresia and forking) with periventricular neuronal
    heterotopia.
  cell_types:
  - preferred_term: ependymal cell
    term:
      id: CL:0000065
      label: ependymal cell
  - preferred_term: choroid plexus epithelial cell
    term:
      id: CL:0000706
      label: choroid plexus epithelial cell
  biological_processes:
  - preferred_term: establishment of planar polarity
    term:
      id: GO:0001736
      label: establishment of planar polarity
    modifier: ABNORMAL
  - preferred_term: non-canonical Wnt signaling pathway
    term:
      id: GO:0035567
      label: non-canonical Wnt signaling pathway
    modifier: ABNORMAL
  locations:
  - preferred_term: brain ventricle
    term:
      id: UBERON:0004086
      label: brain ventricle
  evidence:
  - reference: PMID:34092257
    reference_title: "Neuropathological hallmarks of fetal hydrocephalus linked to CCDC88C pathogenic variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      CCDC88C encodes the protein DAPLE which contributes to ependymal cell
      planar polarity by inhibiting the non-canonical Wnt signaling pathway and
      interacts with MPDZ and PARD3.
    explanation: >-
      States the shared planar-polarity/non-canonical-Wnt module that unites the
      CCDC88C and MPDZ subtypes at this node.
  - reference: PMID:21031079
    reference_title: "Disturbed Wnt Signalling due to a Mutation in CCDC88C Causes an Autosomal Recessive Non-Syndromic Hydrocephalus with Medial Diverticulum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      CCDC88C encodes DAPLE (HkRP2), a Hook-related protein with a binding
      domain for the central Wnt signalling pathway protein Dishevelled.
    explanation: >-
      Independent confirmation of the DAPLE-Dishevelled interaction that places
      this subtype in the non-canonical Wnt/planar-polarity module.
  - reference: PMID:34092257
    reference_title: "Neuropathological hallmarks of fetal hydrocephalus linked to CCDC88C pathogenic variants."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      The pathophysiology of MPDZ-linked hydrocephalus has been attributed to
      hyperpermeability of the choroid plexus epithelial cells in mice
    explanation: >-
      Records the MPDZ-specific barrier-permeability reading of this node;
      evidence is murine, which the entry does not upgrade to a human claim.
  - reference: PMID:36803301
    reference_title: "Bi-allelic variations in CRB2, encoding the crumbs cell polarity complex component 2, lead to non-communicating hydrocephalus due to atresia of the aqueduct of sylvius and central canal of the medulla."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Overall, our findings argue for a common mechanism of CRB2, MPDZ and
      CCDC88C variations that might lead to abnormal apical constriction of the
      ventricular cells of the neural tube that will form the ependymal cells
      lining the definitive central canal of the medulla.
    explanation: >-
      Proposes apical constriction of the neural-tube ventricular cells as the
      shared mechanism of the CRB2/MPDZ/CCDC88C group, refining what this node
      asserts.
  - reference: PMID:36803301
    reference_title: "Bi-allelic variations in CRB2, encoding the crumbs cell polarity complex component 2, lead to non-communicating hydrocephalus due to atresia of the aqueduct of sylvius and central canal of the medulla."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      immunolabelling experiments in our fetal cases showed normal localization
      and level of PAR complex components (PKCι and PKCζ) as well as of tight
      (ZO-1) and adherens (β-catenin and N-Cadherin) junction molecules
      indicating a priori normal apicobasal polarity and cell-cell adhesion of
      the ventricular epithelium suggesting another pathological mechanism
    explanation: >-
      Recorded as PARTIAL, and deliberately kept: in the CRB2 fetal cases
      apicobasal polarity and junctional molecules were normal, so this node
      should not be read as asserting a generalized loss of ependymal polarity.
      The authors propose apical constriction instead.
  downstream:
  - target: Aqueductal Stenosis, Atresia and Forking
    causal_link_type: DIRECT
    hypothesis_groups:
    - csf_dynamics_model
    description: >-
      Failure of neuroepithelial polarity and junctional integrity along the
      aqueduct and central canal produces atresia-forking of those channels.
  - target: Ependymal Motile Cilia Beat Dysfunction and Loss of Directional CSF Flow
    causal_link_type: DIRECT
    description: >-
      Rotational and translational planar polarity of ependymal basal bodies is
      what aligns ciliary beating; losing it decouples the cilia from a common
      axis even when the cilia themselves are assembled normally.
  - target: Periventricular Nodular Heterotopia
    causal_link_type: DIRECT
    description: >-
      Failure of the ventricular neuroepithelial surface leaves nodules of
      arrested neurons along the ventricular wall, observed directly in human
      CCDC88C fetal material.
- name: Ependymal Motile Cilia Beat Dysfunction and Loss of Directional CSF Flow
  biological_scale: CELLULAR
  role: effector
  genes:
  - preferred_term: FOXJ1
    term:
      id: hgnc:3816
      label: FOXJ1
  conforms_to: "ciliopathy_dysfunction#Motile Cilia Beat Dysfunction"
  description: >-
    Multiciliated ependymal cells line the ventricular wall and generate
    directional CSF movement by coordinated ciliary beating. When intracellular
    and intercellular rotational alignment of the basal bodies is lost — as in
    compound ablation of the Dishevelled genes, the same non-canonical Wnt
    effectors that DAPLE regulates — the cilia are present and the cells
    differentiate normally, but the flow they generate is significantly slower,
    and hydrocephalus follows. This node is curated with an explicit caveat: the
    supporting mechanistic evidence is murine, human motile ciliopathies
    infrequently cause hydrocephalus, and the entry does not treat cilia-driven
    flow as the primary determinant of human fetal ventricular volume (see the
    HUMAN_MODEL_MISMATCH discussion).
  cell_types:
  - preferred_term: ependymal cell
    term:
      id: CL:0000065
      label: ependymal cell
  biological_processes:
  - preferred_term: cilium movement
    term:
      id: GO:0003341
      label: cilium movement
    modifier: ABNORMAL
  - preferred_term: cerebrospinal fluid circulation
    term:
      id: GO:0090660
      label: cerebrospinal fluid circulation
    modifier: DECREASED
  locations:
  - preferred_term: brain ventricle
    term:
      id: UBERON:0004086
      label: brain ventricle
  evidence:
  - reference: PMID:25043421
    reference_title: "Loss of Dishevelleds disrupts planar polarity in ependymal motile cilia and results in hydrocephalus."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Defects in ependymal (E) cells, which line the ventricle and generate
      cerebrospinal fluid flow through ciliary beating, can cause hydrocephalus.
    explanation: >-
      States the node's core claim linking ependymal ciliary beating to CSF flow
      and to hydrocephalus.
  - reference: PMID:25043421
    reference_title: "Loss of Dishevelleds disrupts planar polarity in ependymal motile cilia and results in hydrocephalus."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      In hGFAP-Cre;Dvl1(-/-);2(flox/flox);3(+/-) mutants, E cells differentiated
      normally, but the intracellular and intercellular rotational alignments of
      ependymal motile cilia were disrupted.
    explanation: >-
      Establishes that the lesion is one of ciliary alignment rather than of
      ependymal differentiation, which is what makes this node the downstream
      partner of the planar-polarity node rather than a duplicate of it.
  - reference: PMID:35903173
    reference_title: "Ependymal Cilia: Physiology and Role in Hydrocephalus."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Ependymal cilia protrude from ECs, and their synchronous pulsing
      transports CSF from the lateral ventricle to the third and fourth
      ventricles, and then to the subarachnoid cavity for absorption.
    explanation: >-
      Review statement of the normal physiology this node perturbs. Evidence
      source is OTHER because the snippet is a background mechanistic statement.
  downstream:
  - target: Progressive Ventricular Dilatation and Raised Intracranial Pressure
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - csf_dynamics_model
    description: >-
      Slowed and disorganized intraventricular CSF movement contributes to net
      ventricular fluid accumulation. Curated as indirect and hypothesis-scoped:
      the quantitative contribution of ciliary flow to human ventricular volume
      is contested.
- name: Aqueductal Stenosis, Atresia and Forking
  biological_scale: TISSUE
  role: effector
  description: >-
    Narrowing, atresia or forking of the cerebral aqueduct is the single most
    common structural lesion in hydrocephalus that is otherwise confined to the
    brain, and it is the classic proximal obstruction. In CCDC88C-related
    disease the lesion is not a plug but a developmental malformation:
    multifocal atresia-forking, with the residual channel replaced by rosettes
    of ependymal cells, extending beyond the aqueduct into the central canal of
    the medulla. Note that aqueductal patency at autopsy does not exclude the
    subtype — an affected 20-week fetus in one CCDC88C family had a patent
    aqueduct despite MRI evidence of obstruction.
  cell_types:
  - preferred_term: ependymal cell
    term:
      id: CL:0000065
      label: ependymal cell
  locations:
  - preferred_term: midbrain cerebral aqueduct
    term:
      id: UBERON:0002289
      label: midbrain cerebral aqueduct
  biological_processes:
  - preferred_term: cerebrospinal fluid circulation
    term:
      id: GO:0090660
      label: cerebrospinal fluid circulation
    modifier: DECREASED
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Of patients whose clinical phenotype is characterized by hydrocephalus
      without additional major clinical exam findings, the majority have
      obstruction at the level of the aqueduct
    explanation: >-
      Establishes aqueductal obstruction as the dominant lesion site in
      brain-limited congenital hydrocephalus.
  - reference: PMID:34092257
    reference_title: "Neuropathological hallmarks of fetal hydrocephalus linked to CCDC88C pathogenic variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      AS atresia consisted of few rosettes lined by ependymal cells
    explanation: >-
      Human fetal histology showing that the aqueductal lesion is a
      malformation of the ependymal-lined channel rather than a simple blockage.
  downstream:
  - target: Progressive Ventricular Dilatation and Raised Intracranial Pressure
    causal_link_type: DIRECT
    hypothesis_groups:
    - csf_dynamics_model
    description: >-
      Proximal obstruction at the aqueduct prevents egress of CSF from the
      lateral and third ventricles, which distend.
  - target: Aqueductal Stenosis
    causal_link_type: DIRECT
    description: >-
      The narrowed or atretic aqueduct is what is reported radiologically and
      at autopsy as aqueductal stenosis.
- name: Neural Tube Defect with Chiari II Hindbrain Herniation and Small Posterior Fossa
  biological_scale: TISSUE
  role: trigger
  description: >-
    In open neural tube defects the hindbrain deformity and the hydrocephalus
    share a single embryological origin. Under the McLone-Knepper unified theory
    the open neural tube prevents the embryonic ventricular system from
    distending; without that distension the posterior fossa never reaches normal
    size, and the cerebellum, fourth ventricle and medulla are displaced
    caudally. The resulting Chiari II configuration obstructs CSF egress at the
    fourth ventricular outflow and foramen magnum — a distal, not proximal,
    obstruction. This entry cross-references, and deliberately does not absorb,
    the separate spina bifida cystica disease entity.
  locations:
  - preferred_term: brain
    term:
      id: UBERON:0000955
      label: brain
  biological_processes:
  - preferred_term: cerebrospinal fluid circulation
    term:
      id: GO:0090660
      label: cerebrospinal fluid circulation
    modifier: DECREASED
  evidence:
  - reference: PMID:2699756
    reference_title: "The cause of Chiari II malformation: a unified theory."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The cause of the Chiari II hindbrain deformity in children born with a
      myelomeningocele can be explained by the lack of distention of the
      embryonic ventricular system.
    explanation: >-
      States the unified-theory mechanism curated at this node. Evidence source
      is OTHER because the snippet is a theoretical/mechanistic proposal rather
      than a reported study result.
  - reference: PMID:2699756
    reference_title: "The cause of Chiari II malformation: a unified theory."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Defective occlusion and an open neural tube precludes the accumulation of
      fluid and pressure within the cranial vesicles.
    explanation: >-
      Names the proximate embryological failure — loss of ventricular pressure
      through the open neural tube — that this node depends on.
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Animal models suggest that chronic intrauterine CSF leakage produces the
      distinctive Chiari II malformation
    explanation: >-
      Independent statement of the same causal direction — CSF leak upstream of
      the Chiari II malformation — with the model-organism basis named.
  downstream:
  - target: Progressive Ventricular Dilatation and Raised Intracranial Pressure
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - csf_dynamics_model
    description: >-
      Caudal displacement of the hindbrain into a small posterior fossa
      obstructs fourth ventricular outflow and CSF passage at the foramen
      magnum.
  - target: Chiari Type II Malformation
    causal_link_type: DIRECT
    description: >-
      The hindbrain herniation with small posterior fossa is what is reported
      radiologically as the Chiari II malformation.
- name: Intraventricular Haemorrhage and Choroid Plexus Inflammatory Activation
  biological_scale: TISSUE
  role: trigger
  description: >-
    Intraventricular blood — germinal matrix haemorrhage of prematurity, or
    cryptic prenatal microhaemorrhage detectable only as hemosiderin-laden
    macrophages within a structurally normal aqueduct — activates a Toll-like
    receptor 4 and NF-kB-dependent inflammatory response in the choroid plexus
    epithelium. This is an inflammatory rather than a mechanical lesion, and it
    is why post-haemorrhagic hydrocephalus is curated as more than an obstructed
    or scarred absorption surface.
  cell_types:
  - preferred_term: choroid plexus epithelial cell
    term:
      id: CL:0000706
      label: choroid plexus epithelial cell
  locations:
  - preferred_term: choroid plexus
    term:
      id: UBERON:0001886
      label: choroid plexus
  evidence:
  - reference: PMID:28692063
    reference_title: "Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      In a rat model of PHH, we demonstrate that IVH causes a Toll-like receptor
      4 (TLR4)- and NF-κB-dependent inflammatory response in the CPE that is
      associated with a ∼3-fold increase in bumetanide-sensitive CSF secretion.
    explanation: >-
      Establishes the inflammatory response of the choroid plexus epithelium to
      intraventricular haemorrhage that defines this node.
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Thus, some apparently idiopathic hydrocephalus may in fact be due to
      unrecognized prenatal intraventricular hemorrhage.
    explanation: >-
      Supports treating haemorrhage as a prenatal trigger of congenital
      hydrocephalus, not only a postnatal complication.
  downstream:
  - target: Choroid Plexus CSF Hypersecretion
    causal_link_type: DIRECT
    hypothesis_groups:
    - csf_dynamics_model
    description: >-
      TLR4-NF-kB activation in the choroid plexus epithelium drives the
      secretory phenotype at the next node.
  - target: Impaired CSF Absorption and Perivascular Clearance
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - csf_dynamics_model
    description: >-
      Blood products in the subarachnoid space are the classical route to
      obliterative arachnoiditis and impaired CSF translocation, the reading
      that post-haemorrhagic hydrocephalus was historically attributed to.
- name: Choroid Plexus CSF Hypersecretion
  biological_scale: CELLULAR
  role: effector
  description: >-
    The choroid plexus epithelium secretes more fluid than any other epithelium.
    In a rat model of post-haemorrhagic hydrocephalus, TLR4-dependent activation
    of the Ste20-type stress kinase SPAK phosphorylates and stimulates the
    apical NKCC1 cotransporter, producing an approximately three-fold,
    bumetanide-sensitive increase in CSF secretion — so on that evidence the
    secretion rate rises rather than the absorption surface simply failing.
    Scope caveat, and it is the same discipline applied to the cilia and
    perivascular-clearance nodes: the entire SPAK-NKCC1 chain here is rodent,
    and no human measurement of post-haemorrhagic CSF hypersecretion is curated
    in this entry. The node carries a HUMAN_MODEL_MISMATCH discussion for that
    reason. It remains the node with the clearest pharmacological handle in the
    entry, and it is the mechanistic rationale for choroid plexus cauterization
    as a component of endoscopic treatment.
  cell_types:
  - preferred_term: choroid plexus epithelial cell
    term:
      id: CL:0000706
      label: choroid plexus epithelial cell
  locations:
  - preferred_term: choroid plexus
    term:
      id: UBERON:0001886
      label: choroid plexus
  biological_processes:
  - preferred_term: cerebrospinal fluid secretion
    term:
      id: GO:0033326
      label: cerebrospinal fluid secretion
    modifier: INCREASED
  molecular_functions:
  - preferred_term: NKCC1 sodium-potassium-chloride cotransport
    term:
      id: GO:0008511
      label: sodium:potassium:chloride symporter activity
    modifier: INCREASED
  evidence:
  - reference: PMID:28692063
    reference_title: "Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      IVH-induced hypersecretion of CSF is mediated by TLR4-dependent activation
      of the Ste20-type stress kinase SPAK, which binds, phosphorylates, and
      stimulates the NKCC1 co-transporter at the CPE apical membrane.
    explanation: >-
      Names the SPAK-NKCC1 signalling axis that this node asserts.
  - reference: PMID:28692063
    reference_title: "Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Genetic depletion of TLR4 or SPAK normalizes hyperactive CSF secretion
      rates and reduces PHH symptoms
    explanation: >-
      Loss-of-function rescue establishing the axis as necessary for the
      hypersecretion phenotype rather than merely correlated with it.
  downstream:
  - target: Progressive Ventricular Dilatation and Raised Intracranial Pressure
    causal_link_type: DIRECT
    hypothesis_groups:
    - csf_dynamics_model
    description: >-
      A sustained increase in CSF production against unchanged clearance raises
      net intraventricular fluid volume.
- name: Impaired CSF Absorption and Perivascular Clearance
  biological_scale: TISSUE
  role: effector
  description: >-
    The distal, non-obstructive route to ventricular enlargement: CSF is
    produced normally but cannot be translocated out of the craniospinal
    compartment. In the familiar bulk-flow model this is failure at the
    arachnoid granulations, but up to a third of CSF leaves the skull along
    cranial nerve sheaths into the lymphatic system, and CSF has been shown to
    move along paravascular pathways into the parenchyma and thence to the
    systemic circulation. This entry deliberately does NOT declare conforms_to
    against the glymphatic_dysfunction module here. Conformance is a structural
    assertion that tooling reads as satisfied, and the honest state of the
    evidence does not support it: the source literature states plainly that
    whether disturbances of the lymphatic exit pathway contribute to human
    hydrocephalus is not known, and the module itself carries an unresolved
    convective-versus-diffusive controversy. The relationship is recorded as a
    KNOWLEDGE_GAP discussion attached to this node instead, which is where a
    claim this uncertain belongs.
  cell_types:
  - preferred_term: astrocyte
    term:
      id: CL:0000127
      label: astrocyte
  biological_processes:
  - preferred_term: cerebrospinal fluid circulation
    term:
      id: GO:0090660
      label: cerebrospinal fluid circulation
    modifier: DECREASED
  locations:
  - preferred_term: perivascular space
    term:
      id: UBERON:0014930
      label: perivascular space
  - preferred_term: brain
    term:
      id: UBERON:0000955
      label: brain
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Recently, CSF has also been found to flow in a pulsatile manner from the
      intracranial subarachnoid space into the brain parenchyma, and then into
      the systemic circulation, along paravascular pathways
    explanation: >-
      Establishes the paravascular efflux route as normal physiology within the
      hydrocephalus literature. It describes the route, not a lesion in
      hydrocephalus — which is exactly why this entry records the relationship
      as a KNOWLEDGE_GAP rather than as module conformance. Evidence source is
      OTHER because the snippet is review background citing rodent work.
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Notably, up to one third of CSF exits the skull along cranial nerve
      sheaths and into the lymphatic system rather than into the venous sinuses
    explanation: >-
      Quantifies the non-arachnoid-granulation efflux route whose failure this
      node models.
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: NO_EVIDENCE
    evidence_source: OTHER
    snippet: >-
      but whether they play a role in the pathogenesis of human hydrocephalus is
      not yet known
    explanation: >-
      Recorded as NO_EVIDENCE rather than PARTIAL: the source is not partially
      supporting the claim, it is stating that the evidence does not exist. This
      is why the entry declines to declare glymphatic module conformance at this
      node.
  downstream:
  - target: Progressive Ventricular Dilatation and Raised Intracranial Pressure
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - csf_dynamics_model
    description: >-
      Failure to translocate CSF into the venous and lymphatic circulations
      raises the steady-state intracranial CSF volume without any point of
      intraventricular obstruction — the communicating pattern.
- name: Impaired Fetal Neuro-Gliogenesis and Brain Dysgenesis
  biological_scale: CELLULAR
  role: effector
  description: >-
    The parallel, non-plumbing arm. Multiple congenital hydrocephalus genes are
    regulators of neural stem cell biology and converge on human transcriptional
    networks and cell types specific to fetal neuro-gliogenesis. On this
    reading, the enlarged ventricle in a subset of patients is a read-out of
    periventricular brain that was never properly built, rather than of fluid
    pushed against an obstruction. The prediction is clinical and testable: CSF
    diversion should not normalize outcome in these patients, and indeed poor
    neurodevelopmental outcomes and persistent ventriculomegaly after surgery
    are what motivated the search.
  cell_types:
  - preferred_term: neural stem cell
    term:
      id: CL:0000047
      label: neural stem cell
  - preferred_term: radial glial cell
    term:
      id: CL:0000681
      label: radial glial cell
  biological_processes:
  - preferred_term: neural precursor cell proliferation
    term:
      id: GO:0061351
      label: neural precursor cell proliferation
    modifier: ABNORMAL
  - preferred_term: gliogenesis
    term:
      id: GO:0042063
      label: gliogenesis
    modifier: ABNORMAL
  locations:
  - preferred_term: brain
    term:
      id: UBERON:0000955
      label: brain
  evidence:
  - reference: PMID:33077954
    reference_title: "Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Multiple CH genes are key regulators of neural stem cell biology and
      converge in human transcriptional networks and cell types pertinent for
      fetal neuro-gliogenesis.
    explanation: >-
      States the convergence on fetal neuro-gliogenesis that defines this node.
  - reference: PMID:29983323
    reference_title: "De Novo Mutation in Genes Regulating Neural Stem Cell Fate in Human Congenital Hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These results implicate impaired neurogenesis (rather than active CSF
      accumulation) in the pathogenesis of a subset of CH patients
    explanation: >-
      Explicitly contrasts this arm with the CSF-accumulation arm, which is why
      the two are curated as competing hypotheses rather than as one chain.
  downstream:
  - target: Progressive Ventricular Dilatation and Raised Intracranial Pressure
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - neural_stem_cell_dysgenesis_model
    description: >-
      Under the dysgenesis reading the ventricle enlarges because the
      periventricular parenchyma is deficient, so the association with raised
      pressure is variable rather than obligatory.
  - target: Neurodevelopmental Impairment and Periventricular White Matter Injury
    causal_link_type: DIRECT
    hypothesis_groups:
    - neural_stem_cell_dysgenesis_model
    description: >-
      Under this model the neurodevelopmental deficit is primary and shares its
      origin with the ventriculomegaly, rather than being caused by it.
  - target: Intellectual Disability
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - neural_stem_cell_dysgenesis_model
    description: >-
      Cognitive outcome on this arm is a consequence of the dysgenesis itself,
      which is why it is not expected to be rescued by pressure relief alone.
- name: Progressive Ventricular Dilatation and Raised Intracranial Pressure
  biological_scale: TISSUE
  role: central_effector
  description: >-
    The convergent node of the entry: active distension of the ventricular
    system, reached from proximal obstruction (aqueduct), distal obstruction
    (fourth ventricular outflow, foramen magnum), CSF hypersecretion, failed
    absorption, or — on the competing reading — primary brain dysgenesis.
    Progressive distension raises intracranial pressure, which in the infant
    with open sutures presents as accelerating head growth, a full fontanelle
    and splayed sutures before it presents as classical intracranial
    hypertension.
  biological_processes:
  - preferred_term: cerebrospinal fluid circulation
    term:
      id: GO:0090660
      label: cerebrospinal fluid circulation
    modifier: ABNORMAL
  locations:
  - preferred_term: brain ventricle
    term:
      id: UBERON:0004086
      label: brain ventricle
  - preferred_term: telencephalic ventricle
    term:
      id: UBERON:0002285
      label: telencephalic ventricle
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hydrocephalus is a common but complex condition caused by physical or
      functional obstruction of CSF flow that leads to progressive ventricular
      dilatation.
    explanation: >-
      States the canonical definition of the central effector node and its
      upstream requirement of physical or functional obstruction.
  - reference: PMID:39218781
    reference_title: "The Conundrum of Mechanics Versus Genetics in Congenital Hydrocephalus and Its Implications for Fetal Therapy Approaches: A Scoping Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      In many cases, prenatal ultrasound can readily identify ventriculomegaly
      as early as 14-20 weeks of gestation, with severe cases showing poor
      neurodevelopmental outcomes.
    explanation: >-
      Establishes the prenatal timing at which this node becomes detectable and
      links its severity to outcome. Evidence source is OTHER (scoping review).
  downstream:
  - target: Neurodevelopmental Impairment and Periventricular White Matter Injury
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - csf_dynamics_model
    description: >-
      Sustained ventricular distension and raised pressure compress and stretch
      the periventricular white matter.
  - target: Hydrocephalus
    causal_link_type: DIRECT
    description: >-
      Active distension of the ventricular system is what the clinical
      phenotype of hydrocephalus names.
  - target: Ventriculomegaly
    causal_link_type: DIRECT
    description: >-
      Ventricular enlargement is the imaging read-out of this node, detectable
      prenatally from 14-20 weeks of gestation.
  - target: Increased Intracranial Pressure
    causal_link_type: DIRECT
    hypothesis_groups:
    - csf_dynamics_model
    description: >-
      Under the CSF-dynamics model, distension against a fixed cranial volume
      raises intracranial pressure. The dysgenesis arm does not require this
      step, which is why the edge is hypothesis-scoped.
  - target: Macrocephaly
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      In the fetus and infant with unfused sutures the cranium expands in
      response to the rising intraventricular volume, so head circumference
      grows rather than pressure rising acutely.
- name: Neurodevelopmental Impairment and Periventricular White Matter Injury
  biological_scale: ORGANISM
  role: consequence
  description: >-
    The clinical end state: motor, cognitive, visual and epileptic sequelae on a
    background of periventricular white matter compromise. Crucially, this node
    is reached by both hypothesis arms, and the entry does not assume CSF
    diversion reverses it — ventriculoperitoneal shunting does not address a
    genetic cause, carries high complication rates, and yields only marginal
    improvement of neurocognitive deficits.
  cell_types:
  - preferred_term: astrocyte
    term:
      id: CL:0000127
      label: astrocyte
  locations:
  - preferred_term: brain
    term:
      id: UBERON:0000955
      label: brain
  evidence:
  - reference: PMID:39218781
    reference_title: "The Conundrum of Mechanics Versus Genetics in Congenital Hydrocephalus and Its Implications for Fetal Therapy Approaches: A Scoping Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Postnatal surgical approaches, such as ventriculoperitoneal shunts, do not
      address the underlying genetic causes, have high complication rates, and
      result in a marginal improvement of neurocognitive deficits.
    explanation: >-
      Supports curating the neurodevelopmental end state as only partially
      reversible by CSF diversion. Evidence source is OTHER (scoping review).
  - reference: PMID:33077954
    reference_title: "Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The poor neurodevelopmental outcomes and persistence of ventriculomegaly
      in some post-surgical patients highlight our limited knowledge of disease
      mechanisms.
    explanation: >-
      The post-surgical observation that motivates treating this node as
      partly independent of the CSF-dynamics arm.
mechanistic_hypotheses:
- hypothesis_group_id: csf_dynamics_model
  hypothesis_label: CSF Dynamics (Obstruction, Hypersecretion and Absorption Failure) Model
  status: CANONICAL
  description: >-
    The classical and still-dominant reading: hydrocephalus is an active
    distension of the ventricular system caused by physical or functional
    obstruction of CSF flow between its point of production and its point of
    absorption, with post-haemorrhagic disease adding a hypersecretory
    component. Under this model the ventricular enlargement is the primary
    lesion, raised intracranial pressure is its mediator, and CSF diversion is
    mechanistically curative of the fluid problem.
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our preferred definition is that proposed as part of the International
      Hydrocephalus Working Group, which describes “an active distension of the
      ventricular system...resulting from inadequate passage of cerebrospinal
      fluid from its point of production within the cerebral ventricles to its
      point of absorption into the systemic circulation
    explanation: >-
      The consensus definition on which the CSF-dynamics model rests.
  notes: >-
    Scope boundary: this model is not in dispute for post-haemorrhagic,
    post-infectious and frankly obstructive disease. What the alternative
    hypothesis disputes is its sufficiency for the sporadic and Mendelian
    developmental forms.
- hypothesis_group_id: neural_stem_cell_dysgenesis_model
  hypothesis_label: Neural Stem Cell Fate Disruption and Fetal Brain Dysgenesis Model
  status: EMERGING
  description: >-
    The competing reading from large trio exome cohorts: in a substantial
    fraction of sporadic congenital hydrocephalus the causal lesion is genetic
    disruption of early brain development — ventricular-zone neural stem cell
    fate and prenatal neuro-gliogenesis — rather than impaired CSF dynamics.
    Ventriculomegaly is then a consequence of the dysgenesis, which predicts
    that CSF diversion will relieve pressure without restoring
    neurodevelopmental trajectory. Curated as EMERGING, not CANONICAL: the
    evidence is strong human genetics with a stated mechanistic inference, and
    it applies to a subset of patients, not to the disease as a whole.
  evidence:
  - reference: PMID:33077954
    reference_title: "Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These data implicate genetic disruption of early brain development, not
      impaired CSF dynamics, as the primary pathomechanism of a significant
      number of patients with sporadic CH.
    explanation: >-
      The explicit statement of the alternative pathomechanism, in direct
      contrast to the canonical model.
  - reference: PMID:29983323
    reference_title: "De Novo Mutation in Genes Regulating Neural Stem Cell Fate in Human Congenital Hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These results implicate impaired neurogenesis (rather than active CSF
      accumulation) in the pathogenesis of a subset of CH patients, with
      potential diagnostic, prognostic, and therapeutic ramifications.
    explanation: >-
      Independent cohort reaching the same conclusion and, importantly,
      restricting it to a subset of patients.
  notes: >-
    The two hypotheses are not mutually exclusive at the level of the disease —
    they may both be true of different patients — but they are mutually
    exclusive at the level of an individual case, and they make different
    predictions about what shunting can achieve. That is why they are curated as
    two hypothesis groups over a shared central effector node rather than as one
    blended chain.
phenotypes:
- category: Neurological
  name: Hydrocephalus
  description: >-
    Active distension of the ventricular system present at birth or developing in
    early infancy; the defining feature of the entry.
  phenotype_term:
    preferred_term: Hydrocephalus
    term:
      id: HP:0000238
      label: Hydrocephalus
  diagnostic: true
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In infants, hydrocephalus without an obvious extrinsic cause is usually
      referred to as congenital hydrocephalus, since it is often present at
      birth.
    explanation: >-
      Defines the entity and its timing, which is what this phenotype records.
- category: Neurological
  name: Ventriculomegaly
  description: >-
    Enlargement of the cerebral ventricles, frequently detected on prenatal
    ultrasound as early as 14-20 weeks of gestation.
  phenotype_term:
    preferred_term: Ventriculomegaly
    term:
      id: HP:0002119
      label: Ventriculomegaly
  diagnostic: true
  evidence:
  - reference: PMID:39218781
    reference_title: "The Conundrum of Mechanics Versus Genetics in Congenital Hydrocephalus and Its Implications for Fetal Therapy Approaches: A Scoping Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      In many cases, prenatal ultrasound can readily identify ventriculomegaly
      as early as 14-20 weeks of gestation, with severe cases showing poor
      neurodevelopmental outcomes.
    explanation: >-
      Establishes prenatal ventriculomegaly as the presenting finding and gives
      its gestational timing. Evidence source is OTHER (scoping review).
- category: Neurological
  name: Aqueductal Stenosis
  description: >-
    Narrowing or atresia of the cerebral aqueduct; the most common obstruction
    site in hydrocephalus whose phenotype is confined to the brain.
  phenotype_term:
    preferred_term: Aqueductal stenosis
    term:
      id: HP:0002410
      label: Aqueductal stenosis
  subtype: HSAS
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Of those mutation-positive patients, 98% had abnormalities of the corpus
      callosum, 98% had hypoplasia or aplasia of the corticospinal tracts, 90%
      had aqueductal stenosis, and 88% had adducted thumbs.
    explanation: >-
      Autopsy series quantifying aqueductal stenosis in L1CAM-mutation-positive
      patients.
- category: Neurological
  name: Adducted Thumbs
  description: >-
    Flexion-adduction deformity of the thumbs, a near-specific pointer to L1CAM
    testing in a male with unexplained hydrocephalus, though not itself
    diagnostic.
  phenotype_term:
    preferred_term: Adducted thumb
    term:
      id: HP:0001181
      label: Adducted thumb
  subtype: HSAS
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Of those mutation-positive patients, 98% had abnormalities of the corpus
      callosum, 98% had hypoplasia or aplasia of the corticospinal tracts, 90%
      had aqueductal stenosis, and 88% had adducted thumbs.
    explanation: >-
      Quantifies adducted thumbs at 88% of L1CAM-mutation-positive autopsy
      cases, supporting the VERY_FREQUENT band for this subtype.
  - reference: PMID:20301657
    reference_title: "L1 Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Males with HSAS are born with severe hydrocephalus, adducted thumbs, and
      spasticity; intellectual disability is severe.
    explanation: >-
      GeneReviews confirmation that adducted thumbs are part of the defining
      HSAS presentation.
- category: Neurological
  name: Abnormal Corpus Callosum Morphology
  description: >-
    Absent or abnormal corpus callosum, near-universal in L1CAM-related disease
    but also present in the majority of L1CAM-negative congenital hydrocephalus
    referred for testing — so it is a pointer, not a discriminator.
  phenotype_term:
    preferred_term: Abnormal corpus callosum morphology
    term:
      id: HP:0001273
      label: Abnormal corpus callosum morphology
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Among the 79 autopsy subjects without L1CAM mutations, callosal
      abnormalities were seen in 73%, corticospinal tract abnormalities in 59%,
      aqueductal stenosis in 46%, and adducted thumbs in 27%.
    explanation: >-
      Quantifies the same findings in L1CAM-negative cases, which is the basis
      for curating callosal abnormality as non-discriminating.
- category: Neurological
  name: Spasticity
  description: >-
    Spastic tone increase, typically of the lower limbs, reflecting hypoplasia
    or aplasia of the corticospinal tracts in the L1CAM spectrum.
  phenotype_term:
    preferred_term: Spasticity
    term:
      id: HP:0001257
      label: Spasticity
    clinical_course: PROGRESSIVE
  subtype: HSAS
  evidence:
  - reference: PMID:20301657
    reference_title: "L1 Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Males with HSAS are born with severe hydrocephalus, adducted thumbs, and
      spasticity; intellectual disability is severe.
    explanation: >-
      Names spasticity as a defining feature of the HSAS presentation.
- category: Neurological
  name: Intellectual Disability
  description: >-
    Cognitive impairment ranging from severe in HSAS to mild or moderate in the
    less severely affected males of the L1 syndrome spectrum.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:20301657
    reference_title: "L1 Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In less severely affected males, hydrocephalus may be subclinically
      present and documented only because of developmental delay; intellectual
      disability ranges from mild (IQ: 50-70) to moderate (IQ: 30-50).
    explanation: >-
      Gives the range of cognitive outcome across the spectrum, which is why
      this phenotype is curated without a frequency band.
- category: Neurological
  name: Periventricular Nodular Heterotopia
  description: >-
    Nodules of arrested neurons along the ventricular wall, documented in human
    fetal CCDC88C-related hydrocephalus and evidence that the ventricular
    surface itself is malformed rather than merely distended.
  phenotype_term:
    preferred_term: Periventricular nodular heterotopia
    term:
      id: HP:0032388
      label: Periventricular nodular heterotopia
  subtype: HYC1
  evidence:
  - reference: PMID:34092257
    reference_title: "Neuropathological hallmarks of fetal hydrocephalus linked to CCDC88C pathogenic variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Subependymal gray matter heterotopias were observed in both cases
    explanation: >-
      Direct neuropathological observation of periventricular heterotopia in the
      CCDC88C subtype.
- category: Neurological
  name: Chiari Type II Malformation
  description: >-
    Caudal displacement of the medulla, fourth ventricle and cerebellum into the
    spinal canal with a small posterior fossa, near-universal in infants born
    with myelomeningocele.
  phenotype_term:
    preferred_term: Chiari type II malformation
    term:
      id: HP:0025660
      label: Chiari type II malformation
  subtype: Chiari II-associated
  evidence:
  - reference: PMID:21306277
    reference_title: "A randomized trial of prenatal versus postnatal repair of myelomeningocele."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Nearly all infants who are born with myelomeningocele have the
      Arnold–Chiari II malformation, which includes a constellation of anomalies
      that include hindbrain herniation (downward displacement of the medulla,
      fourth ventricle, and cerebellum into the spinal canal), brain-stem
      abnormalities, low-lying venous sinuses, and a small posterior fossa.
    explanation: >-
      States both the near-universal co-occurrence with myelomeningocele and the
      anatomical content of the malformation.
- category: Neurological
  name: Myelomeningocele
  description: >-
    Open neural tube defect with extrusion of the spinal cord into a
    CSF-filled sac; the upstream lesion of the Chiari II-associated subtype.
  phenotype_term:
    preferred_term: Myelomeningocele
    term:
      id: HP:0002475
      label: Myelomeningocele
  subtype: Chiari II-associated
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The vast majority of patients with neural tube defects have hydrocephalus.
    explanation: >-
      Establishes the tight association between open neural tube defect and
      hydrocephalus that this phenotype records.
- category: Neurological
  name: Dandy-Walker Malformation
  description: >-
    Vermian hypoplasia with cystic dilatation of the fourth ventricle and an
    enlarged posterior fossa, producing distal obstruction of CSF egress.
  phenotype_term:
    preferred_term: Dandy-Walker malformation
    term:
      id: HP:0001305
      label: Dandy-Walker malformation
  subtype: Dandy-Walker-associated
  evidence:
  - reference: PMID:21928031
    reference_title: "Hydrocephalus in Dandy-Walker malformation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Further confusion is added by the inclusion, in some classification, of
      different malformations with different prognosis and therapeutic strategy
      under the same label of "Dandy-Walker".
    explanation: >-
      States the classification hazard that governs how this phenotype must be
      read: the "Dandy-Walker" label has been applied to malformations with
      different prognosis and treatment, so the subtype boundary is a curation
      decision rather than a given.
- category: Neurological
  name: Increased Intracranial Pressure
  description: >-
    Raised intracranial pressure from progressive ventricular distension; in
    the infant it manifests first as accelerating head growth and a full
    fontanelle.
  phenotype_term:
    preferred_term: Increased intracranial pressure
    term:
      id: HP:0002516
      label: Increased intracranial pressure
  evidence:
  - reference: PMID:33077954
    reference_title: "Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In these cases, an increase in CSF production relative to CSF reabsorption
      leads to an increase in intracranial pressure (ICP), which causes tissue
      damage, neurological impairment and death if untreated.
    explanation: >-
      Directly asserts raised intracranial pressure as a consequence of the CSF
      imbalance, and names the tissue damage and neurological impairment that
      make it a clinically consequential phenotype rather than a number.
- category: Neurological
  name: Seizure
  description: >-
    Epilepsy is a major comorbidity of childhood hydrocephalus, diagnosed in
    39.6% of a 361-patient shunted cohort with a median onset 300 days after
    hydrocephalus diagnosis. Risk tracks the underlying aetiology far more than
    the shunt itself, and is highest after brain haemorrhage.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  frequency: FREQUENT
  evidence:
  - reference: PMID:31563496
    reference_title: "Risk and risk factors for epilepsy in shunt-treated children with hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      One-hundred forty-three patients with HC (n = 361) had a diagnosis of
      epilepsy (39.6%).
    explanation: >-
      Quantifies epilepsy at 39.6% in a shunted hydrocephalus cohort, which
      places it in the FREQUENT band (30-79%).
  - reference: PMID:31563496
    reference_title: "Risk and risk factors for epilepsy in shunt-treated children with hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The most significant influence on the development of epilepsy is that of the HC itself and its underlying aetiology
    explanation: >-
      Attributes epilepsy risk to the hydrocephalus aetiology rather than to
      shunting, and identifies haemorrhage as the highest-risk subtype — which
      is why this phenotype is not curated as a treatment complication.
- category: Neurological
  name: Large Fontanelles
  description: >-
    Bulging or enlarged fontanelles in the infant with unfused sutures. Together
    with an increased head circumference and a widened lateral ventricular
    atrium it is one of the three parameters used to indicate CSF diversion
    after myelomeningocele closure.
  phenotype_term:
    preferred_term: Large fontanelles
    term:
      id: HP:0000239
      label: Large fontanelles
  diagnostic: true
  evidence:
  - reference: PMID:26352494
    reference_title: "Clinical and ultrasonographic criteria for using ventriculoperitoneal shunts in newborns with myelomeningocele."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These children had LVA width ≥ 15 mm, showed increased HC, or had bulging
      fontanels.
    explanation: >-
      Reports bulging fontanels as one of the observed findings in the
      hydrocephalic children requiring shunting in this cohort.
- category: Neurological
  name: Macrocephaly
  description: >-
    Enlarged head circumference; in the fetus and infant with open sutures the
    cranium expands rather than pressure rising acutely, so macrocephaly is
    often the presenting sign.
  phenotype_term:
    preferred_term: Macrocephaly
    term:
      id: HP:0000256
      label: Macrocephaly
  evidence:
  - reference: PMID:34092257
    reference_title: "Neuropathological hallmarks of fetal hydrocephalus linked to CCDC88C pathogenic variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      which revealed macrocephaly (head circumference >> 97th percentile) with
      severe bilateral ventriculomegaly
    explanation: >-
      Prenatal ultrasound finding of macrocephaly accompanying severe
      ventriculomegaly in a molecularly confirmed case.
genetic:
- name: L1CAM
  gene_term:
    preferred_term: L1CAM
    term:
      id: hgnc:6470
      label: L1CAM
  presence: PRESENT
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: HSAS
  inheritance:
  - name: X-linked
  case_fractions:
  - population: Non-syndromic congenital hydrocephalus with aqueductal stenosis
    case_fraction_low: 5.0
    case_fraction_high: 15.0
    notes: >-
      5-15% of the aqueductal-stenosis majority of non-syndromic congenital
      hydrocephalus is X-linked and L1CAM-related. Note this denominator is not
      the same as the male-only denominator in the companion record, so the two
      ranges are not in conflict.
    evidence:
    - reference: PMID:36803301
      reference_title: "Bi-allelic variations in CRB2, encoding the crumbs cell polarity complex component 2, lead to non-communicating hydrocephalus due to atresia of the aqueduct of sylvius and central canal of the medulla."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        stenosis of the Aqueduct of Sylvius, that connects the third and fourth
        ventricles, accounts for the majority of cases of non-syndromic (no
        extra-cerebral feature) congenital hydrocephalus, of whom 5–15% have an
        X-linked form due to variations in L1CAM
      explanation: >-
        Gives the 5-15% L1CAM share against the aqueductal-stenosis
        non-syndromic denominator.
  - population: Males with non-syndromic congenital hydrocephalus
    case_fraction_low: 5.0
    case_fraction_high: 10.0
    notes: >-
      Approximately 5-10% of males with non-syndromic congenital hydrocephalus;
      population prevalence of the HSAS phenotype about 1:30,000.
    evidence:
    - reference: PMID:34092257
      reference_title: "Neuropathological hallmarks of fetal hydrocephalus linked to CCDC88C pathogenic variants."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Pathogenic L1CAM variants are responsible for a wide phenotypic
        spectrum, X-linked hydrocephalus with stenosis of the aqueduct of
        Sylvius (AS) being the most common genetic form, with a prevalence of
        1:30,000 and accounting for approximately 5–10% of males with
        non-syndromic congenital hydrocephalus.
      explanation: >-
        Directly quantifies the L1CAM share of non-syndromic congenital
        hydrocephalus in males.
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Of these patients, L1CAM mutations remain the single most common cause,
      although mutations in this gene still explain only a minority of
      hydrocephalus.
    explanation: >-
      Establishes L1CAM as the leading single-gene cause while bounding its
      explanatory share, both of which this entry curates.
  notes: >-
    Testing guidance from the same source: L1CAM testing should be strongly
    considered in all males with unexplained hydrocephalus and is regarded as
    mandatory in the presence of a positive family history or adducted thumbs.
- name: CCDC88C
  gene_term:
    preferred_term: CCDC88C
    term:
      id: hgnc:19967
      label: CCDC88C
  presence: PRESENT
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: HYC1
  inheritance:
  - name: Autosomal Recessive
  evidence:
  - reference: PMID:21031079
    reference_title: "Disturbed Wnt Signalling due to a Mutation in CCDC88C Causes an Autosomal Recessive Non-Syndromic Hydrocephalus with Medial Diverticulum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The mutation in the affected patients, a homozygous substitution in the
      donor splice site of intron 29, resulted in a shorter transcript due to
      exclusion of exon 29 and loss of functional protein, as shown by Western
      blotting
    explanation: >-
      Demonstrates loss of functional DAPLE protein as the consequence of the
      causal allele, establishing the loss-of-function mechanism.
- name: MPDZ
  gene_term:
    preferred_term: MPDZ
    term:
      id: hgnc:7208
      label: MPDZ
  presence: PRESENT
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: HYC2
  inheritance:
  - name: Autosomal Recessive
  evidence:
  - reference: PMID:23240096
    reference_title: "Mutation in MPDZ causes severe congenital hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Remarkably, we have also identified the same founder mutation in a
      stillbirth with massive congenital hydrocephalus from another family.
    explanation: >-
      Independent segregation of the same founder allele with severe congenital
      hydrocephalus in a second family, which is what establishes causality.
- name: WDR81
  gene_term:
    preferred_term: WDR81
    term:
      id: hgnc:26600
      label: WDR81
  presence: PRESENT
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: HYC3
  inheritance:
  - name: Autosomal Recessive
  notes: >-
    Curated for completeness of the autosomal recessive non-syndromic series
    (HYC1/HYC2/HYC3) on the basis of the MONDO disease-series-by-gene axiom for
    MONDO:0054794. No evidence block is attached because this entry has not
    verified a primary WDR81 gene-discovery snippet; see CLAUDE.md SOP option C.
- name: TRIM71
  gene_term:
    preferred_term: TRIM71
    term:
      id: hgnc:32669
      label: TRIM71
  presence: PRESENT
  relationship_type: CAUSATIVE
  variant_origin: DE_NOVO
  evidence:
  - reference: PMID:29983323
    reference_title: "De Novo Mutation in Genes Regulating Neural Stem Cell Fate in Human Congenital Hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Exome sequencing of 125 CH trios and 52 additional probands identified
      three genes with significant burden of rare damaging de novo or
      transmitted mutations: TRIM71 (p = 2.15 × 10-7), SMARCC1 (p = 8.15 ×
      10-10), and PTCH1 (p = 1.06 × 10-6).
    explanation: >-
      Names TRIM71 explicitly as one of the three genes reaching exome-wide
      significance for rare damaging de novo or transmitted mutations in
      congenital hydrocephalus.
- name: SMARCC1
  gene_term:
    preferred_term: SMARCC1
    term:
      id: hgnc:11104
      label: SMARCC1
  presence: PRESENT
  relationship_type: CAUSATIVE
  variant_origin: DE_NOVO
  evidence:
  - reference: PMID:29983323
    reference_title: "De Novo Mutation in Genes Regulating Neural Stem Cell Fate in Human Congenital Hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Exome sequencing of 125 CH trios and 52 additional probands identified
      three genes with significant burden of rare damaging de novo or
      transmitted mutations: TRIM71 (p = 2.15 × 10-7), SMARCC1 (p = 8.15 ×
      10-10), and PTCH1 (p = 1.06 × 10-6).
    explanation: >-
      Names SMARCC1 explicitly, with the strongest burden statistic of the three
      genes reaching exome-wide significance in this cohort.
- name: PTCH1
  gene_term:
    preferred_term: PTCH1
    term:
      id: hgnc:9585
      label: PTCH1
  presence: PRESENT
  relationship_type: CAUSATIVE
  variant_origin: DE_NOVO
  evidence:
  - reference: PMID:29983323
    reference_title: "De Novo Mutation in Genes Regulating Neural Stem Cell Fate in Human Congenital Hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Exome sequencing of 125 CH trios and 52 additional probands identified
      three genes with significant burden of rare damaging de novo or
      transmitted mutations: TRIM71 (p = 2.15 × 10-7), SMARCC1 (p = 8.15 ×
      10-10), and PTCH1 (p = 1.06 × 10-6).
    explanation: >-
      Names PTCH1 explicitly as one of the three significantly burdened genes.
  - reference: PMID:29983323
    reference_title: "De Novo Mutation in Genes Regulating Neural Stem Cell Fate in Human Congenital Hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Additionally, two de novo duplications were identified at the SHH locus,
      encoding the PTCH1 ligand
    explanation: >-
      Adds the ligand-side de novo duplications, supporting a Hedgehog-pathway
      contribution rather than a PTCH1-only effect.
- name: AP1S2
  gene_term:
    preferred_term: AP1S2
    term:
      id: hgnc:560
      label: AP1S2
  presence: PRESENT
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  inheritance:
  - name: X-linked
  evidence:
  - reference: PMID:34092257
    reference_title: "Neuropathological hallmarks of fetal hydrocephalus linked to CCDC88C pathogenic variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Pathogenic AP1S2 variants have been linked to Pettigrew syndrome
      characterized by intellectual disability with prominent basal ganglia iron
      deposition or calcification and variable severity of hydrocephalus.
    explanation: >-
      Places AP1S2 among the small set of genes linked to congenital
      hydrocephalus as an isolated or major clinical feature, with the
      distinctive basal ganglia imaging clue.
  notes: >-
    AP1S2-related disease (Fried/Pettigrew syndrome) is a diagnostic
    consideration in a male with intellectual disability and basal ganglia iron
    or calcium deposition; both may be subtle on standard MRI and are better
    seen on CT or on GRE/SWI sequences.
- name: FOXJ1
  gene_term:
    preferred_term: FOXJ1
    term:
      id: hgnc:3816
      label: FOXJ1
  presence: PRESENT
  relationship_type: CAUSATIVE
  variant_origin: DE_NOVO
  inheritance:
  - name: Autosomal Dominant
  evidence:
  - reference: PMID:34132502
    reference_title: "Autosomal dominant variants in FOXJ1 causing primary ciliary dyskinesia in two patients with obstructive hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Recently, pathogenic variants in FOXJ1 (Chr 17q25.1) were identified
      causing PCD associated with hydrocephalus, reduced respiratory cilia
      number, axonemal microtubule disorganization, and occurring in a de novo,
      autosomal dominant inheritance pattern.
    explanation: >-
      Establishes de novo autosomal dominant FOXJ1 variants as a human cause of
      hydrocephalus arising through a motile-cilia mechanism.
  - reference: PMID:34132502
    reference_title: "Autosomal dominant variants in FOXJ1 causing primary ciliary dyskinesia in two patients with obstructive hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Though motile, ependymal cilia influencing cerebrospinal fluid flow in the
      central nervous system share many aspects of structure and function with
      motile cilia in the respiratory tract, hydrocephalus is rarely associated
      with PCD.
    explanation: >-
      Recorded as PARTIAL, and deliberately kept alongside the item above,
      because it states the very asymmetry the HUMAN_MODEL_MISMATCH discussion
      rests on: FOXJ1 is a genuine human motile-cilia route to hydrocephalus,
      and it is the exception rather than the rule among human motile
      ciliopathies.
  notes: >-
    FOXJ1 is curated specifically because it is the principal human
    counterexample to the cilia-hypothesis critique in the
    gap_cilia_hypothesis_human_translatability discussion. Omitting it would
    make that discussion look more one-sided than the literature is. Note the
    inheritance pattern is de novo autosomal dominant, unlike the mostly
    autosomal recessive remainder of primary ciliary dyskinesia.
- name: CRB2
  gene_term:
    preferred_term: CRB2
    term:
      id: hgnc:18688
      label: CRB2
  presence: PRESENT
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  inheritance:
  - name: Autosomal Recessive
  evidence:
  - reference: PMID:36803301
    reference_title: "Bi-allelic variations in CRB2, encoding the crumbs cell polarity complex component 2, lead to non-communicating hydrocephalus due to atresia of the aqueduct of sylvius and central canal of the medulla."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we report 3 cases from 2 families with congenital hydrocephalus due
      to bi-allelic variations in CRB2, a gene previously reported to cause
      nephrotic syndrome, variably associated with hydrocephalus.
    explanation: >-
      Establishes biallelic CRB2 variation as a cause of congenital
      hydrocephalus, extending the apical-junction gene group beyond CCDC88C and
      MPDZ.
  - reference: PMID:36803301
    reference_title: "Bi-allelic variations in CRB2, encoding the crumbs cell polarity complex component 2, lead to non-communicating hydrocephalus due to atresia of the aqueduct of sylvius and central canal of the medulla."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Neurohistopathological analysis allowed us to demonstrate that, contrary
      to what was previously proposed, the pathological mechanisms underlying
      hydrocephalus secondary to CRB2 variations are not due to stenosis but to
      atresia of both Sylvius Aqueduct and central medullar canal.
    explanation: >-
      Human fetal neuropathology distinguishing atresia from stenosis, the same
      lesion pattern independently reported for CCDC88C.
inheritance:
- name: X-linked
  description: >-
    X-linked recessive transmission of L1CAM-related disease (HSAS and the wider
    L1 syndrome spectrum), and of AP1S2-related Fried/Pettigrew syndrome.
    Affected males inherit the variant from a heterozygous mother; heterozygous
    females are usually unaffected but may show typically mild manifestations.
  inheritance_term:
    preferred_term: X-linked inheritance
    term:
      id: HP:0001417
      label: X-linked inheritance
  evidence:
  - reference: PMID:20301657
    reference_title: "L1 Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Males who inherit the L1CAM pathogenic variant will be affected; females
      who inherit the pathogenic variant will be heterozygotes and will usually
      not be affected but may have a range of (typically mild) clinical
      manifestations.
    explanation: >-
      GeneReviews statement of the X-linked transmission pattern and of female
      heterozygote expression.
- name: Autosomal Recessive
  description: >-
    Biallelic transmission of CCDC88C (HYC1), MPDZ (HYC2), WDR81 (HYC3) and
    CRB2. Several index families were consanguineous, and the disease is
    typically severe with prenatal presentation.
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  evidence:
  - reference: PMID:23240096
    reference_title: "Mutation in MPDZ causes severe congenital hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We have identified a family in which severe congenital hydrocephalus of
      the communicating type follows an autosomal recessive mode of inheritance.
    explanation: >-
      Direct statement of autosomal recessive segregation in a molecularly
      solved congenital hydrocephalus family.
environmental:
- name: Intrauterine infection (cytomegalovirus, Toxoplasma gondii, enterovirus, lymphocytic choriomeningitis virus)
  description: >-
    Congenital infection acquired in utero is an established route to
    hydrocephalus present at birth, and neonatal ventriculitis is the dominant
    aetiology of infant hydrocephalus in sub-Saharan Africa. The contribution of
    unrecognized intrauterine infection to apparently idiopathic congenital
    hydrocephalus is suspected but not quantified.
  effect: Triggers post-infectious congenital hydrocephalus through ventriculitis, ependymal injury and impaired CSF flow or absorption.
  influences_mechanisms:
  - target: Impaired CSF Absorption and Perivascular Clearance
    environmental_effect: TRIGGERS
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Ventriculitis and the ensuing inflammatory scarring of the ventricular
      system and subarachnoid space impede CSF translocation, the classical
      route from intrauterine or neonatal infection to hydrocephalus.
    evidence:
    - reference: PMID:29262276
      reference_title: "Endoscopic Treatment versus Shunting for Infant Hydrocephalus in Uganda."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Hydrocephalus in this region is most commonly postinfectious, occurring
        after neonatal ventriculitis.
      explanation: >-
        Establishes ventriculitis as the causal exposure route in the population
        carrying the largest share of infant hydrocephalus worldwide.
  evidence:
  - reference: PMID:29701543
    reference_title: "Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The high crude birth rate, greater proportion of patients with
      postinfectious etiology, and higher incidence of NTDs all contribute to a
      case volume in low- and middle-income countries that outweighs that in
      high-income countries by more than 20-fold.
    explanation: >-
      Quantifies the epidemiological weight of the post-infectious route at
      global scale.
  notes: >-
    No ECTO exposure_term is bound. The concept needed here is intrauterine
    infection by a specific congenital pathogen, and binding a generic
    infectious-agent exposure term would be less accurate than free text; see
    the dismech-terms rule that no term beats a bad one.
- name: Isotretinoin exposure in pregnancy
  description: >-
    Among the medications associated with infantile hydrocephalus when taken
    during pregnancy, isotretinoin has the best documented association. The
    mechanism is presumed to be disruption of retinoic acid morphogen gradients
    in the hindbrain, producing an obstructive malformation — a presumption, not
    a demonstrated chain, and curated as such.
  effect: Teratogenic exposure associated with congenital hydrocephalus, presumed to act through hindbrain morphogen disruption.
  influences_mechanisms:
  - target: Aqueductal Stenosis, Atresia and Forking
    environmental_effect: TRIGGERS
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Disruption of hindbrain retinoic acid gradients is the proposed route to
      an obstructive malformation of the CSF pathway. The intermediates are not
      established.
    evidence:
    - reference: PMID:24932902
      reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Though isotretinoin-associated hydrocephalus is incompletely
        characterized, it is presumably caused by a disruption of retinoic acid
        morphogen gradients in the hindbrain
      explanation: >-
        Recorded as PARTIAL because the source itself hedges: the association is
        documented but the mechanism is presumed rather than demonstrated.
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The best documented association is with isotretinoin
    explanation: >-
      Identifies isotretinoin as the best-documented medication association with
      infantile hydrocephalus.
treatments:
- name: Ventriculoperitoneal Shunt Placement
  description: >-
    The conventional treatment: surgical diversion of CSF from the ventricle to
    the peritoneal cavity. It reliably relieves raised intracranial pressure and
    generally produces a greater reduction in ventricular size than endoscopic
    treatment, but it creates lifelong shunt dependence with a substantial
    revision and infection burden, and — importantly for this entry — it does
    not address a genetic cause and yields only marginal improvement in
    neurocognitive deficits.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: ventriculoperitoneal shunt placement
    term:
      id: NCIT:C168483
      label: Ventriculoperitoneal Shunt Placement
  target_mechanisms:
  - target: Progressive Ventricular Dilatation and Raised Intracranial Pressure
    treatment_effect: INHIBITS
    description: >-
      CSF diversion acts on the central effector node — it removes the
      accumulated fluid and lowers intracranial pressure — and on nothing
      upstream of it.
    evidence:
    - reference: PMID:20301657
      reference_title: "L1 Syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Shunting of the cerebrospinal fluid should be performed as needed to
        reduce intracranial pressure.
      explanation: >-
        States the mechanism and indication of shunting: reduction of
        intracranial pressure, the central effector node's proximate readout.
  evidence:
  - reference: PMID:39218781
    reference_title: "The Conundrum of Mechanics Versus Genetics in Congenital Hydrocephalus and Its Implications for Fetal Therapy Approaches: A Scoping Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Postnatal surgical approaches, such as ventriculoperitoneal shunts, do not
      address the underlying genetic causes, have high complication rates, and
      result in a marginal improvement of neurocognitive deficits.
    explanation: >-
      Recorded as PARTIAL because it supports shunting as standard care while
      explicitly bounding what it achieves. Evidence source is OTHER (scoping
      review).
- name: Endoscopic Third Ventriculostomy with Choroid Plexus Cauterization
  description: >-
    The shunt-free alternative: an endoscopic stoma in the floor of the third
    ventricle diverts CSF flow, and cauterization of the choroid plexus reduces
    CSF production. It is technically harder than shunting and fails more often
    in the first months, but virtually all its failures occur within six months,
    after which the risk is low — a decisive advantage where urgent
    shunt-revision surgery is not reliably available. In a randomized trial in
    Ugandan infants with post-infectious hydrocephalus, cognitive outcomes at 12
    months did not differ significantly from ventriculoperitoneal shunting.
    Uniquely among the treatments here, its cauterization component acts on the
    CSF hypersecretion node rather than only on the fluid already accumulated.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: endoscopic third ventriculostomy
    term:
      id: NCIT:C182204
      label: Third Ventriculostomy
  target_mechanisms:
  - target: Choroid Plexus CSF Hypersecretion
    treatment_effect: INHIBITS
    description: >-
      Cauterization of the choroid plexus reduces the secretory surface and so
      lowers CSF production, acting on the hypersecretion node directly.
    evidence:
    - reference: PMID:29262276
      reference_title: "Endoscopic Treatment versus Shunting for Infant Hydrocephalus in Uganda."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The endoscopic procedure relieves hydrocephalus by diverting the flow of
        cerebrospinal fluid (CSF), and cauterization of the choroid plexus
        reduces CSF production, further reducing hydrocephalus.
      explanation: >-
        States both mechanisms of the combined procedure, and specifically that
        the cauterization component reduces CSF production.
  evidence:
  - reference: PMID:29262276
    reference_title: "Endoscopic Treatment versus Shunting for Infant Hydrocephalus in Uganda."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This single-center study involving Ugandan infants with postinfectious
      hydrocephalus showed no significant difference between endoscopic ETV-CPC
      and ventriculoperitoneal shunting with regard to cognitive outcomes at 12
      months.
    explanation: >-
      Randomized-trial conclusion establishing cognitive equipoise between the
      two procedures in the post-infectious subtype.
  - reference: PMID:29262276
    reference_title: "Endoscopic Treatment versus Shunting for Infant Hydrocephalus in Uganda."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In contrast, ETV–CPC is technically more difficult than shunting, but it
      has the advantage that virtually all failures occur within 6 months
    explanation: >-
      States the failure-timing profile that motivates ETV-CPC where urgent
      shunt revision is not reliably accessible.
- name: Prenatal Repair of Myelomeningocele
  description: >-
    In utero closure of the open neural tube defect before 26 weeks of
    gestation. In the MOMS randomized trial it roughly halved the rate of
    shunt placement by 12 months and improved hindbrain herniation, at the cost
    of increased preterm delivery and uterine dehiscence. Mechanistically this
    is the only treatment in the entry that acts on the *upstream* trigger
    rather than on the accumulated fluid: closing the defect restores the
    embryonic ventricular pressure whose absence produces the Chiari II
    configuration.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: neurosurgical procedure
    term:
      id: NCIT:C15656
      label: Neurosurgical Procedure
  target_mechanisms:
  - target: Neural Tube Defect with Chiari II Hindbrain Herniation and Small Posterior Fossa
    treatment_effect: INHIBITS
    description: >-
      Closing the open neural tube in utero halts chronic CSF leakage, allowing
      the embryonic ventricular system to distend and the posterior fossa to
      develop, which reduces hindbrain herniation and the need for shunting.
    evidence:
    - reference: PMID:21306277
      reference_title: "A randomized trial of prenatal versus postnatal repair of myelomeningocele."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Prenatal surgery also resulted in improvement in the composite score for
        mental development and motor function at 30 months (P=0.007) and in
        improvement in several secondary outcomes, including hindbrain
        herniation by 12 months and ambulation by 30 months.
      explanation: >-
        Shows prenatal repair improving hindbrain herniation itself, which is
        the node this treatment is asserted to act on.
  evidence:
  - reference: PMID:21306277
    reference_title: "A randomized trial of prenatal versus postnatal repair of myelomeningocele."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Actual rates of shunt placement were 40% in the prenatal-surgery group and
      82% in the postnatal-surgery group (relative risk, 0.48; 97.7% CI, 0.36 to
      0.64; P<0.001).
    explanation: >-
      Quantifies the reduction in shunt requirement, the outcome that makes this
      a hydrocephalus-modifying intervention.
  - reference: PMID:21306277
    reference_title: "A randomized trial of prenatal versus postnatal repair of myelomeningocele."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      However, prenatal surgery was associated with an increased risk of preterm
      delivery and uterine dehiscence at delivery.
    explanation: >-
      Recorded as PARTIAL because it states the maternal and fetal harms that
      bound the recommendation.
- name: Early Ventricular Intervention in Post-haemorrhagic Ventricular Dilatation
  description: >-
    Intervening at a low rather than a high ventriculomegaly threshold in
    preterm infants with progressive post-haemorrhagic ventricular dilatation.
    In a post hoc analysis of a multicentre randomized trial, the low-threshold
    strategy was associated with lower odds of death or severe
    neurodevelopmental disability. Curated with the trial's own caveat: this was
    a post hoc analysis and the primary comparison did not reach significance.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: cerebrospinal fluid diversion
    term:
      id: NCIT:C93208
      label: Cerebrospinal Fluid Diversion
  target_mechanisms:
  - target: Progressive Ventricular Dilatation and Raised Intracranial Pressure
    treatment_effect: INHIBITS
    description: >-
      Earlier CSF removal limits the duration and degree of ventricular
      distension before irreversible periventricular injury accrues.
    evidence:
    - reference: PMID:32800815
      reference_title: "Randomized Controlled Early versus Late Ventricular Intervention Study in Posthemorrhagic Ventricular Dilatation: Outcome at 2 Years."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        In a post hoc analysis, earlier intervention was associated with a lower
        odds of death or severe neurodevelopmental disability in preterm infants
        with progressive posthemorrhagic ventricular dilatation.
      explanation: >-
        Recorded as PARTIAL because the authors themselves label the finding a
        post hoc association rather than a confirmed primary result.
  evidence:
  - reference: PMID:32800815
    reference_title: "Randomized Controlled Early versus Late Ventricular Intervention Study in Posthemorrhagic Ventricular Dilatation: Outcome at 2 Years."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The composite adverse outcome was seen in 20 of 58 infants (35%) in the
      low threshold group and 28 of 55 (51%) in the high threshold (P = .07).
    explanation: >-
      The primary comparison, which did not reach conventional significance —
      the reason this treatment is curated as PARTIAL rather than SUPPORT.
clinical_trials:
- name: NCT01936272
  phase: PHASE_III
  status: ACTIVE_NOT_RECRUITING
  description: >-
    Randomized trial of endoscopic third ventriculostomy with choroid plexus
    cauterization versus ventriculoperitoneal shunting in Ugandan infants with
    post-infectious hydrocephalus, with BSID-3 cognitive score at 12 months as
    the primary outcome.
  target_phenotypes:
  - preferred_term: Hydrocephalus
    term:
      id: HP:0000238
      label: Hydrocephalus
  evidence:
  - reference: PMID:29262276
    reference_title: "Endoscopic Treatment versus Shunting for Infant Hydrocephalus in Uganda."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A total of 100 infants were enrolled; 51 were randomly assigned to undergo
      ETV-CPC, and 49 were assigned to undergo ventriculoperitoneal shunting.
    explanation: >-
      Records the randomized allocation of the trial whose result grounds the
      ETV-CPC treatment entry.
- name: NCT00060606
  phase: NOT_APPLICABLE
  status: COMPLETED
  description: >-
    Management of Myelomeningocele Study (MOMS): randomized trial of prenatal
    versus postnatal repair of myelomeningocele, with a co-primary outcome of
    fetal or neonatal death or the need for CSF shunt placement by 12 months.
  target_phenotypes:
  - preferred_term: Hydrocephalus
    term:
      id: HP:0000238
      label: Hydrocephalus
  - preferred_term: Myelomeningocele
    term:
      id: HP:0002475
      label: Myelomeningocele
  evidence:
  - reference: PMID:21306277
    reference_title: "A randomized trial of prenatal versus postnatal repair of myelomeningocele."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      One primary outcome was a composite of fetal or neonatal death or the need
      for placement of a cerebrospinal fluid shunt by the age of 12 months.
    explanation: >-
      Defines the shunt-placement primary endpoint that makes this trial a
      hydrocephalus trial and not only a spina bifida trial.
- name: ISRCTN43171322
  phase: NOT_APPLICABLE
  status: COMPLETED
  description: >-
    ELVIS (Early versus Late Ventricular Intervention Study): multicentre
    randomized controlled trial comparing intervention at a low versus high
    ventriculomegaly threshold in preterm infants with post-haemorrhagic
    ventricular dilatation, reported here at 2 years. Registered on a WHO ICTRP
    primary registry (ISRCTN) rather than ClinicalTrials.gov.
  target_phenotypes:
  - preferred_term: Ventriculomegaly
    term:
      id: HP:0002119
      label: Ventriculomegaly
  evidence:
  - reference: ICTRP:ISRCTN43171322
    reference_title: "A multicentre randomised controlled trial of low versus high threshold treatment in preterm infants with progressive posthaemorrhagic ventricular dilatation"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| Register | ISRCTN |"
    explanation: >-
      WHO ICTRP registration record establishing the trial's identity on a
      non-ClinicalTrials.gov primary registry.
discussions:
- discussion_id: gap_cilia_hypothesis_human_translatability
  prompt: >-
    Does ependymal motile cilia dysfunction cause human congenital
    hydrocephalus, or is the mouse ciliopathy phenotype a species-specific
    result that does not translate to the human fetal brain?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Ependymal Motile Cilia Beat Dysfunction and Loss of Directional CSF Flow
  - pathophysiology#Neuroepithelial Planar Polarity and Apical Constriction Failure
  rationale: >-
    This is a HUMAN_MODEL_MISMATCH rather than a KNOWLEDGE_GAP: the evidence
    exists and is strong, but it is murine, and its translational validity is
    precisely what is disputed. Three mismatches apply. Human ventriculomegaly
    typically arises in utero, before ependymal cilia have functionally matured,
    so cilia cannot be the primary propeller of CSF at the time the phenotype
    begins. Human motile ciliopathies — primary ciliary dyskinesia —
    infrequently cause hydrocephalus, in contrast to the mouse models on which
    the hypothesis was built. And ciliary genes have functions in signalling and
    neural stem cell fate beyond generating flow, so a hydrocephalus phenotype
    in a ciliary-gene mutant may report altered neurodevelopment rather than
    lost flow — which would move the finding onto the dysgenesis hypothesis arm
    of this entry rather than the CSF-dynamics arm. Curators should not upgrade
    the module-conformance link at these nodes into a claim that cilia-driven
    flow determines human fetal ventricular volume.
  evidence:
  - reference: PMID:36341771
    reference_title: "Rethinking the cilia hypothesis of hydrocephalus."
    supports: REFUTE
    evidence_source: OTHER
    snippet: >-
      Second, we highlight that in contrast to mouse models, motile ciliopathies
      infrequently cause hydrocephalus in humans.
    explanation: >-
      The core mismatch: the human phenotype does not follow the mouse
      phenotype, which is what makes this a translational-validity question
      rather than an evidence gap.
  - reference: PMID:36341771
    reference_title: "Rethinking the cilia hypothesis of hydrocephalus."
    supports: REFUTE
    evidence_source: OTHER
    snippet: >-
      First, we discuss neuroembryology and physiology data that do not support
      a role for ependymal cilia as the primary propeller of CSF movement across
      the ventricles in the human brain, particularly during in utero
      development prior to the functional maturation of ependymal cilia.
    explanation: >-
      The developmental-timing argument: the cilia are not yet functional when
      human congenital ventriculomegaly begins.
  - reference: PMID:36341771
    reference_title: "Rethinking the cilia hypothesis of hydrocephalus."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Finally, we postulate that certain cases of hydrocephalus associated with
      ciliary gene mutations may arise not necessarily just from loss of
      cilia-generated CSF flow but also from altered neurodevelopment, given the
      potential functions of ciliary genes in signaling and neural stem cell
      fate beyond generating fluid flow.
    explanation: >-
      Proposes the reassignment of ciliary-gene hydrocephalus to the
      neurodevelopmental arm, which is why this discussion is attached to the
      ciliary nodes rather than resolved against them.
  proposed_experiments:
  - experiment_id: exp_ch_cilia_human_fetal_flow_timing
    name: Timing of ependymal ciliary maturation relative to onset of ventriculomegaly in human fetal brain
    description: >-
      In human fetal brain across the gestational window in which
      ventriculomegaly is first detectable by ultrasound (14-20 weeks), stage
      ependymal multiciliation and ciliary beat competence against the timing of
      ventricular enlargement in the same specimens, and compare cases carrying
      ciliary-gene variants against cases carrying neural-stem-cell-fate gene
      variants. The discriminating prediction is that ventricular enlargement
      preceding functional ciliary maturation cannot be caused by lost
      cilia-generated flow.
  - experiment_id: exp_ch_pcd_cohort_ventricular_volume
    name: Systematic ventricular volumetry in a genotyped primary ciliary dyskinesia cohort
    description: >-
      Measure ventricular volume systematically, rather than by clinical
      referral, in a genotyped primary ciliary dyskinesia cohort stratified by
      the affected axonemal component, to establish whether subclinical
      ventriculomegaly is common in human motile ciliopathy and merely
      under-ascertained, or genuinely rare as the clinical literature implies.
- discussion_id: gap_csf_absorption_glymphatic_role_in_hydrocephalus
  prompt: >-
    Do disturbances of perivascular (glymphatic) and cranial-nerve-sheath
    lymphatic CSF efflux contribute causally to human congenital hydrocephalus,
    or is impaired absorption in this disease adequately described by failure at
    the arachnoid granulations?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Impaired CSF Absorption and Perivascular Clearance
  rationale: >-
    This is a KNOWLEDGE_GAP, not a HUMAN_MODEL_MISMATCH: the human evidence is
    absent rather than contradicted by a model. Up to a third of CSF is known to
    leave the skull along cranial nerve sheaths into the lymphatic system, and
    paravascular CSF-parenchyma exchange is established physiology, but the
    source literature states plainly that whether disturbances of that efflux
    route participate in the pathogenesis of human hydrocephalus is not known.
    This entry therefore declines to declare conformance to the glymphatic
    module at all: conformance is a structural assertion tooling reads as
    satisfied, and the anatomical route is established while its causal role in
    human hydrocephalus is not. The module's own unresolved
    convective-versus-diffusive controversy is a second reason to withhold the
    link rather than a caveat attached to a declared one. This discussion is the
    artifact that records the relationship instead. Resolving this matters practically: if
    the lymphatic and perivascular routes are causal contributors, communicating
    congenital hydrocephalus acquires a therapeutic target that CSF diversion
    does not address.
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      but whether they play a role in the pathogenesis of human hydrocephalus is
      not yet known
    explanation: >-
      The explicit statement of the gap, made by the review that introduces the
      lymphatic efflux route into the hydrocephalus literature.
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Altered pulsatility of CSF flow has repeatedly been described in
      conjunction with human hydrocephalus
    explanation: >-
      Records the human observation adjacent to this gap. The source's own
      caveat is quoted separately in the next evidence item rather than
      paraphrased here.
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      but whether it is cause or consequence remains unclear
    explanation: >-
      The source's cause-versus-consequence caveat on that observation, quoted
      as its own item because the inline numeric citation marker between the two
      clauses cannot be carried in a single verbatim snippet.
  proposed_experiments:
  - experiment_id: exp_ch_perivascular_efflux_infant_tracer
    name: Non-invasive assessment of perivascular and lymphatic CSF efflux in infant hydrocephalus
    description: >-
      In infants with communicating congenital hydrocephalus versus
      age-matched controls, assess perivascular and cranial-nerve-sheath
      lymphatic efflux with non-invasive imaging (intrathecal-contrast-free MRI
      surrogates plus cervical lymphatic imaging), acquired before and after CSF
      diversion. Measuring both before and after diversion is what separates a
      causal absorption deficit from a consequence of the distended ventricle —
      the cause-versus-consequence ambiguity the source review flags for CSF
      pulsatility.
- discussion_id: gap_csf_hypersecretion_human_translatability
  prompt: >-
    Does inflammation-driven choroid plexus CSF hypersecretion occur in human
    post-haemorrhagic hydrocephalus, or is the TLR4-SPAK-NKCC1 axis a rodent
    finding whose magnitude and therapeutic relevance in the preterm human
    infant are unmeasured?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Choroid Plexus CSF Hypersecretion
  - pathophysiology#Intraventricular Haemorrhage and Choroid Plexus Inflammatory Activation
  rationale: >-
    This is a HUMAN_MODEL_MISMATCH for the same reason as the cilia discussion:
    the evidence is strong and mechanistically complete — including
    loss-of-function rescue — but it is entirely rat. No human measurement of
    post-haemorrhagic CSF secretion rate is curated here. The mismatch matters
    because this node carries the entry's only pharmacological target: if human
    post-haemorrhagic hydrocephalus is dominated by impaired absorption rather
    than by hypersecretion, then bumetanide or SPAK inhibition would be treating
    a mechanism that is not rate-limiting in patients, and the observed benefit
    of choroid plexus cauterization would need a different explanation. The
    entry states the rodent provenance in the node description rather than
    letting the SPAK-NKCC1 chain read as established human physiology.
  evidence:
  - reference: PMID:28692063
    reference_title: "Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      PHH is classically attributed to primary impairments in CSF reabsorption,
      but little experimental evidence supports this concept. In contrast, the
      potential contribution of CSF secretion to PHH has received little
      attention.
    explanation: >-
      The authors' own framing: neither the classical absorption account nor the
      secretion account rests on human experimental evidence, which is precisely
      the open question recorded here.
  proposed_experiments:
  - experiment_id: exp_ch_human_phh_csf_secretion_rate
    name: Direct measurement of CSF secretion rate in preterm infants with post-haemorrhagic ventricular dilatation
    description: >-
      In preterm infants already undergoing CSF drainage for post-haemorrhagic
      ventricular dilatation, measure CSF production rate directly from drainage
      volumes under controlled pressure, comparing infants with recent
      intraventricular haemorrhage against infants drained for non-haemorrhagic
      indications. Pair with choroid plexus inflammatory markers and
      phospho-NKCC1 in the drained CSF. The discriminating prediction is that
      the haemorrhagic group shows a raised production rate; if production is
      equal and only clearance differs, the rodent axis does not carry to
      humans.
- discussion_id: gap_ch_dysgenesis_versus_dynamics_case_assignment
  prompt: >-
    For an individual infant with congenital hydrocephalus, what evidence
    assigns the case to the CSF-dynamics model versus the neural stem cell
    dysgenesis model, and does that assignment predict the neurodevelopmental
    benefit of CSF diversion?
  kind: OPEN_QUESTION
  status: OPEN
  attaches_to:
  - pathophysiology#Progressive Ventricular Dilatation and Raised Intracranial Pressure
  - pathophysiology#Impaired Fetal Neuro-Gliogenesis and Brain Dysgenesis
  rationale: >-
    The two mechanistic hypotheses curated in this entry are not merely
    theoretical alternatives — they predict different things about what
    shunting can achieve, and the persistence of ventriculomegaly and poor
    neurodevelopmental outcome in some post-surgical patients is the clinical
    observation that motivated the dysgenesis model. What is missing is a
    prospective test: whether genotype (a burdened neural-stem-cell-fate gene
    versus an obstructive or haemorrhagic aetiology) predicts the
    neurodevelopmental response to CSF diversion. Until that exists, curators
    should not collapse the two hypothesis groups, and should not present
    genotype as a treatment-selection criterion.
  evidence:
  - reference: PMID:33077954
    reference_title: "Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The poor neurodevelopmental outcomes and persistence of ventriculomegaly
      in some post-surgical patients highlight our limited knowledge of disease
      mechanisms.
    explanation: >-
      States the unexplained clinical observation that this open question is
      asking to resolve.
  proposed_experiments:
  - experiment_id: exp_ch_genotype_stratified_shunt_outcome
    name: Genotype-stratified prospective cohort of neurodevelopmental outcome after CSF diversion
    description: >-
      Enrol infants undergoing first CSF diversion for congenital hydrocephalus
      with trio exome or genome sequencing at baseline, and follow standardized
      neurodevelopmental outcome to at least 24 months. Pre-specify the
      comparison of patients carrying damaging variants in
      neural-stem-cell-fate genes against those with obstructive, haemorrhagic
      or infectious aetiology. The dysgenesis model predicts that pressure
      relief is achieved in both groups while neurodevelopmental trajectory
      improves only in the second.
diagnosis:
- name: L1CAM Molecular Genetic Testing
  description: >-
    Hemizygous pathogenic L1CAM variant identified by molecular genetic testing
    in a male proband with suggestive findings establishes the diagnosis of L1
    syndrome. Diagnosis in a female is unusual but possible. Testing should be
    strongly considered in every male with unexplained hydrocephalus and is
    regarded as mandatory where there is a positive family history or adducted
    thumbs — but note that no single finding or combination of findings
    confirms or excludes the diagnosis clinically, which is what makes the
    molecular test decisive rather than confirmatory.
  presence: Positive in affected males with L1 syndrome
  evidence:
  - reference: PMID:20301657
    reference_title: "L1 Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The diagnosis of L1 syndrome is established in a male proband with
      suggestive findings and a hemizygous pathogenic variant in L1CAM
      identified by molecular genetic testing.
    explanation: >-
      GeneReviews diagnostic criterion for the HSAS subtype, quoted from the
      DIAGNOSIS/TESTING section.
  - reference: PMID:20301657
    reference_title: "L1 Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The diagnosis of L1 syndrome in a female is unusual but not impossible
      (most likely in the setting of general delay and/or hydrocephalus) and is
      established with the identification of a heterozygous pathogenic variant
      in L1CAM by molecular genetic testing.
    explanation: >-
      Recorded as PARTIAL because it bounds the male-proband criterion: female
      diagnosis is possible, so an X-linked pattern should not be used to
      exclude testing in a female with hydrocephalus and developmental delay.
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Therefore, L1CAM testing should be strongly considered in all males with
      unexplained hydrocephalus, but should be regarded as mandatory for those
      with a family history or adducted thumbs.
    explanation: >-
      States the testing indication curated in this diagnosis entry.
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      no single finding or combination of findings can confirm or exclude the
      diagnosis
    explanation: >-
      Recorded as PARTIAL because it limits the value of the clinical findings
      and is the reason the molecular test carries the diagnosis.
- name: Neuroimaging Assessment for Basal Ganglia Iron or Calcium Deposition
  description: >-
    In a male with intellectual disability and hydrocephalus, head CT or
    iron/calcium-sensitive MRI sequences (GRE, SWI) should be used to look for
    basal ganglia deposition, which points to AP1S2-related Fried/Pettigrew
    syndrome rather than L1 syndrome. Both iron and calcium may be subtle or
    invisible on standard MRI sequences, so a negative routine MRI does not
    exclude it.
  presence: Positive in AP1S2-related disease
  evidence:
  - reference: PMID:24932902
    reference_title: "Infantile hydrocephalus: a review of epidemiology, classification and causes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We recommend considering AP1S2 testing in males with intellectual
      disability and imaging abnormalities that suggest deposition of iron or
      calcium with the basal ganglia.
    explanation: >-
      States the imaging-triggered testing recommendation curated here.
  - reference: PMID:34092257
    reference_title: "Neuropathological hallmarks of fetal hydrocephalus linked to CCDC88C pathogenic variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Pathogenic AP1S2 variants have been linked to Pettigrew syndrome
      characterized by intellectual disability with prominent basal ganglia iron
      deposition or calcification and variable severity of hydrocephalus.
    explanation: >-
      Independent statement of the imaging finding that discriminates
      AP1S2-related disease within the congenital hydrocephalus differential.
- name: Neurologic Surveillance After Diagnosis
  description: >-
    Ongoing neurologic evaluation at regular intervals to monitor hydrocephalus,
    developmental progress and spastic paraplegia. Curated as a diagnostic
    activity rather than a treatment because it is a monitoring protocol, not
    an intervention that acts on a mechanism node.
  evidence:
  - reference: PMID:20301657
    reference_title: "L1 Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Surveillance: Neurologic evaluation at regular intervals to monitor
      hydrocephalus, developmental progress, and spastic paraplegia.
    explanation: >-
      GeneReviews surveillance recommendation, quoted from the MANAGEMENT
      section.
datasets:
- accession: geo:GSE133063
  title: A Novel Silent Mutation in the L1CAM Gene causing Fetal Hydrocephalus
  description: >-
    Human fetal case with an L1CAM variant causing hydrocephalus. Triaged as
    directly relevant: the disease and the causal gene both match the HSAS
    subtype curated in this entry, rather than merely sharing a gene symbol.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  sample_count: 1
  publication: PMID:31572438
  notes: >-
    Discovered with just discover-datasets (DIRECT, gene:L1CAM match) and
    resolved with just verify-datasets. Relevance triaged manually per
    CLAUDE.md: verification proves existence, not aboutness. No evidence block —
    bulk-discovered dataset records carry provenance notes rather than
    manufactured quotes.
- accession: geo:GSE121867
  title: RNA Sequencing of CSF Samples from Patients with Intraventricular Hemorrhage and Neural Tube Defects
  description: >-
    CSF transcriptomes from human patients with intraventricular haemorrhage and
    with neural tube defects — the two acquired/malformation routes curated as
    the post-haemorrhagic and Chiari II-associated subtypes here.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  data_type: BULK_RNA_SEQ
  sample_count: 70
  publication: PMID:30951672
  notes: >-
    Discovered with just discover-datasets (DIRECT) and resolved with just
    verify-datasets. Relevance triaged manually: both patient groups map onto
    curated subtypes of this entry.
- accession: geo:GSE272062
  title: Lysophosphatidic acid (LPA)-dependent propagation of neuroinflammation in an optimized model of post-hemorrhagic hydrocephalus
  description: >-
    Single-cell transcriptomics in a mouse model of post-haemorrhagic
    hydrocephalus, relevant to the intraventricular-haemorrhage and choroid
    plexus inflammatory nodes of this entry.
  organism:
    preferred_term: house mouse
    term:
      id: NCBITaxon:10090
      label: Mus musculus
  data_type: SINGLE_CELL_RNA_SEQ
  sample_count: 6
  publication: PMID:40971013
  notes: >-
    Discovered with just discover-datasets (DIRECT) and resolved with just
    verify-datasets. Model-organism dataset; relevance triaged manually against
    the post-haemorrhagic subtype.
- accession: geo:GSE189420
  title: TRIM71R595H/R595H mutations and TRIM71-KO in mESC lead to similar transcriptomic changes
  description: >-
    Transcriptomic consequences of TRIM71 hypomorphic and null alleles in mouse
    embryonic stem cells. TRIM71 is one of the neural-stem-cell-fate genes
    curated on the dysgenesis hypothesis arm of this entry.
  organism:
    preferred_term: house mouse
    term:
      id: NCBITaxon:10090
      label: Mus musculus
  data_type: BULK_RNA_SEQ
  sample_count: 20
  genes:
  - preferred_term: TRIM71
    term:
      id: hgnc:32669
      label: TRIM71
  publication: PMID:35379995
  notes: >-
    Discovered with just discover-datasets (DIRECT, name match) and resolved
    with just verify-datasets. Relevance triaged manually: TRIM71 is curated in
    this entry's genetic section, so this is a gene-and-mechanism match rather
    than a gene-symbol-only hit.
animal_models:
- name: Rat post-haemorrhagic hydrocephalus (intraventricular haemorrhage model)
  species: Rat
  genotype: Wild type with induced intraventricular haemorrhage; TLR4-null and SPAK-null comparators
  category: INDUCED
  description: >-
    Induced intraventricular haemorrhage in the rat, used to dissect the
    inflammatory route from blood in the ventricle to CSF hypersecretion.
    Genetic depletion of TLR4 or SPAK normalizes secretion and reduces symptoms,
    which is what makes the axis necessary rather than merely correlated.
  publication: PMID:28692063
  modeled_mechanisms:
  - target: Choroid Plexus CSF Hypersecretion
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: >-
      Reproduces the post-haemorrhagic secretory phenotype and supplies the
      loss-of-function rescue that establishes SPAK-NKCC1 as necessary for it.
    limitations: >-
      The entire chain is rodent. No human measurement of post-haemorrhagic CSF
      hypersecretion is curated in this entry, and rat ventricular anatomy,
      CSF turnover rate and the timing of germinal matrix haemorrhage differ
      from the preterm human infant in whom the clinical syndrome occurs.
    readouts:
    - name: Bumetanide-sensitive CSF secretion rate
      target: Choroid Plexus CSF Hypersecretion
      direction: INCREASED
      interpretation: >-
        Approximately three-fold rise in CSF secretion after intraventricular
        haemorrhage, sensitive to NKCC1 blockade.
      evidence:
      - reference: PMID:28692063
        reference_title: "Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          In a rat model of PHH, we demonstrate that IVH causes a Toll-like
          receptor 4 (TLR4)- and NF-κB-dependent inflammatory response in the
          CPE that is associated with a ∼3-fold increase in bumetanide-sensitive
          CSF secretion.
        explanation: >-
          Reports the measurement and its magnitude directly.
    evidence:
    - reference: PMID:28692063
      reference_title: "Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Genetic depletion of TLR4 or SPAK normalizes hyperactive CSF secretion
        rates and reduces PHH symptoms
      explanation: >-
        The rescue result that makes this model informative for the
        hypersecretion node rather than merely descriptive of it.
- name: Dishevelled compound-mutant mouse (ependymal planar polarity)
  species: Mouse
  genotype: hGFAP-Cre;Dvl1(-/-);Dvl2(flox/flox);Dvl3(+/-)
  category: GENETICALLY_ENGINEERED
  description: >-
    Compound conditional ablation of the three Dishevelled genes in the
    ependymal lineage. The informative feature is what is spared: ependymal
    cells differentiate normally and cilia are assembled, so the phenotype
    isolates loss of ciliary planar alignment from loss of cilia themselves.
  publication: PMID:25043421
  modeled_mechanisms:
  - target: Ependymal Motile Cilia Beat Dysfunction and Loss of Directional CSF Flow
    relationship: RECAPITULATES
    fidelity: LOW
    description: >-
      Reproduces loss of intracellular and intercellular rotational alignment of
      ependymal motile cilia, with measurably slower generated flow and
      consequent hydrocephalus.
    limitations: >-
      Fidelity is recorded as LOW deliberately, not because the mouse experiment
      is weak but because its translational validity to human congenital
      hydrocephalus is contested: human ventriculomegaly typically begins in
      utero before ependymal cilia functionally mature, and human motile
      ciliopathies infrequently cause hydrocephalus. See the
      gap_cilia_hypothesis_human_translatability discussion.
    readouts:
    - name: Ependymal-generated cerebrospinal fluid flow velocity
      target: Ependymal Motile Cilia Beat Dysfunction and Loss of Directional CSF Flow
      direction: DECREASED
      interpretation: >-
        Flow generated by mutant ependymal cells is significantly slower than
        control, linking the alignment defect to a transport deficit.
      evidence:
      - reference: PMID:25043421
        reference_title: "Loss of Dishevelleds disrupts planar polarity in ependymal motile cilia and results in hydrocephalus."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          As a consequence, the fluid flow generated by the
          hGFAP-Cre;Dvl1(-/-);2(flox/flox);3(+/-) E cells was significantly
          slower than that observed in control mice.
        explanation: >-
          Reports the flow measurement that grounds this readout.
    evidence:
    - reference: PMID:25043421
      reference_title: "Loss of Dishevelleds disrupts planar polarity in ependymal motile cilia and results in hydrocephalus."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        In hGFAP-Cre;Dvl1(-/-);2(flox/flox);3(+/-) mutants, E cells
        differentiated normally, but the intracellular and intercellular
        rotational alignments of ependymal motile cilia were disrupted.
      explanation: >-
        Establishes that the model isolates ciliary alignment from ependymal
        differentiation, which is what makes it informative for this node
        specifically.
notes: >-
  Scope boundaries for future curators. (1) Spina bifida cystica /
  myelomeningocele is a separate disease entity (issue #8965) and is NOT yet
  curated in kb/disorders/. The Chiari II-associated subtype here deliberately
  covers only the hydrocephalus that complicates it. When that entry is created
  it should be linked from this subtype rather than merged into it. (2) The two mechanistic hypotheses
  are deliberately not blended — see the OPEN_QUESTION discussion. (3)
  Conformance is declared to ciliopathy_dysfunction only, at two nodes, with
  attached discussions bounding what those links assert; they should not be read
  as importing settled human mechanism. Conformance to glymphatic_dysfunction is
  deliberately NOT declared, and the CSF-clearance node states the reason in
  full: the source literature says plainly that whether disturbances of the
  lymphatic exit pathway contribute to human hydrocephalus is not known, and the
  module itself carries an unresolved convective-versus-diffusive controversy.
  The relationship is recorded in prose rather than as a structural assertion
  tooling would read as satisfied. (4) The
  alpha-dystroglycanopathies (POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, ISPD)
  and syndromic forms with more than 100 associated genes are out of scope for
  this entry's subtype axis, which is restricted to forms in which
  hydrocephalus is the isolated or major clinical feature plus the four
  acquired/malformation routes named in the curation issue.

📚

References & Deep Research

References

1

PMID:20301657

L1 Syndrome.

No top-level findings curated for this source.

Deep Research

1

Falcon ▸

Congenital Hydrocephalus: Disease Characteristics Research Report

Edison Scientific Literature 33 citations 2026-08-20T07:29:12.966846

Congenital Hydrocephalus: Disease Characteristics Research Report

Executive summary

Congenital hydrocephalus (CH) is a heterogeneous developmental disorder in which impaired cerebrospinal-fluid (CSF) production–flow–absorption homeostasis causes prenatal or neonatal ventricular enlargement, often with raised intracranial pressure and secondary injury to the developing brain. It is not a single molecular disease: causes include monogenic and chromosomal disorders, aqueductal or hindbrain malformations, neural-tube defects, hemorrhage, and congenital infection. A useful current model therefore combines developmental brain dysgenesis with the traditional CSF-dynamics disorder concept. A 2024 review states that CH “results from an imbalance in production, flow, or absorption of cerebrospinal fluid.” (aragon2024geneticetiologiesand pages 1-2)

The most defensible aggregate identifier is MONDO:0016349. The strongest established monogenic associations are L1CAM and AP1S2 (X-linked) and MPDZ and CCDC88C (autosomal recessive), while newer human evidence supports a broader architecture including SMARCC1, TRIM71, WDR81, FOXJ1, PTCH1, LDB1, CLASP1, DNMBP, and FSD1L. Genetic factors may contribute to as many as 40% of cases, although older stringent estimates assigned a specific molecular diagnosis to fewer than 5%, reflecting case selection and rapidly changing sequencing knowledge rather than a contradiction. (OpenTargets Search: congenital hydrocephalus, liu2024congenitalhydrocephalusa pages 3-5, liu2024congenitalhydrocephalusa pages 1-3)

Definitive treatment remains surgical—usually ventriculoperitoneal shunting or, in selected infants, endoscopic third ventriculostomy with choroid-plexus cauterization (ETV/CPC). These procedures control CSF and intracranial pressure but generally do not reverse the initiating developmental defect. No disease-modifying drug, gene therapy, or RNA therapy is approved for CH. (aragon2024geneticetiologiesand pages 1-2, warf2023endoscopicthirdventriculostomy pages 1-2)

1. Disease information

Definition and scope

CH denotes hydrocephalus beginning prenatally or present at birth/early infancy. Excess ventricular CSF produces ventriculomegaly; if pressure rises, surrounding white matter and cortex are stretched or compressed, cerebral perfusion may fall, and progressive neurological injury can follow. “Congenital ventriculomegaly” is related but not fully synonymous: ventriculomegaly is an imaging phenotype and may be mild, stable, or non-hypertensive, whereas hydrocephalus implies pathological CSF dynamics and usually progressive ventricular distension or clinical consequences. (aragon2024geneticetiologiesand pages 1-2, zhang2024areviewof pages 1-2, isaacs2018agespecificglobalepidemiology pages 2-4)

Identifiers and synonyms

MONDO: MONDO:0016349, congenital hydrocephalus. Subtypes include MONDO:0010611, X-linked hydrocephalus with stenosis of the aqueduct of Sylvius; MONDO:0014085, nonsyndromic autosomal-recessive hydrocephalus 2; MONDO:0017116, congenital communicating hydrocephalus; and MONDO:0054794, congenital hydrocephalus 3 with brain anomalies. (OpenTargets Search: congenital hydrocephalus)
MeSH: Hydrocephalus, D006849; congenital forms are generally indexed with congenital-abnormality qualifiers rather than a uniquely specific MeSH disease record. (NCT06664372 chunk 1)
ICD-10-CM: Q03.-, congenital hydrocephalus; Q03.0 malformations of aqueduct of Sylvius, Q03.1 atresia of foramina of Magendie and Luschka, Q03.8 other congenital hydrocephalus, Q03.9 unspecified.
ICD-11: congenital hydrocephalus is represented among structural developmental anomalies of the nervous system; the exact extension code should be validated against the current national ICD-11 implementation.
OMIM: best represented by etiologic subtypes rather than one universal record—classically L1CAM-related X-linked hydrocephalus/HSAS, MPDZ-related nonsyndromic hydrocephalus, CCDC88C-related hydrocephalus, and WDR81-related congenital hydrocephalus with brain anomalies.
Synonyms: congenital/infantile hydrocephalus, hydrocephalus present at birth, congenital communicating or obstructive hydrocephalus, and—less precisely—congenital ventriculomegaly. “Aqueductal stenosis” is a mechanism/subtype, not a synonym for all CH.

This report synthesizes aggregated disease-level resources, systematic reviews, cohorts, trials, and model studies. It does not use individual EHR-level patient data.

2. Etiology

Causal factors

Genetic/developmental: pathogenic variation affecting neuronal adhesion and axon development (L1CAM), vesicle trafficking (AP1S2), epithelial polarity and junctions (MPDZ), Wnt/ciliary orientation (CCDC88C), chromatin regulation and neural progenitors (SMARCC1), RNA regulation/neurogenesis (TRIM71), ciliogenesis (FOXJ1), and broader cortical or hindbrain development. (deng2025geneticandmolecular pages 15-15, liu2024congenitalhydrocephalusa pages 3-5, deng2025geneticandmolecular pages 4-5)
Structural: cerebral-aqueduct stenosis, fourth-ventricular outlet obstruction, Dandy–Walker spectrum, Chiari II/myelomeningocele, craniosynostosis, intracranial cysts, and tumors. Aqueductal stenosis accounts for much nonsyndromic obstructive CH. (zhang2024areviewof pages 1-2, liu2024congenitalhydrocephalusa pages 3-5)
Hemorrhagic: fetal or neonatal intraventricular hemorrhage can obstruct CSF pathways and impair absorption; in preterm infants, posthemorrhagic hydrocephalus is especially important but is not always classified as strictly congenital. (newland2024understandingandmodeling pages 2-4, warf2023endoscopicthirdventriculostomy pages 1-2)
Infectious: congenital infections and neonatal meningitis can produce inflammation, ependymal injury, fibrosis, and obstruction. Globally, infection is a major pediatric cause, especially in resource-limited settings. (newland2024understandingandmodeling pages 2-4, dewan2019globalhydrocephalusepidemiology pages 1-2)
CSF-secretory/transport defects: altered choroid-plexus NKCC1 and other ion transporters can increase or dysregulate CSF secretion; pure CSF overproduction is less common than obstruction or developmental dysgenesis. (zhang2024areviewof pages 1-2, deng2025geneticandmolecular pages 5-6, liu2024congenitalhydrocephalusa pages 1-3)

Risk factors

Genetic risks include a pathogenic family variant, affected male relatives in L1CAM/AP1S2 families, parental consanguinity for recessive disease, and parental germline mosaicism or a de novo dominant variant. The recurrence risk is therefore cause-specific: approximately 50% of sons of a heterozygous mother may inherit an X-linked variant; recessive carrier couples have a 25% affected-pregnancy risk; and a proven de novo variant usually carries low—but non-zero—recurrence risk because of germline mosaicism.

Environmental/obstetric risks supported at the hydrocephalus or associated-malformation level include maternal/fetal infection, prematurity and intraventricular hemorrhage, neural-tube defects, poorly controlled pregestational diabetes, obesity, teratogenic exposures, and inadequate folate for neural-tube-defect-associated cases. These factors should not be interpreted as explaining most isolated CH. The higher burden in low- and middle-income countries reflects more neural-tube defects and postinfectious disease, high birth rates, and reduced access to prenatal and neurosurgical care. (dewan2019globalhydrocephalusepidemiology pages 1-2)

Protective factors and gene–environment interaction

There is no validated protective human allele for CH. Prevention is largely cause-specific: periconceptional folic acid prevents many neural-tube defects and thereby some secondary Chiari II/myelomeningocele-associated hydrocephalus; vaccination and infection prevention reduce congenital and neonatal infectious causes; optimized maternal diabetes control reduces congenital-malformation risk; and safe obstetric/neonatal care reduces prematurity-associated hemorrhage. Population surveillance, however, did not find folate-fortification status significantly associated with hydrocephalus incidence as a whole, emphasizing that folate is not a general CH preventive therapy. (isaacs2018agespecificglobalepidemiology pages 1-2)

Proposed gene–environment mechanisms include folate-dependent methylation interacting with developmental susceptibility, and inflammatory injury interacting with ciliary/ependymal reserve. These remain incompletely established in humans; most mechanistic evidence comes from animal studies. (deng2025geneticandmolecular pages 5-6)

3. Phenotypes

The phenotype is highly variable by etiology, timing, pressure, associated malformations, and access to treatment.

Ventriculomegaly/hydrocephalus (HP:0002119/HP:0000238): prenatal or neonatal; mild to severe; stable in some mild ventriculomegaly but generally progressive when active hydrocephalus is untreated.
Macrocephaly and accelerated head growth (HP:0000256), widened sutures and bulging fontanelle (HP:0000239): typical infant signs because the skull remains compliant.
Raised intracranial pressure (HP:0002516): irritability, poor feeding, vomiting, sleepiness, “sun-setting” eyes, apnea or bradycardia, and progressive neurological decline. Severity can fluctuate with shunt function.
Aqueductal stenosis (HP:0002625): common obstructive imaging phenotype, particularly in L1CAM-related disease.
Corpus-callosum dysgenesis (HP:0001273), cortical malformation, enlarged ventricles, reduced white matter, or hindbrain malformation: congenital and usually stable structural abnormalities, although their functional consequences evolve with development.
Developmental delay (HP:0001263), intellectual disability (HP:0001249), speech/language impairment, and learning disability: variable, often lifelong; major determinants of education, independence, and caregiver burden.
Motor impairment: hypotonia or spasticity (HP:0001257), abnormal gait (HP:0001288), poor coordination, and cerebral-palsy-like disability.
Seizures (HP:0001250), visual dysfunction and endocrine/hypothalamic sequelae occur in subsets, driven more by associated brain injury or malformation than ventricular size alone.

Pediatric morbidity documented across studies includes seizures, developmental delay, psychomotor impairment, and gait difficulty. Frequencies cannot be assigned reliably across “CH” because cohorts differ sharply in cause and severity; phenotype frequencies should be stored by molecular or structural subtype whenever possible. Untreated disease can progress to severe disability or death, whereas early successful pressure control may stabilize or improve pressure-related manifestations. (isaacs2018agespecificglobalepidemiology pages 9-13, isaacs2018agespecificglobalepidemiology pages 2-4)

Quality-of-life effects include repeated emergency assessments and operations, cognitive and motor disability, school limitations, caregiver stress, and substantial cost. U.S. pediatric inpatient hydrocephalus care has been estimated at about $2 billion annually. No single CH-specific QoL instrument is universally accepted; Hydrocephalus Outcome Questionnaire, PedsQL, PROMIS pediatric domains, caregiver-burden measures, and functional/developmental testing are more informative than ventricular size alone. (isaacs2018agespecificglobalepidemiology pages 9-13)

4. Genetic and molecular information

Established and emerging genes

The conservative established set comprises L1CAM, AP1S2, MPDZ, and CCDC88C. Recent disease-resource evidence also strongly associates WDR81, SMARCC1, TRIM71, and additional candidates. L1CAM variants may explain approximately 5–15% of CH, especially males with aqueductal stenosis and L1-spectrum findings. (OpenTargets Search: congenital hydrocephalus, liu2024congenitalhydrocephalusa pages 3-5)

L1CAM: X-linked; missense, nonsense, frameshift, splice and deletion variants. Loss of neuronal cell-adhesion signaling disrupts axon guidance, corticospinal-tract and callosal development; severe loss-of-function variants often produce hydrocephalus, adducted thumbs, spasticity and intellectual disability.
AP1S2: X-linked loss-of-function; abnormal adaptor-protein-mediated vesicle trafficking; syndromic intellectual disability with hydrocephalus in some individuals.
MPDZ: autosomal recessive, generally biallelic loss-of-function; disrupts apical junctions/polarity in neuroepithelium and ependyma, causing communicating or obstructive hydrocephalus.
CCDC88C: autosomal recessive; biallelic variants perturb Wnt signaling and ciliary orientation/CSF flow.
WDR81: recessive; congenital hydrocephalus with brain anomalies and variable cerebellar/neurodevelopmental disease.
SMARCC1: dominant/de novo and familial variants with incomplete penetrance; altered BAF/SWI–SNF chromatin remodeling in neural progenitors and ependymal development.
TRIM71: predominantly dominant/de novo human evidence; perturbs RNA regulation and neural-progenitor fate.
FOXJ1: heterozygous loss-of-function can impair multiciliated ependymal differentiation and produce communicating hydrocephalus, sometimes with motile-ciliopathy features.
Other phenotype-dependent genes include PTCH1, SHH, CRB2, EML1, PIK3CA, PTEN, MTOR, FMN2, FXYD2, ZEB1, SBF2, GNAI2, CC2D2A, DNAH5, IFT172, and VANGL2. Many cause broader syndromes in which hydrocephalus is one feature. (liu2024congenitalhydrocephalusa pages 15-16, liu2024congenitalhydrocephalusa pages 3-5, liu2024congenitalhydrocephalusa pages 5-6)

Open Targets’ current CH association set contains 11 targets, led by L1CAM, MPDZ, WDR81, CCDC88C, SMARCC1 and TRIM71; this is useful for prioritization but is not equivalent to a clinically curated definitive-gene list. (OpenTargets Search: congenital hydrocephalus)

Variant interpretation

Most causal variants are germline. Somatic mosaic activating variants in PI3K–AKT–mTOR pathway genes may cause segmental brain overgrowth with ventriculomegaly/hydrocephalus. Variant classes include loss-of-function, deleterious missense, splice-altering variants, exon/gene deletions, copy-number variants and chromosomal rearrangements. Population frequency should be checked in ancestry-matched gnomAD data; a credible severe dominant or X-linked variant is normally absent or extremely rare, while recessive carrier alleles can be present at low frequency. Exact frequency and ACMG classification must be recorded per variant and transcript—there is no disease-wide allele frequency.

VUSs must not be used alone for prenatal prognosis, pregnancy decisions, or cascade testing. Segregation, phenotype concordance, ClinVar/ClinGen evidence, RNA studies, and functional assays should be pursued. Penetrance is gene- and variant-specific; incomplete penetrance is particularly documented for SMARCC1. Expressivity is often broad. Anticipation is not characteristic. Germline mosaicism is relevant after apparently de novo disease. Consanguinity increases recessive disease yield; no universal carrier frequency or single founder variant applies globally. (deng2025geneticandmolecular pages 15-15, liu2024congenitalhydrocephalusa pages 15-16)

Chromosomal and epigenetic abnormalities

Aneuploidies, pathogenic CNVs and rearrangements may present with ventriculomegaly plus multiple anomalies, justifying chromosomal microarray as a first-line prenatal test. Epigenetic evidence is strongest for altered chromatin regulation through SMARCC1 and experimental folate/methylation effects; a reproducible CH-specific methylation signature suitable for clinical diagnosis has not been established. (liu2024congenitalhydrocephalusa pages 15-16, deng2025geneticandmolecular pages 5-6)

5. Environmental information

Relevant non-genetic contributors are fetal/neonatal hemorrhage, intrauterine or neonatal infection, neural-tube defects, teratogenic medication/exposure, and structural obstruction. Smoking, alcohol, pollution, occupational exposure and radiation are not established specific causes of isolated CH, although they may increase general adverse-pregnancy or malformation risk. Evidence should therefore be annotated as associated, not causal, unless a specific fetal infection, hemorrhage, or teratogenic syndrome is demonstrated.

Potential infectious agents include cytomegalovirus, toxoplasma, rubella and other congenital infections, and neonatal bacterial meningitis. Mechanistically, infection causes ependymal/choroid-plexus inflammation, debris and fibrosis, impaired absorption, or aqueductal obstruction. The resulting condition may be congenital or early acquired depending on timing.

6. Mechanism and pathophysiology

Integrated causal chain

Upstream developmental trigger—pathogenic variant, malformation, hemorrhage, or infection—can cause one or more of the following:

Ciliogenesis/motility failure: FOXJ1, DNAH5, WDR16/WDR78 and related defects impair coordinated beating of ependymal multicilia → abnormal local CSF movement and altered ventricular-wall signaling → ventricular enlargement. Suggested GO: cilium movement (GO:0003341), cilium assembly, CSF circulation. (liu2024congenitalhydrocephalusa pages 3-5, liu2024congenitalhydrocephalusa pages 5-6, liu2024congenitalhydrocephalusa pages 1-3)
Neuroepithelial junction/polarity failure: MPDZ, CCDC88C, NAPA and related defects disrupt adherens/tight junctions and planar polarity → ventricular-zone denudation, abnormal aqueduct development or closure → obstructed flow. Suggested GO: cell–cell junction organization (GO:0045216), epithelial cell polarity, vesicle-mediated transport. (liu2024congenitalhydrocephalusa pages 6-8, deng2025geneticandmolecular pages 4-5)
Disordered neurogenesis/chromatin/RNA regulation: SMARCC1, TRIM71, PTCH1/SHH, PTEN–PI3K–mTOR and other pathways alter neural-progenitor proliferation, differentiation and brain architecture → dysplastic cortex, aqueduct or posterior fossa plus secondary CSF obstruction. Suggested GO: neurogenesis (GO:0022008), neural precursor proliferation, chromatin remodeling.
Choroid-plexus transport dysregulation: altered NKCC1, Na+/K+-ATPase, bicarbonate/chloride transport, TRPV4 or SGK1 signaling → excessive or mistimed ion/water secretion → increased ventricular CSF load. The choroid plexus produces an estimated 80–90% of CSF. Suggested GO: ion transport (GO:0006811), transepithelial transport and water homeostasis. (deng2025geneticandmolecular pages 5-6, liu2024congenitalhydrocephalusa pages 1-3)
Subcommissural organ–Reissner fiber abnormalities: defective SCO-spondin/Reissner-fiber formation alters aqueduct patency and CSF protein homeostasis; evidence is strongest in zebrafish and rodents. (liu2024congenitalhydrocephalusa pages 6-8, deng2025geneticandmolecular pages 5-6)
Inflammation/hemorrhage: blood products or pathogens activate macrophages/microglia, NF-κB, cytokine, TGF-β and related pathways → ependymal/ciliary injury, fibrosis and impaired CSF absorption/flow. Suggested GO: inflammatory response (GO:0006954), glial activation, response to oxidative stress. (deng2025geneticandmolecular pages 15-15)

The common downstream chain is ventricular CSF accumulation → ventricular wall stretch and raised pressure → reduced cerebral perfusion and white-matter compression → axonal/myelin injury, gliosis, inflammation and sometimes apoptosis → motor, cognitive, visual and seizure phenotypes. (zhang2024areviewof pages 1-2, deng2025geneticandmolecular pages 4-5, NCT06693752 chunk 1)

Principal cell types are multiciliated ependymal cells, choroid-plexus epithelial cells, radial glia/neural stem and progenitor cells, neurons, oligodendrocyte-lineage cells, astrocytes, microglia/macrophages and vascular endothelium. Relevant subcellular structures include motile cilia/axoneme, basal bodies, apical junction complexes, endosomes/lysosomes, nucleus/chromatin and ion-transporter-rich apical membranes.

Molecular profiling and advanced technology

Human CH-specific single-cell, spatial transcriptomic, proteomic, metabolomic and lipidomic reference datasets remain sparse. Rat expression studies report altered Cck, Nfix, Lgals3, Gsta1, Xdh, reduced Ptpn20, and elevated phosphorylated NKCC1, but these are model-derived biomarkers, not validated clinical diagnostics. (deng2025geneticandmolecular pages 4-5, deng2025geneticandmolecular pages 5-6)

Current functional genomics relies heavily on CRISPR/knockout mice and zebrafish, morpholino knockdown, fetal/neonatal MRI, CSF proteomics, and patient-specific sequencing. Organoids and iPSC-derived neuroepithelial/choroid-plexus systems are promising for variant testing and drug screening, but no organoid assay is standard of care.

7. Anatomical structures affected

The primary organ is the central nervous system, especially the ventricular system, cerebral aqueduct, foramina/outlets of the fourth ventricle, subarachnoid spaces and CSF-absorption pathways. Directly affected tissues include ependyma, choroid plexus, periventricular white matter, germinal matrix/ventricular zone, cortex, corpus callosum, optic pathways and, in syndromic disease, cerebellum and brainstem. Disease is typically bilateral/central rather than lateralized; asymmetry may occur with a focal obstruction or unilateral ventriculomegaly.

Suggested UBERON concepts are brain ventricular system, lateral/third/fourth ventricle, cerebral aqueduct, choroid plexus, ependyma, cerebral cortex, corpus callosum, cerebellum and subarachnoid space. Secondary extracranial involvement is syndrome-specific—for example kidney cysts in ciliopathies, skeletal/limb findings in L1 syndrome or neural-tube defects, and craniofacial abnormalities in craniosynostosis. (newland2024understandingandmodeling pages 2-4, liu2024congenitalhydrocephalusa pages 1-3)

The following curation table consolidates phenotype, anatomy, cell, mechanism, gene and intervention annotations.

domain	key item	suggested ontology term/identifier	evidence/interpretation
disease	Congenital hydrocephalus	MONDO:0016349	Congenital/pediatric hydrocephalus entity used in Open Targets; defined as abnormal CSF accumulation beginning prenatally or at birth, with major genetic and structural heterogeneity (OpenTargets Search: congenital hydrocephalus, aragon2024geneticetiologiesand pages 1-2, zhang2024areviewof pages 1-2, liu2024congenitalhydrocephalusa pages 1-3)
phenotype	Hydrocephalus	HPO: HP:0000238	Core phenotype; excess CSF with ventricular enlargement and potential elevated intracranial pressure (aragon2024geneticetiologiesand pages 1-2, zhang2024areviewof pages 1-2)
phenotype	Ventriculomegaly	HPO: HP:0002119	Common imaging phenotype in fetal/neonatal diagnosis; often detected prenatally by ultrasound/MRI (aragon2024geneticetiologiesand pages 1-2, zhang2024areviewof pages 1-2)
phenotype	Macrocephaly	HPO: HP:0000256	Common clinical manifestation in infant hydrocephalus; head circumference monitoring is standard clinical follow-up (NCT06310213 chunk 1)
phenotype	Bulging fontanelle	HPO: HP:0000239	Practical bedside sign of raised intracranial pressure in infants; relevant to hydrocephalus monitoring (NCT06310213 chunk 1)
phenotype	Increased intracranial pressure	HPO: HP:0002516	Downstream physiologic consequence of ventricular enlargement; a major treatment target and monitoring endpoint (zhang2024areviewof pages 1-2, NCT06693752 chunk 1, NCT06693752 chunk 2)
phenotype	Aqueductal stenosis	HPO: HP:0002625	Major obstructive mechanism; especially associated with L1CAM-related/X-linked forms and non-syndromic CH (liu2024congenitalhydrocephalusa pages 3-5, deng2025geneticandmolecular pages 4-5)
phenotype	Developmental delay	HPO: HP:0001263	Frequent long-term neurodevelopmental outcome in pediatric hydrocephalus cohorts (isaacs2018agespecificglobalepidemiology pages 9-13)
phenotype	Intellectual disability	HPO: HP:0001249	Reported in monogenic forms including L1 syndrome; severity variable (newland2024understandingandmodeling pages 2-4, deng2025geneticandmolecular pages 4-5)
phenotype	Seizures	HPO: HP:0001250	Important neurologic comorbidity/morbidity in pediatric hydrocephalus (isaacs2018agespecificglobalepidemiology pages 9-13)
phenotype	Spasticity / gait abnormality	HPO: HP:0001257; HP:0001288	Motor impairment and gait difficulty are recognized morbidity features in affected children (isaacs2018agespecificglobalepidemiology pages 9-13)
phenotype	Corpus callosum abnormalities	HPO: HP:0001273	Corpus callosum malformations are prominent in some genetic cases, particularly L1CAM-related disease (newland2024understandingandmodeling pages 2-4)
anatomy	Brain ventricular system	UBERON: brain ventricular system (verify exact ID in target ontology)	Primary anatomic compartment enlarged in disease (zhang2024areviewof pages 1-2)
anatomy	Lateral ventricle	UBERON: lateral ventricle (verify exact ID in target ontology)	Frequently measured on prenatal/postnatal imaging and targeted in shunt catheter placement (zhang2024areviewof pages 1-2, NCT06664372 chunk 1)
anatomy	Third ventricle	UBERON: third ventricle (verify exact ID in target ontology)	Relevant to obstructive hydrocephalus and ETV procedure (zhang2024areviewof pages 1-2, warf2023endoscopicthirdventriculostomy pages 1-2)
anatomy	Fourth ventricle	UBERON: fourth ventricle (verify exact ID in target ontology)	Included in ventricular system anatomy affected by CSF flow abnormalities (zhang2024areviewof pages 1-2)
anatomy	Cerebral aqueduct	UBERON: cerebral aqueduct (verify exact ID in target ontology)	Critical site for aqueductal stenosis/obstruction (liu2024congenitalhydrocephalusa pages 3-5, deng2025geneticandmolecular pages 4-5)
anatomy	Choroid plexus	UBERON: choroid plexus (verify exact ID in target ontology)	Major CSF-producing tissue; implicated in secretion, barrier, and surgical cauterization strategies (liu2024congenitalhydrocephalusa pages 1-3, NCT06693752 chunk 1, NCT06664372 chunk 1)
anatomy	Ependyma	UBERON: ependyma (verify exact ID in target ontology)	Ventricular lining central to ciliary motility and barrier/junction defects (zhang2024areviewof pages 1-2, liu2024congenitalhydrocephalusa pages 3-5)
anatomy	Cerebral cortex	UBERON: cerebral cortex (verify exact ID in target ontology)	Affected secondarily by compression and developmentally in some genetic forms (zhang2024areviewof pages 1-2, liu2024congenitalhydrocephalusa pages 6-8)
anatomy	Corpus callosum	UBERON: corpus callosum (verify exact ID in target ontology)	Malformation documented in monogenic disease presentations (newland2024understandingandmodeling pages 2-4)
cell type	Ependymal cell	CL: ependymal cell (verify exact ID in target ontology)	Key motile-cilia-bearing cell type regulating CSF movement; repeatedly implicated in CH (zhang2024areviewof pages 1-2, liu2024congenitalhydrocephalusa pages 3-5, liu2024congenitalhydrocephalusa pages 5-6)
cell type	Choroid plexus epithelial cell	CL: choroid plexus epithelial cell (verify exact ID in target ontology)	Core CSF-secretory/barrier cell; transporter dysregulation implicated mechanistically (zhang2024areviewof pages 1-2, deng2025geneticandmolecular pages 5-6, NCT06693752 chunk 1)
cell type	Neural stem/progenitor cell	CL: neural stem cell / neural progenitor cell (verify exact ID in target ontology)	Junctional and neurogenic defects in ventricular zone progenitors linked to aqueductal and cortical abnormalities (liu2024congenitalhydrocephalusa pages 6-8, liu2024congenitalhydrocephalusa pages 3-5)
cell type	Neuron	CL: neuron (verify exact ID in target ontology)	Downstream injury/developmental disruption contributes to cognitive and motor phenotypes (newland2024understandingandmodeling pages 2-4, liu2024congenitalhydrocephalusa pages 6-8)
cell type	Astrocyte	CL: astrocyte (verify exact ID in target ontology)	Glial activation reported in animal mechanistic cascades downstream of obstruction (deng2025geneticandmolecular pages 4-5)
cell type	Microglia	CL: microglial cell (verify exact ID in target ontology)	Inflammatory signaling is increasingly implicated in hydrocephalus pathobiology (deng2025geneticandmolecular pages 15-15)
mechanism	Cilium movement	GO:0003341	Strongest recurring upstream mechanism; motile cilia defects impair CSF propulsion (liu2024congenitalhydrocephalusa pages 3-5, liu2024congenitalhydrocephalusa pages 5-6, liu2024congenitalhydrocephalusa pages 1-3)
mechanism	CSF circulation	GO: cerebrospinal fluid circulation (verify exact ID in target ontology)	Central disease process linking cilia, obstruction, and transporter dysfunction to ventricular dilation (zhang2024areviewof pages 1-2, liu2024congenitalhydrocephalusa pages 1-3)
mechanism	Ion transport	GO:0006811	Choroid plexus ion transporters regulate CSF secretion; NKCC-related dysregulation highlighted in models (zhang2024areviewof pages 1-2, deng2025geneticandmolecular pages 5-6, liu2024congenitalhydrocephalusa pages 1-3)
mechanism	Cell-cell junction organization	GO:0045216	Apical/junctional defects in ventricular zone and ependyma contribute to aqueductal stenosis and barrier dysfunction (liu2024congenitalhydrocephalusa pages 6-8, liu2024congenitalhydrocephalusa pages 3-5)
mechanism	Neurogenesis	GO:0022008	Developmental pathway implicated through TRIM71, SMARCC1 and other neurodevelopmental genes (liu2024congenitalhydrocephalusa pages 6-8, liu2024congenitalhydrocephalusa pages 3-5)
mechanism	Inflammatory response	GO:0006954	Neuroinflammatory signaling is a recognized contributor/modifier in hydrocephalus biology (deng2025geneticandmolecular pages 15-15)
mechanism	Apoptosis	GO:0006915	Included among proposed molecular pathways contributing to tissue injury and ventricular pathology (liu2024congenitalhydrocephalusa pages 1-3)
gene / inheritance	L1CAM	HGNC: L1CAM; X-linked inheritance	Established CH gene; classic X-linked aqueductal stenosis/L1 syndrome; accounts for a notable fraction of congenital cases (liu2024congenitalhydrocephalusa pages 3-5, deng2025geneticandmolecular pages 4-5, OpenTargets Search: congenital hydrocephalus)
gene / inheritance	AP1S2	HGNC: AP1S2; X-linked inheritance	Established X-linked CH-associated gene with vesicle trafficking role (liu2024congenitalhydrocephalusa pages 3-5, deng2025geneticandmolecular pages 4-5, liu2024congenitalhydrocephalusa pages 1-3)
gene / inheritance	MPDZ	HGNC: MPDZ; autosomal recessive inheritance	Established recessive CH gene; linked to planar polarity/junctional integrity and aqueduct/ependymal pathology (liu2024congenitalhydrocephalusa pages 3-5, deng2025geneticandmolecular pages 4-5, OpenTargets Search: congenital hydrocephalus)
gene / inheritance	CCDC88C	HGNC: CCDC88C; autosomal recessive inheritance	Established recessive CH gene; associated with cilia orientation/CSF flow abnormalities (liu2024congenitalhydrocephalusa pages 3-5, deng2025geneticandmolecular pages 4-5, OpenTargets Search: congenital hydrocephalus)
gene / inheritance	FOXJ1	HGNC: FOXJ1; expanded evidence / candidate dominant mechanism	Strong mechanistic/candidate evidence for communicating hydrocephalus through impaired ependymal differentiation/ciliogenesis (liu2024congenitalhydrocephalusa pages 3-5, deng2025geneticandmolecular pages 15-15)
gene / inheritance	SMARCC1	HGNC: SMARCC1; expanded evidence / autosomal dominant with incomplete penetrance reported	Increasing evidence linking chromatin remodeling and neural progenitor defects to CH (liu2024congenitalhydrocephalusa pages 15-16, liu2024congenitalhydrocephalusa pages 3-5, deng2025geneticandmolecular pages 15-15)
gene / inheritance	TRIM71	HGNC: TRIM71; expanded evidence / candidate	Neurodevelopmental candidate implicated in communicating CH and neural progenitor biology (liu2024congenitalhydrocephalusa pages 3-5, OpenTargets Search: congenital hydrocephalus)
intervention	Ventriculoperitoneal shunt	NCIT-style: Ventriculoperitoneal Shunt Procedure (verify in NCIT)	Global standard surgical treatment; failure/revision remains common (aragon2024geneticetiologiesand pages 1-2, navaei2018controlledtrialto pages 1-2, NCT06664372 chunk 1)
intervention	Endoscopic third ventriculostomy	NCIT-style: Endoscopic Third Ventriculostomy (verify in NCIT)	Standard option for selected obstructive cases; can avoid shunt dependence in some infants (zhang2024areviewof pages 1-2, warf2023endoscopicthirdventriculostomy pages 1-2, navaei2018controlledtrialto pages 1-2)
intervention	Choroid plexus cauterization	NCIT-style: Choroid Plexus Cauterization (verify in NCIT)	Used with ETV in infant hydrocephalus; long-term shunt freedom reported in selected cohorts (warf2023endoscopicthirdventriculostomy pages 1-2, navaei2018controlledtrialto pages 1-2)
intervention	Physical therapy	NCIT-style: Physical Therapy (verify in NCIT)	Supportive rehabilitation for motor impairment/spasticity/gait dysfunction; ontology-ready supportive care term (isaacs2018agespecificglobalepidemiology pages 9-13)
intervention	Occupational therapy	NCIT-style: Occupational Therapy (verify in NCIT)	Supportive rehabilitation for developmental and functional deficits; commonly relevant in pediatric neurodisability (isaacs2018agespecificglobalepidemiology pages 9-13)
intervention	Speech therapy	NCIT-style: Speech Therapy (verify in NCIT)	Supportive rehabilitation for neurodevelopmental sequelae when language/communication are affected (isaacs2018agespecificglobalepidemiology pages 9-13)

Table: This compact ontology-ready table maps congenital hydrocephalus to suggested disease, phenotype, anatomy, cell type, mechanism, gene, and intervention terms. It is designed to support knowledge-base curation while flagging ontology IDs that should be verified in the target terminology.

8. Temporal development

Onset is prenatal or neonatal. Ventriculomegaly may be detected at the second-trimester anatomy scan and characterized further by serial ultrasound and fetal MRI. Course ranges from stable mild isolated ventriculomegaly to rapidly progressive macrocephaly and neurological decompensation.

A practical chronology is: prenatal ventricular enlargement → neonatal monitoring for head growth and pressure signs → temporizing CSF drainage when needed → definitive diversion → lifelong surveillance for developmental sequelae and treatment failure. There is no formal stage system. “Compensated/arrested” hydrocephalus can remain clinically stable, but shunt-dependent disease is chronic and lifelong. Apparent remission usually reflects successful diversion or stable compensation, not elimination of the developmental cause.

Fetal and early postnatal brain development constitute the critical vulnerability window: prolonged pressure and white-matter distortion may cause irreversible injury, while overly early ETV/CPC is less successful because infant CSF absorption pathways are immature. In a 2023 cohort, corrected age below 2.5 months predicted reoperation or conversion to shunting. (warf2023endoscopicthirdventriculostomy pages 1-2)

9. Inheritance and population

Epidemiology

A 78-study global meta-analysis found congenital-hydrocephalus incidences of 145/100,000 births in Africa, 316/100,000 in Latin America, and 68/100,000 in the United States/Canada. Incidence was 123/100,000 (95% CI 98–152) in low-/middle-income countries versus 79/100,000 (95% CI 68–90) in high-income countries. Nearly 400,000 new pediatric hydrocephalus cases were projected annually, with three quarters in Africa, Latin America and Southeast Asia. (dewan2019globalhydrocephalusepidemiology pages 1-2)

A separate 52-study meta-analysis covering 171,558,651 people estimated pediatric prevalence at 88/100,000 (95% CI 72–107) and birth-diagnosed incidence at 81/100,000 (95% CI 69–96). Isolated congenital hydrocephalus incidence was estimated at 49.5/100,000, rising to 81.2/100,000 when spina-bifida-associated cases were included. (isaacs2018agespecificglobalepidemiology pages 9-13, isaacs2018agespecificglobalepidemiology pages 1-2)

These estimates are more reliable than the broader “approximately 1 in 500 births” figure quoted in a 2024 molecular review, because definitions, ascertainment and inclusion of acquired pediatric disease vary. (liu2024congenitalhydrocephalusa pages 1-3)

Population genetics

Inheritance may be X-linked, autosomal recessive, autosomal dominant/de novo, mosaic, chromosomal, or multifactorial. Male excess is expected in L1CAM/AP1S2 disease and was present in one infant trial (66% male), but there is no universal sex ratio for all CH. (navaei2018controlledtrialto pages 1-2)

No robust evidence supports anticipation. Penetrance and expressivity are variant-specific; SMARCC1 can show incomplete penetrance, whereas severe biallelic loss-of-function disorders are often highly penetrant. Founder effects and carrier frequencies exist for individual variants/populations but cannot be generalized. Consanguinity increases homozygous recessive disease and should prompt trio exome/genome analysis plus homozygosity-aware interpretation.

10. Diagnostics

Clinical and imaging diagnosis

Prenatal ultrasound is first-line: atrial width, ventricular progression, head size, neural-tube defect, posterior fossa and other anomalies are assessed. Fetal MRI better defines aqueduct, corpus callosum, cortical development, hemorrhage and associated malformations. After birth, serial head circumference, fontanelle tension, eye findings, feeding, alertness and neurodevelopment are integrated with transfontanelle ultrasound; MRI is preferred for anatomy and CSF-flow assessment, while CT is reserved for urgent situations where speed outweighs ionizing-radiation risk. (zhang2024areviewof pages 1-2, NCT06310213 chunk 1)

There is no diagnostic blood, urine, enzyme or CSF biomarker specific for CH. ICP measurement, shunt tap/EVD data, ophthalmic examination and CSF studies are used selectively. EEG is indicated for suspected seizures, not routine diagnosis. Biopsy is not generally appropriate.

Genetic testing strategy

Detailed prenatal/postnatal phenotype and three-generation pedigree.
Chromosomal microarray after structural anomalies/ventriculomegaly; karyotype when aneuploidy or balanced rearrangement is suspected.
Targeted testing for a recognizable subtype—for example L1CAM sequencing plus deletion/duplication analysis in an affected male with aqueductal stenosis/adducted thumbs.
A hydrocephalus/brain-malformation panel or preferably trio WES/WGS when CMA is nondiagnostic. WGS offers more complete structural, intronic, repeat and mosaic-variant detection; WES remains widely available and useful.
Reanalysis as gene–disease knowledge evolves; parental segregation and recurrence-risk counseling.

A small fetal-CNS-anomaly series reported prenatal exome diagnostic yield of 53% (10/19) and clinical impact in 63%, illustrating utility but not a CH-specific expected yield. A 2024 scoping review emphasized causes from secondary insults to germline pathogenic variants and the need to combine molecular testing with phenotype. (aragon2024geneticetiologiesand pages 1-2)

RNA sequencing may resolve splice variants, but appropriate fetal/brain tissue is rarely available. Proteomics, metabolomics, methylation testing, liquid biopsy, mitochondrial testing and repeat-expansion assays are not routine unless another syndrome is suspected.

Differential diagnosis and screening

Differentiate active hydrocephalus from ex-vacuo ventriculomegaly due to tissue loss, benign enlargement of subarachnoid spaces, isolated stable mild ventriculomegaly, hydranencephaly, porencephaly, intracranial cysts, megalencephaly, and acquired posthemorrhagic/postinfectious hydrocephalus. No universal newborn biochemical screen exists. Prenatal ultrasound is the principal population screen; carrier, cascade, prenatal and preimplantation testing are appropriate after identification of a familial pathogenic variant.

11. Outcome and prognosis

Outcome depends more on etiology, associated brain malformations/injury, infection, prematurity, treatment timing and complications than on ventricular size alone. Untreated-hydrocephalus mortality has been reported across a very wide 20–87% range, reflecting heterogeneous settings and historical cohorts; this should not be used as an individualized estimate. (isaacs2018agespecificglobalepidemiology pages 9-13)

Long-term morbidity includes intellectual/developmental disability, epilepsy, cerebral palsy/spasticity, visual impairment, endocrine dysfunction, chronic headache and repeated operations. A trial registry summarizes long-term disability in up to 78%, but this is background rather than a peer-reviewed subtype-specific estimate. (NCT06693752 chunk 1)

Major complications are shunt obstruction, infection, disconnection, migration, overdrainage/subdural collection and underdrainage; ETV can close, especially early after treatment. Prognostic indicators include severe associated malformation, infection, prematurity/hemorrhage, very young age at ETV/CPC, prior CSF diversion, severe preoperative ventriculomegaly and intraoperative bleeding. In the 2023 infant cohort, FOHR >0.613 predicted conversion after ETV/CPC. (warf2023endoscopicthirdventriculostomy pages 1-2)

There is no validated molecular prognostic biomarker applicable across CH. Genotype improves counseling—for example severe L1CAM loss-of-function disease generally carries greater neurodevelopmental risk—but within-gene variability remains substantial.

12. Treatment

Standard surgical treatment

Ventriculoperitoneal shunt (VPS): most widely used treatment; diverts ventricular CSF to the peritoneum. Suggested NCIT term: Ventriculoperitoneal Shunt Procedure. It is effective but creates lifelong device dependence and revision risk. A current congenital trial cites revision in 30–40% of cases. (NCT06664372 chunk 1)
ETV: fenestrates the third-ventricular floor to bypass obstruction; most appropriate for selected obstructive anatomy.
ETV/CPC: adds cauterization to reduce CSF production and can avoid a permanent shunt in selected infants. In 348 infants, estimated long-term shunt freedom was 59% through 11 years; approximately 80% of children treated at ≥2.5 months avoided a shunt, whereas only 26.9% of those <2.5 months with prior diversion remained shunt-free. (warf2023endoscopicthirdventriculostomy pages 1-2)
In a randomized trial of 49 infants with obstructive hydrocephalus, 36-month success was 88.5% for VPS and 68.2% for ETV/CPC, without a statistically significant difference. (navaei2018controlledtrialto pages 1-2)
Temporary measures: ventricular reservoir taps, ventriculosubgaleal shunt, external ventricular drainage or serial lumbar puncture in selected premature/posthemorrhagic infants.

Antibiotic-impregnated catheters and standardized infection-prevention bundles reduce shunt infection in pediatric practice. Acute shunt malfunction or infection is a neurosurgical emergency.

Pharmacological, advanced and supportive therapy

No drug reliably eliminates hydrocephalus or replaces diversion. Acetazolamide, furosemide and osmotic agents are not definitive chronic therapy and can cause electrolyte, renal and systemic toxicity. Antiseizure medication, analgesia and antibiotics treat complications rather than CH itself. No established CH pharmacogenomic guideline exists.

Preclinical targets include NKCC1, TRPV4, SGK1, inflammatory pathways, aquaporins and PI3K–AKT–mTOR signaling, but none is approved as disease-modifying CH therapy. Gene replacement, CRISPR, ASO, siRNA, stem-cell and immunotherapy approaches remain experimental/preclinical.

Physical, occupational, speech/feeding, vision and educational therapies should begin early and be individualized. Management commonly requires neurosurgery, neurology, developmental pediatrics, rehabilitation, ophthalmology, genetics and social support.

Emerging applications and trials

NCT06310213, first posted 15 March 2024: modified smart soft contact lens for non-invasive ICP monitoring; enrolling by invitation, 25 infants, with comparison against clinical assessment, EVD readings and pre/post-shunt measurements. It is an unapproved investigational device. (NCT06310213 chunk 1)
NCT06664372, first posted 29 October 2024: transfontanelle ultrasound-guided frontal VPS catheter placement in 30 children, intended to reduce proximal obstruction; listed as not yet recruiting in the retrieved record. (NCT06664372 chunk 1)
NCT06693752, first posted 18 November 2024: Phase 2 pilot of Lumason contrast-enhanced brain ultrasound, 20 infants, assessing safety, perfusion and correlation with ICP/ischemia; the retrieved record lists recruitment beginning in 2026. (NCT06693752 chunk 1, NCT06693752 chunk 2)

These trials improve diagnosis or surgical precision; none tests a curative molecular therapy.

13. Prevention

Primary prevention: periconceptional folic acid and food fortification for neural-tube-defect prevention; rubella and other recommended maternal vaccination before pregnancy; avoidance of teratogens; infection prevention and prompt maternal treatment; optimized diabetes and nutritional care; and prevention of prematurity where possible. These measures prevent only attributable subsets, not most monogenic CH.

Secondary prevention: prenatal ultrasound/MRI, diagnostic CMA/WES/WGS, serial monitoring of fetal ventricles and infant head growth, and rapid referral to fetal medicine, genetics and pediatric neurosurgery. Fetal closure of myelomeningocele can reduce subsequent hindbrain herniation and shunt requirement in appropriately selected pregnancies, but fetal ventricular shunting for isolated hydrocephalus remains investigational/high risk.

Tertiary prevention: reliable follow-up, caregiver education about malfunction/infection, infection-prevention bundles, accurate catheter placement, developmental surveillance, seizure/vision management, and early rehabilitation.

For a known pathogenic variant, genetic counseling should address inheritance, penetrance, germline mosaicism, carrier/cascade testing, chorionic-villus or amniotic-fluid diagnosis, and PGT-M. Population-wide carrier screening is not currently justified because of extreme locus heterogeneity.

14. Other species and natural disease

Naturally occurring internal hydrocephalus occurs in mammals and birds. In dogs (Canis lupus familiaris, NCBI Taxon 9615), it is a common brain malformation, especially in toy and brachycephalic breeds such as Chihuahua; restricted cranial capacity and craniovertebral/Chiari-like abnormalities can impair CSF flow. VPS is used clinically in selected dogs. In cats (Felis catus, Taxon 9685), congenital hydrocephalus is uncommon, with a suspected recessive form in Siamese cats. Ruminant congenital hydrocephalus is often caused by teratogenic viruses; avian and large-felid acquired disease can accompany vitamin-A deficiency. These conditions are non-zoonotic. (schmidt2019hydrocephalusinanimals pages 2-4)

A naturally occurring autosomal-recessive syndrome in mixed-breed Oriental cats is caused by homozygous GDF7 c.221_227delGCCGCGC (p.Arg74Profs). It produces ventriculomegaly, interhemispheric cysts, commissural malformation, hippocampal hypoplasia and mild ataxia. The variant segregated in 43 genotyped cats and was absent from 192 unaffected cats, supporting breeder testing and comparative developmental biology. (yu2020adeletionin pages 1-3)

Veterinary disease is valuable because it occurs in a naturally sized, genetically diverse brain, but heterogeneous husbandry, limited pathology, cost-dependent ascertainment and species-specific skull anatomy constrain translation.

15. Model organisms

Mouse (Mus musculus; Taxon 10090): L1cam, Foxj1, Smarcc1, Ccdc39, Ccdc88c, Mpdz, Napa/hyh, Hydin/hy3, Rnd3, Msx1 and other knockout/knock-in models reproduce ventriculomegaly, aqueductal obstruction, ciliary defects, ependymal denudation or neurodevelopmental abnormalities. The hyh Napa model is recessive and highly penetrant; aqueduct obstruction is evident by postnatal day 1 with later myelin degeneration and glial activation. (deng2025geneticandmolecular pages 4-5, newland2024understandingandmodeling pages 7-8)
Rat (Rattus norvegicus; Taxon 10116): H-Tx models aqueductal stenosis; Wpk/Tmem67−/− models communicating hydrocephalus plus polycystic kidneys and dies at 18–21 days; LEW/Jms shows neonatal, male-biased inherited hydrocephalus. Rat size facilitates shunts, imaging, ICP monitoring and pharmacology. (newland2024understandingandmodeling pages 7-8)
Zebrafish (Danio rerio; Taxon 7955): transparent embryos and rapid CRISPR/morpholino studies permit live analysis and chemical screening. Models involving wdr16, nphp7, l1camb, ccdc88c, Reissner-fiber genes and ion transport reproduce ventricular dilation or ciliary-flow abnormalities. Limitations include substantial differences in ventricular anatomy, CSF physiology and duplicated genes. (liu2024congenitalhydrocephalusa pages 6-8, deng2025geneticandmolecular pages 5-6, liu2024congenitalhydrocephalusa pages 5-6)
Induced models: kaolin creates inflammatory obstructive hydrocephalus; intraventricular blood models posthemorrhagic disease; 6-aminonicotinamide produces Dandy–Walker-like cerebellar hypoplasia and ventriculomegaly within 72 hours. These are useful for downstream pressure/inflammation and device studies but do not model a congenital human genotype. (newland2024understandingandmodeling pages 5-7)
Cellular systems: primary choroid-plexus epithelial cultures, ependymal differentiation cultures, organoids and iPSC-derived neuroepithelia support transporter, barrier, ciliary and variant-functional studies. They lack whole-brain pressure, absorption and biomechanical interactions.

A recurrent expert conclusion is that no single model captures CH’s genetic, developmental, biomechanical and inflammatory dimensions; replication across human genetics, cell systems and at least two vertebrate models is preferable before therapeutic translation. (liu2024congenitalhydrocephalusa pages 5-6, newland2024understandingandmodeling pages 16-17)

Evidence interpretation and knowledge gaps

The strongest evidence comprises global epidemiological meta-analyses, human gene–disease associations, molecularly diagnosed families and infant surgical cohorts. Mechanistic detail is disproportionately model-derived. Current priorities are large ancestry-diverse trio-WGS cohorts, standardized prenatal/postnatal phenotyping, long-read and mosaic-variant detection, human single-cell/spatial atlases of ventricular interfaces, validated pressure/perfusion biomarkers, and trials that measure neurodevelopment rather than ventricular size alone.

Important negative findings for database curation are: no universal biochemical biomarker; no established protective allele; no approved pharmacologic, gene, RNA or cell therapy; no single penetrance, carrier-frequency or sex-ratio estimate; no disease-wide molecular prognosis; and no evidence that folate prevents isolated monogenic hydrocephalus. The 2024 literature’s most important conceptual advance is the shift from treating CH solely as “plumbing failure” toward a developmental disorder involving neural progenitors, ependyma, cilia, choroid plexus and brain–CSF interfaces. (aragon2024geneticetiologiesand pages 1-2, liu2024congenitalhydrocephalusa pages 3-5, liu2024congenitalhydrocephalusa pages 1-3)

References

(aragon2024geneticetiologiesand pages 1-2): Caroline Aragón, D'aviyan Robinson, Megan Kocher, Katie Barrick, Lihsia Chen, and Heather Zierhut. Genetic etiologies and diagnostic methods for congenital ventriculomegaly and hydrocephalus: a scoping review. Birth Defects Research, Dec 2024. URL: https://doi.org/10.1002/bdr2.2287, doi:10.1002/bdr2.2287. This article has 4 citations and is from a peer-reviewed journal.
(OpenTargets Search: congenital hydrocephalus): Open Targets Query (congenital hydrocephalus, 16 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(liu2024congenitalhydrocephalusa pages 3-5): Xiu-Yun Liu, Xin Song, Marek Czosnyka, Chiara Robba, Zofia Czosnyka, Jennifer Lee Summers, Hui-Jie Yu, Guo-Yi Gao, Peter Smielewski, Fang Guo, Mei-Jun Pang, and Dong Ming. Congenital hydrocephalus: a review of recent advances in genetic etiology and molecular mechanisms. Military Medical Research, Aug 2024. URL: https://doi.org/10.1186/s40779-024-00560-5, doi:10.1186/s40779-024-00560-5. This article has 19 citations and is from a peer-reviewed journal.
(liu2024congenitalhydrocephalusa pages 1-3): Xiu-Yun Liu, Xin Song, Marek Czosnyka, Chiara Robba, Zofia Czosnyka, Jennifer Lee Summers, Hui-Jie Yu, Guo-Yi Gao, Peter Smielewski, Fang Guo, Mei-Jun Pang, and Dong Ming. Congenital hydrocephalus: a review of recent advances in genetic etiology and molecular mechanisms. Military Medical Research, Aug 2024. URL: https://doi.org/10.1186/s40779-024-00560-5, doi:10.1186/s40779-024-00560-5. This article has 19 citations and is from a peer-reviewed journal.
(warf2023endoscopicthirdventriculostomy pages 1-2): Benjamin C. Warf, Daniel S. Weber, Emily L. Day, Coleman P. Riordan, Steven J. Staffa, Lissa C. Baird, Katie P. Fehnel, and Scellig S. D. Stone. Endoscopic third ventriculostomy with choroid plexus cauterization: predictors of long-term success and comparison with shunt placement for primary treatment of infant hydrocephalus. Journal of Neurosurgery: Pediatrics, 32:201-213, Aug 2023. URL: https://doi.org/10.3171/2023.4.peds2310, doi:10.3171/2023.4.peds2310. This article has 37 citations and is from a peer-reviewed journal.
(zhang2024areviewof pages 1-2): Mingzhao Zhang, Xiangjun Hu, and Lifeng Wang. A review of cerebrospinal fluid circulation and the pathogenesis of congenital hydrocephalus. Neurochemical Research, 49:1123-1136, Feb 2024. URL: https://doi.org/10.1007/s11064-024-04113-z, doi:10.1007/s11064-024-04113-z. This article has 23 citations and is from a peer-reviewed journal.
(isaacs2018agespecificglobalepidemiology pages 2-4): Albert M. Isaacs, Jay Riva-Cambrin, Daniel Yavin, Aaron Hockley, Tamara M. Pringsheim, Nathalie Jette, Brendan Cord Lethebe, Mark Lowerison, Jarred Dronyk, and Mark G. Hamilton. Age-specific global epidemiology of hydrocephalus: systematic review, metanalysis and global birth surveillance. PLoS ONE, 13:e0204926, Oct 2018. URL: https://doi.org/10.1371/journal.pone.0204926, doi:10.1371/journal.pone.0204926. This article has 339 citations and is from a peer-reviewed journal.
(NCT06664372 chunk 1): Omar Salah Mohamed Omran. Insertion of Frontal Ventricular Catheter of VP Shunt in Congenital Hydrocephalus Guided by Trans Fontanelle Ultrasound. Assiut University. 2024. ClinicalTrials.gov Identifier: NCT06664372
(deng2025geneticandmolecular pages 15-15): Xuehai Deng, Yiqian Chen, Qiyue Duan, Jianlin Ding, Zhong Wang, Junchi Wang, Xinlong Chen, Liangxue Zhou, and Long Zhao. Genetic and molecular mechanisms of hydrocephalus. Frontiers in Molecular Neuroscience, Jan 2025. URL: https://doi.org/10.3389/fnmol.2024.1512455, doi:10.3389/fnmol.2024.1512455. This article has 7 citations.
(deng2025geneticandmolecular pages 4-5): Xuehai Deng, Yiqian Chen, Qiyue Duan, Jianlin Ding, Zhong Wang, Junchi Wang, Xinlong Chen, Liangxue Zhou, and Long Zhao. Genetic and molecular mechanisms of hydrocephalus. Frontiers in Molecular Neuroscience, Jan 2025. URL: https://doi.org/10.3389/fnmol.2024.1512455, doi:10.3389/fnmol.2024.1512455. This article has 7 citations.
(newland2024understandingandmodeling pages 2-4): Verayna Newland, Lauren L. Jantzie, and Bonnie L. Blazer-Yost. Understanding and modeling the pathophysiology of hydrocephalus: in search of better treatment options. Physiologia, 4:182-201, Apr 2024. URL: https://doi.org/10.3390/physiologia4020010, doi:10.3390/physiologia4020010. This article has 10 citations.
(dewan2019globalhydrocephalusepidemiology pages 1-2): Michael C. Dewan, Abbas Rattani, Rania Mekary, Laurence J. Glancz, Ismaeel Yunusa, Ronnie E. Baticulon, Graham Fieggen, John C. Wellons, Kee B. Park, and Benjamin C. Warf. Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis. Journal of neurosurgery, 130:1-15, Apr 2019. URL: https://doi.org/10.3171/2017.10.jns17439, doi:10.3171/2017.10.jns17439. This article has 542 citations and is from a domain leading peer-reviewed journal.
(deng2025geneticandmolecular pages 5-6): Xuehai Deng, Yiqian Chen, Qiyue Duan, Jianlin Ding, Zhong Wang, Junchi Wang, Xinlong Chen, Liangxue Zhou, and Long Zhao. Genetic and molecular mechanisms of hydrocephalus. Frontiers in Molecular Neuroscience, Jan 2025. URL: https://doi.org/10.3389/fnmol.2024.1512455, doi:10.3389/fnmol.2024.1512455. This article has 7 citations.
(isaacs2018agespecificglobalepidemiology pages 1-2): Albert M. Isaacs, Jay Riva-Cambrin, Daniel Yavin, Aaron Hockley, Tamara M. Pringsheim, Nathalie Jette, Brendan Cord Lethebe, Mark Lowerison, Jarred Dronyk, and Mark G. Hamilton. Age-specific global epidemiology of hydrocephalus: systematic review, metanalysis and global birth surveillance. PLoS ONE, 13:e0204926, Oct 2018. URL: https://doi.org/10.1371/journal.pone.0204926, doi:10.1371/journal.pone.0204926. This article has 339 citations and is from a peer-reviewed journal.
(isaacs2018agespecificglobalepidemiology pages 9-13): Albert M. Isaacs, Jay Riva-Cambrin, Daniel Yavin, Aaron Hockley, Tamara M. Pringsheim, Nathalie Jette, Brendan Cord Lethebe, Mark Lowerison, Jarred Dronyk, and Mark G. Hamilton. Age-specific global epidemiology of hydrocephalus: systematic review, metanalysis and global birth surveillance. PLoS ONE, 13:e0204926, Oct 2018. URL: https://doi.org/10.1371/journal.pone.0204926, doi:10.1371/journal.pone.0204926. This article has 339 citations and is from a peer-reviewed journal.
(liu2024congenitalhydrocephalusa pages 15-16): Xiu-Yun Liu, Xin Song, Marek Czosnyka, Chiara Robba, Zofia Czosnyka, Jennifer Lee Summers, Hui-Jie Yu, Guo-Yi Gao, Peter Smielewski, Fang Guo, Mei-Jun Pang, and Dong Ming. Congenital hydrocephalus: a review of recent advances in genetic etiology and molecular mechanisms. Military Medical Research, Aug 2024. URL: https://doi.org/10.1186/s40779-024-00560-5, doi:10.1186/s40779-024-00560-5. This article has 19 citations and is from a peer-reviewed journal.
(liu2024congenitalhydrocephalusa pages 5-6): Xiu-Yun Liu, Xin Song, Marek Czosnyka, Chiara Robba, Zofia Czosnyka, Jennifer Lee Summers, Hui-Jie Yu, Guo-Yi Gao, Peter Smielewski, Fang Guo, Mei-Jun Pang, and Dong Ming. Congenital hydrocephalus: a review of recent advances in genetic etiology and molecular mechanisms. Military Medical Research, Aug 2024. URL: https://doi.org/10.1186/s40779-024-00560-5, doi:10.1186/s40779-024-00560-5. This article has 19 citations and is from a peer-reviewed journal.
(liu2024congenitalhydrocephalusa pages 6-8): Xiu-Yun Liu, Xin Song, Marek Czosnyka, Chiara Robba, Zofia Czosnyka, Jennifer Lee Summers, Hui-Jie Yu, Guo-Yi Gao, Peter Smielewski, Fang Guo, Mei-Jun Pang, and Dong Ming. Congenital hydrocephalus: a review of recent advances in genetic etiology and molecular mechanisms. Military Medical Research, Aug 2024. URL: https://doi.org/10.1186/s40779-024-00560-5, doi:10.1186/s40779-024-00560-5. This article has 19 citations and is from a peer-reviewed journal.
(NCT06693752 chunk 1): Misun Hwang, MD. CEUS Evaluation of Hydrocephalus in Neonates and Infants. Children's Hospital of Philadelphia. 2026. ClinicalTrials.gov Identifier: NCT06693752
(NCT06310213 chunk 1): Jignesh Tailor. Non-Invasive Pressure Monitor for Neonates & Infants at Risk of Developing Hydrocephalus. Indiana University. 2025. ClinicalTrials.gov Identifier: NCT06310213
(NCT06693752 chunk 2): Misun Hwang, MD. CEUS Evaluation of Hydrocephalus in Neonates and Infants. Children's Hospital of Philadelphia. 2026. ClinicalTrials.gov Identifier: NCT06693752
(navaei2018controlledtrialto pages 1-2): Amir Navaei, Sara Hanaei, Zohreh Habibi, Morteza Jouibari, Vahid Heidari, Soheil Naderi, and Farideh Nejat. Controlled trial to compare therapeutic efficacy of endoscopic third ventriculostomy plus choroid plexus cauterization with ventriculoperitoneal shunt in infants with obstructive hydrocephalus. Asian Journal of Neurosurgery, 13:1042-1047, Dec 2018. URL: https://doi.org/10.4103/ajns.ajns_63_17, doi:10.4103/ajns.ajns_63_17. This article has 20 citations.
(schmidt2019hydrocephalusinanimals pages 2-4): Martin Schmidt and Nele Ondreka. Hydrocephalus in animals. Pediatric Hydrocephalus, pages 53-95, Jan 2019. URL: https://doi.org/10.1007/978-3-319-27250-4_36, doi:10.1007/978-3-319-27250-4_36. This article has 59 citations.
(yu2020adeletionin pages 1-3): Yoshihiko Yu, Erica K. Creighton, Reuben M. Buckley, and Leslie A. Lyons. A deletion in gdf7 is associated with a heritable forebrain commissural malformation concurrent with ventriculomegaly and interhemispheric cysts in cats. Genes, 11:672, Jun 2020. URL: https://doi.org/10.3390/genes11060672, doi:10.3390/genes11060672. This article has 8 citations.
(newland2024understandingandmodeling pages 7-8): Verayna Newland, Lauren L. Jantzie, and Bonnie L. Blazer-Yost. Understanding and modeling the pathophysiology of hydrocephalus: in search of better treatment options. Physiologia, 4:182-201, Apr 2024. URL: https://doi.org/10.3390/physiologia4020010, doi:10.3390/physiologia4020010. This article has 10 citations.
(newland2024understandingandmodeling pages 5-7): Verayna Newland, Lauren L. Jantzie, and Bonnie L. Blazer-Yost. Understanding and modeling the pathophysiology of hydrocephalus: in search of better treatment options. Physiologia, 4:182-201, Apr 2024. URL: https://doi.org/10.3390/physiologia4020010, doi:10.3390/physiologia4020010. This article has 10 citations.
(newland2024understandingandmodeling pages 16-17): Verayna Newland, Lauren L. Jantzie, and Bonnie L. Blazer-Yost. Understanding and modeling the pathophysiology of hydrocephalus: in search of better treatment options. Physiologia, 4:182-201, Apr 2024. URL: https://doi.org/10.3390/physiologia4020010, doi:10.3390/physiologia4020010. This article has 10 citations.

Artifacts

Edison artifact artifact-00

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	11
Resolved	11
Unresolved (possible confabulation)	0
Unverifiable	0
References weighed for topical relevance	11
On topic	6
Off topic	0

All extracted references resolved successfully.

Ask OpenScientist

OpenScientist Report

Classifications

Inheritance

Subtypes

Mechanistic Hypotheses

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Environmental Factors

Diagnosis

Prevalence

Related Datasets

Clinical Trials

Animal Models

Source YAML

References & Deep Research

References

Deep Research

Congenital Hydrocephalus: Disease Characteristics Research Report

Executive summary

1. Disease information

Definition and scope

Identifiers and synonyms

2. Etiology

Causal factors

Risk factors

Protective factors and gene–environment interaction

3. Phenotypes

4. Genetic and molecular information

Established and emerging genes

Variant interpretation

Chromosomal and epigenetic abnormalities

5. Environmental information

6. Mechanism and pathophysiology

Integrated causal chain

Molecular profiling and advanced technology

7. Anatomical structures affected

8. Temporal development

9. Inheritance and population

Epidemiology

Population genetics

10. Diagnostics

Clinical and imaging diagnosis

Genetic testing strategy

Differential diagnosis and screening

11. Outcome and prognosis

12. Treatment

Standard surgical treatment

Pharmacological, advanced and supportive therapy

Emerging applications and trials

13. Prevention

14. Other species and natural disease

15. Model organisms

Evidence interpretation and knowledge gaps

Artifacts

Reference Validation